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Abstract 
Branimycin is a novel antibiotic, which belongs to a structurally new family of antibiotics: the nargenicins. It has 
demonstrated distinct antimicrobial activity, most notably against Staphylococcus aureus. Synthesis of branimycin would 
confirm the proposed structure and provide access to its derivatives. 
Our retrosynthetic disconnection of branimycin gives two key synthetic intermediates: a cis-decalin core and a polyketide 
side-chain. This PhD thesis presents results of studies on the following topics:  
? Improvement of the synthesis of the polyketide side-chain;  
? Study of six approaches towards the cis-decalin core;  
? Coupling of the cis-decalin core with the side-chain and subsequent elaboration to a highly advanced synthetic 
intermediate of branimycin 
The studied approaches towards the cis-decalin core were based on the following key steps:  
• an intramolecular [3+2] cyclization;  
• a ketyl radical cyclization;  
• desymmetrization of diepoxynaphthalene via a sequence of SN’-openings of oxa-bridges with carbon or hydride 
nucleophiles. 
In the course of studies of the intramolecular [3+2] cyclization of a nitrile oxide, for creation of the branimycin ring B, a 
beneficial effect of high temperatures in favor of cyclization vs. polymerization was observed. These results, coupled with a 
number of revealed literature precedents, allowed the generalization of this effect; and propose that an increase in reaction 
temperature will likely favor any kind of cyclization (characterized by strain and/or slow conformational changes) over 
dimerization and other intermolecular reactions with low activation enthalpy. A plausible explanation of this effect was also 
proposed. 
The approaches to the cis-decalin core, via desymmetrization of diepoxynaphthalene, proved viable ways to access 
highly functionalized cis-decalins with different patterns of substituents. The best results were obtained via an SN’ opening of 
one of two oxa-bridges of diepoxynaphthalene, with Me2PhSiCH2MgCl under copper catalysis, followed by SN’ opening of 
the second oxa-bridge, with formal hydride anion under chiral nickel catalysis. This sequence resulted in the synthesis of an 
enantioenriched cis-decalin fragment, which was successively coupled with the lithiated side-chain. After several synthetic 
manipulations, a key Eschenmoser-Claisen rearrangement was carried out, for which new conditions were developed: closed 
vessel, microwave irradiation, molecular sieves, DMF. Furthermore, it was shown that higher temperatures and shorter 
reaction times were important for obtaining a high yield. Additional synthetic transformations culminated in the synthesis of 
a seco-acid, which was cyclized to give a highly strained 9-membered lactone containing the internal trans-double bond. 
Summarizing, the combined synthetic efforts delivered a highly advanced intermediate which contained the entire carbon 
framework of branimycin including the 9-membered macrolactone. 
  
IV 
  
Zusammenfassung 
Branimycin ist ein neuartiges Antibiotikum sowie ein Vertreter einer strukturell neuen Familie von Antibiotika: den 
Nargenicinen. Es zeigt deutliche antimikrobielle Aktivität, insbesondere gegenüber Staphylococcus aureus. Die Synthese 
von Branimycin wäre der endgültige Strukturbeweis und würde einen Zugriff zu dessen Derivaten ermöglichen.  
Die retrosynthetische Zerlegung von Branimycin ergibt zwei synthetische Intermediate: einen cis-Dekalin Kern sowie 
eine polyketidische Seitenkette. In dieser Dissertation werden folgende Ergebnisse präsentiert: 
? Verbesserung der Synthese der polyketidischen Seitenkette 
? Sechs verschiedene Zugänge zur Herstellung des cis-Dekalin Kerns 
? Verknüpfung des cis-Dekalin Fragments mit der Seitenkette gefolgt von weiteren Syntheseschritten zu einer sehr 
fortgeschrittenen Vorstufe von Branimycin. 
Die Zugänge zur Herstellung des Kernfragments basieren auf folgenden Schlüsselschritten: 
• Einer intramolekularen [3+2]-Cyclisierung 
• Einer Ketyl-Radikal Cyclisierung 
• Desymmetrisierung eines Diepoxynaphthalins durch SN’ Öffnungen von Oxabrücken mittels Kohlenstoff- bzw. 
Hydrid-Nukleophilen. 
Im Zuge der Studien der intramolekularen [3+2]-Cyclisierung eines Nitriloxids um den Ring B von Branimycin zu 
erhalten, stellte sich heraus, daß bei höheren Temperaturen eine Cyclisierung gegenüber Polymerisation begünstigt wird. 
Diese Resultate erlauben aufgrund zahlreicher Beispiele in der Fachliteratur eine Verallgemeinerung dieses Effekts: ein 
ansteigen der Reaktionstemperatur begünstigt wahrscheinlich jede Cyclisierung (welche durch Spannung und/oder langsame 
Konformationsänderungen geprägt ist) gegenüber Dimerisierung und anderen intermolekularen Reaktionen mit niedriger 
Aktivierungsenthalpie. Eine plausible Erklärung für diesen Effekt wurde ebenfalls ausgearbeitet. 
Es gelang mittels Desymmetrisierung von Diepoxynaphthalin hochfunktionalisierte cis-Dekaline mit unterschiedlichem 
Substitutionsmuster zu generieren. Die besten Ergebnisse lieferte eine SN’ Öffnung der einen Oxa-Brücke des 
Diepoxynaphthalins mit Me2PhSiCH2MgCl unter Kupfer Katalyse, gefolgt von einer SN’ Öffnung der zweiten Oxa-Brücke 
mit einem formalen Hydrid-Anion unter Verwendung eines chiralen Nickel Katalysators.  
Diese Synthesesequenz führte zu einer Anreicherung des gewünschten cis-Dekalin Enantiomers, welches desweiteren 
erfolgreich mit der lithiierten Seitenkette verbunden werden konnte. Nach einigen darauffolgenden Syntheseschritten wurde 
eine Eschenmoser-Claisen Umlagerung durchgeführt wofür neue Reaktionsbedingungen entwickelt wurden: geschlossenes 
System, Mikrowelle, Molekularsiebe, DMF. Im Zuge dessen stellte sich heraus, daß höhere Temperaturen und kürzere 
Reaktionszeiten die Ausbeute erhöhen. Weitere Transformationen resultierten in einer Seco-Säure deren Cyclisierung ein 
sehr gespanntes, eine trans-Doppelbindung inkludierendes neungliedriges Lacton ergab. 
Im Zuge dieser Doktorarbeit wurde ein sehr fortgeschrittenes Intermediat hergestellt, das bereits das gesamte 
Kohlenstoffgerüst von Branimycin enthält, inklusive des neungliedrigen Makrolactons  
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1. Branimycin and Related Natural Products 
1.1. Isolation, Biological Activity and Structure Elucidation of the Nargenicin Family 
The Nargenicin family could be described by the oxygen-bridged cis-decalin core annulated to a macrolactone, which so 
far is represented by ten members (Scheme 1).    
H
H
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Name R1 R2 R3 R4 R5 R6 Ref. 
Nodusmicin (2) OMe H OH H H H 1 
Nargenicin A1 (3) OMe H OH H PC H 2 
18-Deoxynargenicin (4) OMe H H H PC H 3 
Nargenicin B1 (5) H OH OH OMe PC OMe 4 
Nargenicin B2 (6) H OH H OH PC OMe 4 
Nargenicin B3 (7) H OH OH OMe PC H 4 
Nargenicin C1 (8) OMe H OH OMe PC OMe 4 
 
 
 
           Ref. 5  
                      Ref. 6 
 
              Ref. 7 
Scheme 1: Members of the Nargenicin family 
The various nargenicins and nodusmicin exhibit antibacterial activity against several microorganism, among which 
Staphylococcus aureus is probably the most interesting. Luminamicin and lustromycin were shown to be active against 
pathogenic species of Clostridium. Branimycin proved to be active against Staphylococcus aureus, E-coli, Bacillus subtilis 
and Streptomyces viridochromogenes. 
Determination of their structures proved not to be trivial. NMR studies of the initially isolated nargenicin A1 allowed 
initial assignment of all stereocenters except positions 2, 16, 17 and 18 residing on the flexible macrolactone ring (Scheme 
1). Degradation studies of nargenicin A1 revealed that nodusmicin, another  antibiotic, differs only at the C9 position in 
lacking 2-pyrrole-carboxylate functionality. Fortunately, nodusmicin proved crystalline and its structure was unambiguously 
determined by X-ray diffraction studies. Based on this information,  the structure of nargenicin A1 was also successfully 
elucidated.  
                                                          
1 Whaley, H. A.; C. G. Chidester, C. G.; Mizsak, S. A.; Wnuk, R. J. Tetrahedron Lett. 1980, 21, 3659-3662. 
2 (a) Celmer, W. D.; Chmurny, G. N.; Moppett, C. E.; Ware, R. S.; Watts, P. C.; Whipple, E. B. J. Am. Chem. Soc. 1980, 102, 4203. (b) 
Celmer, W. D.; Cullen, W. P.; Moppett, C. E.; Jefferson, M. T.; Huang, L. H.; Shibakawa, R.; Tone, J. U.S. Patent 4,148,883, 1979. 
3 Magerlein, B. J.; Reid, R. J. J. Antibiot. 1982, 35, 254-255. 
4 Celmer, W. D.; Cullen, W. P.; Shibakawa, R.; Tone, J. U.S. Patent 4,435,747. 
5 (a) Speitling, M. Ph.D. Thesis, Universität Göttingen, 1998. (b) Speitling, M.; Grün-Wollny, I.; Hannske, F. G.; Laatsch, H. 12. And 13. 
IRSEER Naturstofftage der DECHEMA e.V. Irsee 2000, 2001, poster sessions. 
6 (a) Omura, S.; Iwata, R.; Iwai, Y.; Taga, S.; Tanaka, Y.; Tomoda, H. J. Antibiot. 1985, 38, 1322-1326. (b) Gouda, H.; Sunazuka, T.; Ui, 
H.; Handa, M.; Sakoh, Y.; Iwai, Y.; Hirono, S.; Omura, S. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 18286-18291. 
7 (a) Omura, S.; Imamura, N.; Oiwa, R.; Kuga, H.; Iwata, R.; Masuma, R.; Iwai, Y. J. Antibiot. 1986, 39, 140. (b) Tomoda, T.; Iwata, R.; 
Takahashi, Y.; Iwai, Y.; Oiwa, R.; Omura, S. J. Antibiot. 1986, 39, 1205-1210. 
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The absolute configuration of nargenicin A1 was determined8 by non empirical CD exciton chirality method and 
independently confirmed by feeding experiments (vide infra). Basing on these results, absolute configurations of other 
members of the Nargenicin family were hypothesized. 
The structure of 18-deoxynargenicin was confirmed by selective deoxygenation of nargenicin A1 at the C18 position.9  
Although structures of luminamycin (coloradocin) and lustramycin differ from nargenicin A1 quite substantially, they 
also could be ascribed to this family; they combine an oxa-bridge across a cis-decalin core and a condensed 10-membered 
lactone with a very similar substitution pattern. For determination of the structure of luminamicin, Mosher derivatization and 
molecular dynamic studies were carried out. To date, the structure of lustromycin is still not fully established, lacking 
assignment of the C2 and C3 stereocenters. 
Elucidation of the branimycin structure5 (Scheme 1) was only based on NMR studies and, similar to nargenicin A1, only 
the stereocenters situated on the rigid cis-decalin frame could be reliably established (C3, C6-C12). Although assignment of 
the stereocenters at positions C2, C15-C17 was reported (based on NOE-experiments), we believe these results should be 
considered with great care due to a possible flexibility of the lactone ring (especially at the acyclic C17-position). 
As a consequence, the total synthesis of branimycin would have not only a purely chemical interest, but would also 
confirm (or revise) the structure of branimycin. 
1.2. Biosynthesis 
Two independent studies of 13C labeling revealed,8,10 that the carbon skeletons of  nargenicin A1 and nodusmicin are 
assembled in nature from 4 propionate and 5 acetate units; and the Me group of the C2-OMe derived from methionine, thus 
demonstrating their polyketide origin (Scheme 2).  
 
Scheme 2: Biosynthetic origin of nargenicin A 
Experiments carried out in an 18O2-atmosphere revealed8 that the oxa-bridge, as well as the C2-O and C18-O are 
introduced into the structure at late stages of biosynthesis and are derived from molecular oxygen. Analyzing obtained 
results, the authors conclude that: 
• The C4-C13 bond is not constructed via a simple aldol-type reaction, as the C13 oxygen is not derive from 
propionate. 
• Epoxy-alcohol cyclization to form the oxa-bridge or epoxy-olefin cyclization to form C7-C12 can be excluded 
as neither the C9-O nor C11-O are derived from 18O2. 
Instead, the authors propose lactonization and intramolecular Diels-Alder cyclization reactions to be responsible for 
formation of the cis-decalin core (Scheme 3): 
                                                          
8 (a) Cane, D. E.; Yang, C.-C. J. Antibiot. 1985, 38,423-426. (b) Cane, D. E.; Yang, C.-C. J. Am. Chem. Soc. 1984, 106, 6633-6634. 
9 Magerlein, B. J.; Reid, R. J. J. Antibiot. 1982, 35, 254-255. 
10 Snyder, W. C.; Rinehart, K. L. J. Am. Chem. Soc. 1984, 106, 787-789. 
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Scheme 3: Proposed biosynthesis of nargenicin A1. Feeding experiment. 
This hypothesis was to some extent supported by the incorporation of labeled polyketide chain elongation intermediate 
11 into nargenicin A1 in feeding experiments. Obtained results suggest that the diene moiety could indeed participate in 
formation of the cis-decalin core, and that stereocenters are set prior to the chain elongation. 
Biosynthetic studies on luminamicin (coloradocin) showed11 the same origin of carbons of the cis-decalin core and 10-
membered lactone, as corresponding carbons of nargenicin A1. Related studies with 18O-labbelled molecular oxygen have not 
been reported so far, therefore it is not clear whether different positioning of oxa-bridges in these molecules results from 
different oxygen sources.  
Unfortunately, no biosynthetic studies for branimycin have been reported so far. Even if to assume, that the general 
pathway to branimycin could be similar to the one leading to nargenicin A1, two questions still cannot be answered: firstly, 
what is the origin of the 9-memberd lactone (in contrast to the 10-membered lactones of all other members of the Nargenicin 
family); and secondly, how the CH2OMe group at the C2 position was introduced. 
 
 
 
 
 
 
 
 
 
 
 
                                                          
11 McAlpine, J. B.; Mitscher, L. A.; Jackson, M.; Rasmussen, R. R.; Velde D.V.; Veliz, E. Tetrahedron 1996, 52, 10327-10334. 
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2. Synthetic Approaches Towards Members of the Nargenicin Family 
This chapter presents literature describing various approaches towards syntheses of nargenicins and branimycin. 
Synthetic studies towards luminamicin12 and lustromycin12a are not discussed, as to date efforts have focused solely on 
creation of the oxa-bridged cis-decalin core; which principally differs from branimycin in the position of the oxa-bridge.  
2.1. Kallmerten′s Synthesis of Oxa-Bridged cis-Decalin Nucleus of the Nargenicins. 
The first synthetic effort towards the nargenicin family was reported by Kallmerten13 on the development of a very 
elegant approach towards the oxa-bridged cis-decalin core of nargenicins (Scheme 4). The cis-decalin system was 
synthesized in a racemic manner via Diels-Alder cycloaddition between diene 13 and quinone 14. Subsequent reduction of 
both carbonyl groups gave 15, which was further acetalized to leave only one OH-group free. Introduction of the methyl 
substituent at C10 (nargenicin numbering) was accomplished via an SN′-displacement of a mesylate derived from alcohol 16. 
 
Scheme 4: Kallmerten′s model studies towards nargenicins core 
The acetal was then cleaved and the allylic alcohol selectively oxidized to deliver ketone 18. The remaining free OH-group 
was protected as a MOM-ether, followed by regioselective epoxidation at the more electron rich double bond to give epoxide 
19 (dr 1.8 : 1). The key step of Kallmerten′s approach comprises a 1,2-addition of a C-nucleophile (MeMgBr as a model 
nucleophile) to the carbonyl group, and the subsequent formation of the oxa-bridge via intramolecular opening of the 
epoxide with the resulted alkoxide. 
2.2. Kallmerten′s Synthesis of 18-Deoxynargenicin 
A few years later, Kallmerten′s group reported14 the first total synthesis of 18-deoxynargenicin, basing on the earlier 
approach towards the oxa-bridged nargenicins core (Chapter 2.1). The C14-C19 side chain was synthesized based on 
opening of the chiral epoxide 21 and subsequent coupling of a sulfonate with a methylcuprate reagent (Scheme 5). Alkyne 22 
                                                          
12 (a) Sunazuka, T.; Handa, M.; Hirose, T.; Matsumaru, T.; Togashi, Y.; Nakamura, K.; Iwai, Y.; Omura, S Tetrahedron Lett., 2007, 48, 
5297-5300. (b) Gossinger, E; Schwartz, A.; Sereinig, N. Tetrahedron 2000,  56,  2007-2014. (c) Evans, J. M.; Kallmerten, J. Synlett 
1992, 4, 269-271. 
13 Kallmerten, J. Tetrahedron Lett. 1984, 25, 2843-2846. 
14 Plata, D. J.; Kallmerten, J. J. Am. Chem. Soc. 1988, 110, 4041-4042. 
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was elaborated to give 23 in three steps: TBS-protection, terminal C-methylation and regioselective hydrozirconation- 
iodination. 
 
Scheme 5: Kallmerten′s synthesis of the C14-C19 side-chain 
Connection of side chain 23 with cis-decalin core rac-19 with concomitant formation of the oxa-bridge was achieved 
(Scheme 7) following their earlier strategy  to give a mixture of diastereomeric products, as starting epoxy ketone 19 was 
 
Scheme 6: Kallmerten′s synthesis of seco-acid 27a,b 
used in racemic form. Allylic oxidation gave α,β-unsaturated ketone 25, which was subjected to stereoselective conjugate 
addition with C3-nucleophile. The resulting enolate was then trapped as the phosphoimidate, which was reduced to the 
corresponding alkene 26 under Birch conditions. Conversion of the C4 side chain to the corresponding ester, α-oxygenation, 
methylation, saponification and global deprotection gave seco-acid 27a,b as a mixture of diastereomers. Finally, 
macrolactonization and esterification at 9-OH completed the synthesis of 18-deoxynergenicin (Scheme 7). Interestingly, 
from two diastereomeric acids 27a,b, only the desired diastereomer gave the product of macrolactonization.  
 
Scheme 7: Completion of the synthesis of 18-deoxynargenicin  
Although the whole synthesis developed by Kallmerten is quite elegant, many steps unfortunately resulted in rather low 
yields (allylic oxidation, introduction of the C4 side chain) or stereoselectivity (epoxidation, ester α-oxygenation). Moreover, 
the cis-decalin core 19 was synthesized in racemic form. Nevertheless, so far it remains the only complete synthesis of a 
member of the nargenicin family. 
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2.3. Kallmerten′s synthesis of C14-C19 side-chains of nargenicins via [2,3] Wittig 
rearrangement 
The same group also undertook studies15 towards introduction of the C14-Cl9 side chain based on translation of stereo-
information of core 19 (Scheme 8). The key steps include chelation-directed 1,2-stereoselective addition of MeLi to the 
carbonyl group of 29, etherification and subsequent highly stereoselective [2,3] Wittig rearrangement to deliver 31. To 
complete a formal synthesis of 18-deoxynargenicin, 31 was converted into synthetic intermediate 24 (cf. Scheme 6).  
 
 
Scheme 8: Kallmerten′s synthesis of the C14-C19 side-chain via [2,3] Wittig rearrangement 
 
Installation of the oxygen functionality at C18 was achieved via diastereoselective reduction of a ketone, which in turn 
was derived from ester 32 (Scheme 9). 
 
Scheme 9: Introduction of the C18 stereocenter 
Although the sequences to 24 and 33 are highly diastereoselective, this approach suffers from lengthy linear sequences 
and relatively low overall yields. 
2.4. Roush′ IMDA Approach to the cis-Decalin Core of Nargenicins 
Roush at al. carried out investigations of an intramolecular Diels-Alder reaction (IMDA) aimed at the synthesis of the 
cis-decalin core of nargenicin A1.16 Based on the expected for the key IMDA chair-like transition state (Scheme 10), a 
required substrate 39 was synthesized. Towards this end, aldehyde 34 underwent a crotylation reaction, to provide 35. The 
acetonide protecting group was shifted; and the vinyl substituent converted to the corresponding aldehyde by ozonolysis. The 
                                                          
15 Rossano, L. T.; Plata, D. J.; Kallmerten, J. J. Org. Chem. 1988, 53, 5189-5191. 
16 Coe, J. W.; Roush, W. R. J. Org. Chem. 1989, 54, 915-930. 
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latter underwent further oxidation to the carboxylic acid, which after esterification with CH2N2 gave 36. The alcohol group 
was then oxidized to the aldehyde, which after a Wittig olefination reaction  gave a mixture of diene isomers. Isomerization 
of the Z-diene with a catalytic amount of I2 gave the desired E-diene 38 in configurationally pure form. Finally, 38 was 
elaborated to deliver 39 in two standard steps, thus setting the stage for the key IMDA.  
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Scheme 10: Roush′ IMDA Approach to the cis-Decalin Core of Nargenicins 
 
Surprisingly, the product 40 obtained from the IMDA reaction under thermal conditions, possessed a different 
configuration from that which was  expected (41), what could be explained by the high preference for such a cyclization 
through boat-like transition state (Scheme 10). Investigations of various diastereomeric substrates revealed that the 
involvement of a boat-like transition state in decatrienone intramolecular Diels-Alder reactions appears to be general. 
2.5. Roush′ Transannular Diels-Alder Cyclization to Nargenicin A1 Framework 
As studies of the IMDA reaction did not result in the synthesis of the nargenicin core, Roush et al. turned their attention 
to an alternative approach, to create complete carbon framework of nargenicin via a transannular Diels-Alder reaction.17 
Indeed, this approach seems to be very attractive, as all stereocenters would come from the requisite progenitor acyclic 
substrate, which in turn could be constructed employing well developed methods for synthesis of polyketide moieties. 
Moreover, the troublesome 10-membered lactone would be established by a ring contraction of the more easily synthesizable 
18-membered lactone. 
                                                          
17 Roush, W. R.; Koyama, K.; Curtin, M. L.; Moriarty, K. J. J. Am. Chem. Soc. 1996, 118, 7502-7512. 
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Scheme 11: Roush′ Transannular Diels-Alder Cyclization to Nargenicin A1 Framework. 
Towards this end condensation between ketone 44 and aldehyde 45 gave dienone 46 possessing the required dienophile 
moiety for the forthcoming Diels-Alder cyclization. The diene moiety was then introduced via Suzuki coupling to give 48, 
which in turn was subjected to saponification conditions and selective TES-deprotection. The key macrolactonization was 
performed employing Yamaguchi conditions, and yielded 18-membered lactone 50 together with the product of subsequent 
transannular Diels-Alder cyclization, 51. Macrolactone 50 was converted to 51 under thermal conditions.  
Although the carbon framework of nargenicin was established quite efficiently,  all attempts to introduce the requisite oxa-
bridge unfortunately failed, and so far this approach has not culminated in the completion of the synthesis. 
Interestingly, a sequence of a macrolactonization - transannular Diels-Alder cyclization is possibly used by nature for the 
biosynthesis of nargenicin A1,  as proposed by Cane et al. based on biosynthetic studies.18 
2.6. Gössinger′s Approach Towards Nodusomicin 
Similar to the approach of Kallmerten to the nargenicin cis-decalin core, approach of Gössinger et al.19 starts from Diels-
Alder reaction of quinone 14 and cyclopentadiene 53 (Scheme 12). Subsequent reduction gave diol 55, which was 
desymmetrized employing chiral derivatizing reagent, acetal 58. In contrast to Kallmerten′s approach, this scheme gave 
access to a chiral cis-decalin core. 
                                                          
18 Cane, D. E.; Guanglin, L. J. Am. Chem. Soc. 1995,117, 6633-6634. 
19 (a) Gössinger, E.; Graupe, M.; Kratky, C.; Zimmermann, K. Tetrahedron 1997, 53, 3083-3100. (b) Gössinger, E.; Schwartz, A.; 
Sereinig, N. Tetrahedron 2000, 56, 2007-2014. (c) Gössinger, E.; Schwartz, A.; Sereinig, N. Tetrahedron 2001, 57, 3045-3061. 
Chapter 2                                          9 
 
 
Scheme 12: Gössinger′s approach towards enantiopure cis-decalin core 56 
α,β-Unsaturated ketone 59 (Scheme 13), was prepared in a few steps from 56 and subjected to the stereoselective 
conjugate addition with dimethylcuprate, which was followed by stereoselective hydroxylation of the resulted silyl enolate. 
Carbonyl reduction and selective mono-protection delivered 60. The double bond was then “desymmetrized” by formation of 
a THF-ring via intramolecular nucleophilic addition of sodium alcoholate and successive Cl-substitution and dechlorination 
in one step. The EE-protecting group was exchanged with benzyl, and the bridge situated acetal was hydrolized to give 
monoketone 61. 
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Scheme 13: Gössinger′s approach towards nodumicin 
Crucial for the next step, the stereoselective addition of Me to the bridge residing carbonyl group was achieved by reaction 
with AlMe3. Tertiary alcohol 62 was subjected to regioselective cleavage of the bridge via a pinacol-like rearrangement by 
treatment with an acid in a strong ionizing media. Subsequent introduction of the double bond gave endione 63. The free 
OH-group was protected as its MOM-ether and a C4-side chain was introduced in three steps: regioselective reduction of the 
cyclic keto-group; formation of β-iodoacetal; and reductive radical cyclization to furnish 64. Reduction of ketone 64, 
followed by elimination of the resulted OH-group created the required exo-double bond. A sequence of standard 
transformations gave 65, which was subjected to pivotal oxa-bridge formation via an oxymercuration reaction. Treatment of 
the resulted organomercury intermediate with NaBH4/O2 provided compound 66.  Compound 66 was the most advanced 
synthetic intermediate towards nargenicin A1, reported by Gössinger group. 
Studies towards the assembly of C14-C19 side chain resulted in development of the sequence are presented in Scheme 
14. The cyclic ketone was selectively protected via formation of an acetal. The remaining carbonyl was converted into 
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Scheme 14: Introduction of the C14-C19 side-chain 
hydrozone and then into vinyllithium species 68, which was reacted with aldehyde 69. Reductive Barton-McCombie 
deoxygenation sequence accompanied with by a double bond shift led to 71 as a 5:1 mixture of E/Z geometric isomers. 
The approach developed by Gössinger encompasses an impressive sequence of stereoselective reactions and creative 
ideas. Unfortunately, the relatively high number of steps and retirement of Prof. Gössinger precluded completion of the 
nargenicin synthesis.  
2.7. Approaches Towards Branimycin in Mulzer Group 
The general retrosynthetic analysis of branimycin in the Mulzer group features cleavage of macrolactone and 
disconnection at C12-C13 (Scheme 15). This provides the corresponding metallated side chain S and the cis-decalin core C 
possessing C12-keto group. 
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Scheme 15: General retrosynthetic analysis of branimycin in the Mulzer group 
Besides aiming to accomplish the synthesis of branimycin, the focal point of the investigations in the Mulzer group lies 
on the development of various approaches towards the cis-decalin core C.  
2.8. INOC Approach to the cis-Decalin Core of Branimycin (Mulzer Group) 
This approach20 (Scheme 16) was based on a possibility to construct the cis-decalin core of branimycin by 
intramolecular nitrile oxide cyclization (INOC). The synthesis commenced from literature known compound 73, derived 
from naturally occurring (-)-quinic acid. Silyl enol ether 73 was alkylated at the α-position, to deliver ketone 74. Luche 
reduction, followed by esterification under Mitsunobu conditions provided allylic ester 75. In the next step, chelation-
controlled glycolate enolate Ireland-Claisen rearrangement led to acid 76 as a single isomer. C2-Elongation at the acid carbon 
                                                          
20 Enev, V. S.; Drescher, M.; Mulzer, J. Tetrahedron 2007, 63, 5930-5939. 
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was performed in 5 standard steps to deliver Z-α,β-unsaturated aldehyde 77. Challenging formation of the corresponding Z-
α,β-unsaturated oxime without isomerization of the double bond to the E-isomer was performed employing polymer 
supported di-tert-butylpyridine, as a base, and thus the stage for the key INOC reaction was set. Treatment of the oxime with 
NCS/Py resulted in one step oxime chlorination; formation of a nitrile oxide and 1,3-diploal cycloaddition, giving the cis-
decalin core 78 in high yield. 
 
 
Scheme 16: INOC Approach to the cis-decalin core of branimycin 
Stereoselective dihydroxylation, acetal formation, reductive cleavage of the isoxazoline moiety, followed by  protection of 
the resulting alcohol as its TMS-ether gave a ketone, which was treated with vinylmagnesium bromide (as a model 
nucleophile), thus demonstrating, that such highly functinalized hindered substrate can undergo nucleophilic addition (79) to 
the carbonyl group (79) and not only enolization. 
 
Scheme 17: Introduction of the C3 appendage via Eschenmoser-Claisen rearrangement 
In the same work the authors tested introduction of the C3-appendage via Eschenmoser-Claisen rearrangement. 
Unfortunately, substantial epimerization occurred under conditions of the isoxazoline ring cleavage (Scheme 17). 
2.9. INOC Approach Towards the Ring B of Branimycin (Mulzer Group) 
An alternative  approach towards the cis-decalin core of branimycin employed another INOC reaction for construction 
of the ring B.21,22 The synthesis started with  a copper catalyzed stereoselective Michael addition of vinyl Grignard reagent to 
83. Subsequent aldol reaction with acrolein and TBS-protection gave 84 as a mixture of diastereomers. PMB-cleavage, 
oxidation of the resulted alcohol to its aldehyde and reaction with hydroxylamine gave requisite oxime 85. Treatment of 85 
with tBuOCl or NaClO gave the desired products of INOC although in rather low yields. 
                                                          
21 Mulzer, J.; Castagnolo, D.; Felzmann, W.; Marchart, S.; Pilger, C.; Enev V. S. Chem. Eur. J. 2006, 12, 5992 – 6001. 
22 Partly unpublished results are presented. 
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Scheme 18: INOC Approach towards the ring B of branimycin 
Improvement of the key INOC reaction step was a part of this PhD thesis. Obtained results are discussed in Chapter4. 
2.10. Double Claisen Rearrangement – RCM Approach Towards the cis-Decalin Core of 
Branimycin (Mulzer Group) 
This approach was based on an idea to create the cis-decalin moiety by ring closing metathesis.23 Departing from the 
appropriately functionalized ring B, vinylic substituents required for RCM were introduced in a stereoselective manner by 
two successive Ireland-Claisen rearrangements. 
 
Scheme 19: Double Claisen rearrangement – RCM approach to the cis-decalin core of branimycin 
The synthesis started from previously synthesized alcohol 74’.20 Protecting group manipulations followed by acylation 
gave allylic ester 87, which was involved in a chelation-controlled glycolate enolate Ireland-Claisen rearrangement to give 
acid 88. Esterification, reduction to its corresponding aldehyde followed by Wittig olefination provided 89, containing the 
first of two vinylic substituent required for the forthcoming RCM. TES-cleavage and esterification, under Mitsunobu 
conditions, gave allylic ester, which was involved in the second Ireland-Claisen rearrangement to furnish acid 90. Repetition 
of the established 3-step sequence introduced the second vinylic substituent in 91. Ring closing metathesis successfully 
provided cis-decalin 92, which was subjected to PMB-deprotection; Dess-Martin oxidation  and epoxidation of the more 
electron rich double bond to accomplish the desired cis-decalin core 93. 
2.11. Trans-Annular Diels-Alder Approach to the cis-Decalin Core of Branimycin (Mulzer Group) 
In this approach24 from the Mulzer group, chiral information was transferred from lactone 95 (containing only one chiral 
center) to create 6 new chiral centers, 4 of which were set in just one step by a trans-annular Diels-Alder reaction.  
Thus, protection of alcohol in 95 followed by diastereoselective Michael addition of vinyl Grignard reagent provided 
lactone 96, which was partially reduced and protected as methyl the acetal.  The double bond was then cleaved oxidatively 
                                                          
23 Marchart, S.; Mulzer, J.; Enev, V. S. Org. Lett. 2007, 9, 813−816. 
24 Felzmann, W.; Arion, V. B.; Mieusset, J. L.; Mulzer, J. Org. Lett. 2006, 8, 3849−3851. 
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and the resulting aldehyde used in a modified Julia olefination, after which TBDPS deprotection furnished stannylated diene 
98. A one-pot sequence of TPAP oxidation/Roush-Masamune olefination provided unsaturated ester bearing a vinyl iodide 
moiety 99. The key intramolecular Stille-coupling reaction furnished the desired macrocycle 100, which under thermal  
 
Scheme 20: Trans-annular Diels-Alder Approach to the cis-decalin core of branimycin 
conditions was converted smoothly to 101, containing  the required cis-decalin core of branimycin, in highly 
diastereoselective manner (Scheme 20). 
 
2.12. SN′ oxa-Bridge Opening – RCM Approach to the cis-Decalin Core of Branimycin (Mulzer 
Group) 
Similar to a previous approach from the Mulzer group (Chapter 2.10), this approach relied on the possibility to establish 
cis-decalin moiety via an RCM reaction.  
The synthesis commenced with the opening of the oxa-bridge of 102 with a Grignard reagent under copper catalysis, to 
provide racemic 103.  Resolution of enantiomers by chiral HPLC and subsequent benzyl cleavage gave enantiomerically 
pure triol 104. After regioselective formation of the PMB-acetal, with p-methoxybenzaldehyde, the remaining free primary 
alcohol was oxidized to its aldehyde by Dess-Martin periodinane. Olefin 106 was obtained, employing an especially devised 
modification of the Peterson protocol for enolizable substrates. Regioselective reductive opening of the PMB-acetal resulted 
in liberation of the primary alcohol to give 107, which after oxidation  resulted in aldehyde107. Further reaction of aldehyde 
 
Scheme 21: SN′ oxa-Bridge opening – RCM approach to the cis-decalin core of branimycin 
107 with an allyl-chromium reagent gave a mixture of diastereomeric alcohols, 108. Oxidation to ketone, followed by 
epoxidation of the most electron rich double bond delivered epoxide 109 possessing both vinyl substituents for the RCM 
reaction. Ring closing metathesis resulted in clean formation of cis-decalin core 110 (Scheme 21). 
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Scheme 22: Coupling of the side-chain with the cis-decalin core and formation of the oxa-bridge 
Connection of the cis-decalin core with the side chain and the subsequent oxa-bridge formation were performed by 
coupling epoxy ketone 110 with pre-metalated side chain 111 (derived from its corresponding vinyl iodide25) to give the 
expected oxa-bridged product 112 (Scheme 22). In contrast to Kallmerten’s approach (Chapter 2.2), ketone 110 contains the 
α-proton highly acidified by the adjacent double bond. This makes addition (vs. enolization) of any nucleophiles to the 
carbonyl highly challenging! 
 
                                                          
25 Felzmann, W.; Castagnolo, D.; Rosenbeiger, D.; Mulzer, J. J. Org. Chem. 2007, 72, 2182-2186. 
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3. Structural Features of Branimycin and Outline of the Synthetic Plan 
Besides its promising biological activity, branimycin (Scheme 15) attracted our attention by its very challenging 
structure. The key features of the branimycin structure are: 
• a cis-decalin core  
• an oxa-bridge across the cis-decalin core 
• a 9-membered lactone with an internal trans-double bond 
• a highly oxygenated structure 
• 12 stereocenters 
Our general retrosynthetic analysis of branimycin features cleavage of the macrolactone and disconnection of the C12-C13 
bond (Scheme 15). This gives corresponding metallated side chain S and cis-decalin core D. For the latter, we imagined two 
candidates: core D1, containing C2-appendage at C3; and core D2, where the C2-appendage would be introduced at a later 
stage of the synthesis.  
 
Scheme 23: Retrosynthesis of branimycin 
Cis-Decalin Core 
Four approaches towards D1 and two approaches towards D2 have been investigated in the course of our studies. 
Approaches towards core D1 are outlined in Scheme 24: 
• two approaches based on creation of the carbocycle B via formation of the C9-C10 bond, introduction of alkene 
substituents at the C6 and C11 positions, and subsequent formation of the ring A via a ring closing metathesis. One 
of the approaches expected formation of the C9-C10 bond via an intramolecular [3+2] nitrile oxide cyclization 
(Chapter 4.3). In the other approach, this bond would be formed via a ketyl radical cyclization (Chapter 4.2). 
• two approaches where the cis-decalin carbon framework was created right at the beginning, and all following 
transformations were focused on construction of the functional group pattern via desymmetrization of 
diepoxynaphthalene 141 (Chapters 8 and 9). 
Approaches towards core D2 can be seen in Scheme 25: 
• an approach based on the functionalization of the initially presented ring B, followed by introduction of substituents 
at the C6 and C11 positions; and formation of ring A via ring closing metathesis (Chapter 5). 
• an approach where the cis-decalin carbon framework was constructed right at the beginning, and all following 
transformations were focused on creation of the functional group pattern via desymmetrization of 
diepoxynaphthalene (Chapter 10). 
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Scheme 24: Approaches towards core D1 
 
Scheme 25: Approaches towards core D2 
C13-C18 Side-Chain 
The synthesis of side-chain S has been previously reported25 in the Mulzer group. Substantial improvements have also, 
however, been achieved regarding its synthesis (Chapter 11). 
End-Game 
After connection of the cis-decalin core and the C13-C18 side-chain, the key points of the end game are as follows: 
• In the approaches towards cis-decalin core of type D2, the C2-appendage at the position C3 should be introduced at 
a late stage via an SN′ substitution or Claisen rearrangement  (Scheme 26): 
 
 
Scheme 26: Introduction of the C3 appendage 
• Appendage CH2OMe, at the C2-position, could be introduced either after macrolactonization by functionalization of 
the corresponding lactone; or alternatively, the order of these two steps could be reversed. 
• Side-chain C13-C18 possesses two alcohol groups at C16 and C17. Although selective macrolactonization at 16-OH 
in the presence of free 17-OH cannot be excluded a priori, this route appears quite risky, as a10-membered lactone 
(i.e. cyclization on 17-OH) should be less strained than the 9-membered lactone (i.e. cyclization on 16-OH). 
Therefore, 16-OH and 17-OH should be protected by orthogonal protecting groups. 
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4. Lactone-Based RCM Approach Towards the cis-Decalin Core of Branimycin 
4.1.  Introduction and Synthetic Outline  
The first option which we envisioned for a retrosynthetic disconnection of cis-decalin core D1 is shown in Scheme 27. It was 
based on the possibility to create a cis-dicalin moiety via ring closing metathesis of corresponding diene E, which would be 
derived from lactone F.  
 
Scheme 27: Lactone-based RCM approach towards core D1 
Earlier studies in the Mulzer group (Scheme 18) towards the synthesis of lactone F resulted26 in development of synthesis of 
isoxazoline 86 (Scheme 18, 86 equals G, with P = TBS) via intramolecular 1,3-dipolar cyclization of nitrile oxide 85′ (H, P 
= TBS) derived from oxime 85 (I, P = TBS). Although the whole sequence the oxime 85 (I, P = TBS) was very efficient 
(Chapter 2.9)26, the key [3+2] cycloaddition resulted in only 31% yield of isoxazoline 86 (G, P = TBS).  
Our initial goal consisted of optimization of this key [3+2] cycloaddition and parallel investigation of an alternative 
approach to lactone F via intramolecular cyclization of ketyl radical J, derived from aldehyde K.   
4.2.  Ketyl Radical Cyclization Approach Towards Key Lactone Intermediate 
Requisite aldehyde 116 (K, P = TBS) for the cyclization was synthesized basing on the synthesis developed for 85 
(Scheme 18). Lactone 83 was involved in an aldol reaction with literature known27 aldehyde28 E-methoxyacroleine (Scheme 
28), giving a mixture 1 : 1 of diastereomeric alcohols. Subsequent TBS protection, cleavage of PMB and Dess-Martin 
oxidation of the resultant alcohol gave desired aldehyde 116.  
                                                          
26 Mulzer, J.; Castagnolo, D.; Felzmann, W.; Marchart, S.; Pilger, C.; Enev V. S. Chem. Eur. J. 2006, 12, 5992 – 6001. 
27 Smithers, R. H. J. Org. Chem. 1978, 43, 2833-2838. 
28 We could not say a priori which configuration of the aldehyde double bond should give the desired configuration of new stereocenters. 
Therefore, the most easily accessible E-aldehyde 116 was chosen.  
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Scheme 28: Synthesis of aldehyde 116 
Unfortunately, all attempts to induce cyclization proved unsuccessful. Thus, treatment of aldehyde 116 with SmI2 gave 
only a mixture of  pinacol coupling products 117; whereas reaction with Bu3SnH and AIBN resulted in reduction to alcohol 
118.  
 
Scheme 29: Attempts towards the ketyl radical cyclizations 
At this point we turned to the second approach, based on [3+2] cyclization, and further investigation of ketyl radical 
cyclizations were abounded. 
4.3.  INOC Approach Towards Key Lactone Intermediate. 
Parallel to the ketyl radical cyclization approach (Chapter 4.2), investigations were continued on intramolecular nitrile 
oxide cyclization (INOC) approach, which had been started earlier in our group (Chapter 4.1).  
 
 
Scheme 30: Two approaches to nitrile oxide 85’ 
As oxime 85 gave a low yield (31%) in cyclization to 86, we decided to generate nitrile oxide 85′ from its corresponding 
nitro compound 120, instead of originally used oxime 85 (Scheme 30). Towards this end, iodide 119 was synthesized from a 
known21 precursor 84 via PMB-deprotection, followed by an Appel reaction (Scheme 31).  
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Scheme 31: Synthesis of nitro compound 120 
Unfortunately, all attempts to convert iodide 119 into nitro compound 120 gave a mixture of 120 and nitrite 121 in 
moderate yields, and therefore this pathway was abandoned. 
Coming back to generation of nitrile oxide from oximes, we analyzed possible reasons for the low yield of the 
cyclization of TBS-protected oxime 85. We realized, that the major29 diastereomer 85a gives rise to product 86a with OTBS-
substituent in the axial position, which could lead to a 1,3-diaxial repulsion in transition state 85′a (Scheme 32).  
 
 
Scheme 32: Cyclization of the major diastereomer 85a 
We speculated that by changing to a smaller protecting group could diminish this unfavorable diaxial interaction. To this 
end, compound 124 with less bulky PMB-protecting group and compound 125 bearing no protecting group at the OH group 
were synthesized (Scheme 33). Thus, alcohol 95 was protected as its TBDPS-ether, followed by vinyl cuprate 1,4- addition; 
aldol reaction with acrolein and protection of the resulting alcohol with PMB-Bundle′s reagent, to give compound 123. The 
silyl group was cleaved with NH4F, the obtained alcohol oxidized to its corresponding aldehyde and converted to oxime 124. 
Compound 125 was synthesized from oxime 85 by TBS-cleavage under mild conditions (Scheme 33).  
Unfortunately, cyclization of oxime 125 under standard conditions resulted in decomposition, whereas oxime 124 gave 
the desired product in almost the same yield (30%) as was obtained  from cyclization of oxime 85. 
Continue variations in oximes structure, compound 127 with a methyl lactol moiety instead of the lactone group was 
synthesized from 84 in 5 steps (Scheme 33): reduction of lactone to lactol, methyl protection, PMB-deprotection, oxidation 
to aldehyde and conversion into oxime 127. Disappointingly, cyclization of 127 gave the desired product 128 in the “already 
traditional” ca. 30% yield. 
 
                                                          
29 Extensive studies by Dr. Pilger (Prof. Mulzer research group) did not result in desired inversion of stereoselectivity. A possibility to 
invert the configuration at C10 before cyclization did not seem promising (easy) due to lability of the vinyl aldol fragment in 84 
(Scheme 18).  
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Scheme 33: Synthesis and [3+2] cyclizations of various substrates 
As a “rescue plan”, we decided to introduce a dummy SPh-group at C12 in 128, which due to geminal steric repulsion 
had to bring the allylic alcohol substituent closer to the oxime group and possibly facilitate cyclization (Scheme 34). For this 
reason, lactone 83 was treated with LDA followed by PhSSPh to obtain 129. Unfortunately, all attempts to perform the 
subsequent aldol reaction with acrolein gave mostly 1,4-addition product 130, instead of the desired 1,2-addition product, 
131.30 Alternative aldol reactions via Ti, Zn or Si-enolates resulted only in recovering starting lactone 129. 
 
 
Scheme 34: Effect of the dummy PhS-group 
After all variations in the structures of oximes, we decided to come back to original oxime 85, easily accessible, and 
study its cyclization more deep. After extensive experimentations, the yield of the desired [3+2] cyclization was dramatically 
improved. Results of undertaken investigations are to be submitted for publication in Tetrahedron Letters (for a copy of the 
manuscript see Chapter 4.4). Although the initial goal of our studies was achieved; an approach which had been investigated 
in parallel, appeared more promising. Therefore this INOC-based approach was fully abandoned. 
                                                          
30 This could be explained via possibly reversible 1,2-addition due to the stabilization of enolate of 129 with the SPh-substituent and 
destabilization of the aldol product due to 1,2-steric repulsion of the SPh-group with the CH(OLi)vinyl-fragment.  
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Noteworthy, studies presented in Chapter 4.4 resulted in the development of a certain general conclusion, discussed in 
Chapter 13. 
4.4.  Publication:31  
Remarkable Temperature Effect on the Yield of an Intramolecular [3+2] Cyclization 
 
Alexey Gromov, Valentin Enev, Christian Pilger and Johann Mulzer* 
 
Institute of Organic Chemistry, University of Vienna, Währingerstrasse 38, A-1090 Vienna, Austria 
 
Abstract: Favoring of intramolecular cyclizations over oligomerization and other intermolecular processes can often 
be achieved by conducting the reaction at higher temperatures. Unfortunately, this effect seems to be relatively 
underrepresented in the synthetic organic literature. Herein we report one more example supporting this trend – an 
intramolecular nitrile oxide 1,3-dipolar cycloaddition. The yield of the desired product rose from 53% at 0 °C to 79% at 80 
°C. A plausible kinetic background of this phenomenon is proposed in terms of activation enthalpy. 
 
Selectivity of a reaction (enantio-, diastereo-, regio-, chemoselectivity) carried out under kinetic control is often believed 
to increase at lower temperatures and decrease at higher temperatures. Although this phenomenon is observed quite often, 
this behavior should not be taken as a general rule. Indeed, a literature survey reveals a number of examples when at higher 
temperatures selectivity dramatically increased32 and even the selectivity sense was inverted.33 Moreover, temperature 
dependence can have a rather complex character, e.g. selectivity increases together with temperature, and after reaching a 
maximum starts decreasing, what is commonly attributed to a switch in a selectivity determining step.34 
As a part of an ongoing study towards the total synthesis of branimycin35 1, we explored an approach based on the 
construction of carbocycle B employing an intramolecular 1,3-dipolar cycloaddition of nitrile oxide 3, derived from its 
corresponding oxime 4 (Scheme 2).35 Although the whole sequence to 4 was quite efficient, the key [3+2] cyclization proved 
problematic. 
Initial attempts to perform a sequence of in situ chlorination (with t-BuOCl/Py or NaClO/H2O/DCM) - nitrile oxide 
formation - cyclization (Scheme 2) resulted in only 25-35% yield of the desired product 2a,b. Therefore, we decided to carry 
out the chlorination as a separate reaction.  
Thus, chloroxime 5a,b was synthesized by reaction of 4a,b with NCS36 (Scheme 2), and then treated with a wide 
variety of different reagents: bases (Et3N, 2,2′,6,6′-tetramethylpiperidine, NaHCO3, MeMgCl); Lewis acids (Ag2O, AgOTf + 
2,6-ditertbutyl pyridine, LiClO4+Py); combination of a weak base 2,6-ditertbutyl pyridine with a strong ionizing solvent 
CF3CH2OH; solid reagents-adsorbents (Al2O3, SiO2, 4Å MS, 3Å MS). Surprisingly, in all cases the yield of product 2a,b was 
                                                          
31 To be submitted for reviewing to Tetrahedron Letters. Compounds and Schemes numbering is kept as in the original manuscript. 
References and footnotes numbering continues numbering of this PhD thesis. 
32 For example see: (a) Ireland-Claisen rearrangement: Watanabe, T.; Hirai, G.; Kato, M.; Hashizume, D.; Miyagi, T.; Sodeoka, M. Org. 
Lett., 2008, 10, 4167-4170. (b) Radical allylation: Sibi, M. P.; Rheault, T. R. J. Am. Chem. Soc. 2000, 122, 8873-8879. (c) Carbonyl 
reduction with CBS: Cho, T. R.; Chun, Y. S. J. Chem. Soc., Perkin Trans. 1, 1999, 2095–2100. 
33 For example see: (a) Carbonyl reduction with CBS: Corey, E. J.; Yi, K. Y.; Matsuda, S. P. T. Tetrahedron Lett. 1992, 33, 2319 – 2322. 
(b) Michael addition: Sibi, M. P.; Gorikunti, U.; Liu, M. Tetrahedron 2002, 58, 8357–8363. 
34 For example see: (a) Addition of RLi to carbonyl: Cainelli, G.; Giacomini, D.; Galletti, P. Chem. Commun., 1999, 567–572. (b)[2+2]-
Cycloaddition: Li, B.; Wang, Y.; Du, D.-M.; Xu, J. J. Org. Chem, 2007, 72, 990-997. 
35 Mulzer, J.; Castagnolo, D.; Felzmann, W.; Marchart, S.; Pilger, C.; Enev V. S. Chem. Eur. J. 2006, 12, 5992 – 6001. 
36 Davidson, N. E.; Rutherford, T. J.; Botting, N. P. Carbohydr. Res. 2001, 330, 295-307. 
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Scheme 1: Retrosynthesis of branimycin 
in the same range of 25-35%. This fact suggested us, that constantly low yields under such different conditions could have a 
common origin. As there were no identifiable low molecular weight side products, we speculated that formation of nitrile 
oxide 3a,b is not problematic, but that its intramolecular cyclization for some reasons is unfavorable and that 3a,b could 
undergo intermolecular [3+2] cycloadditions instead leading to polymer formation. 
 
Scheme 2: Intramolecular [3+2] cycloaddition 
For further optimization studies we decided to employ the simplest option – treatment of 4a,b with NaClO in 
DCM/H2O. Slow addition of the substrate to the reagent did not substantially improve the yield possibly due to the presence 
of a double bond in the product 2a, b, which could also react with nitrile oxides. In contrast, conducting the reaction simply 
under higher dilution (1.5x10-3 M) resulted in distinct increase of yield (Table 1). Although encouraged by this result, it was 
still not satisfactory; as further dilution seemed impractical for synthesis of large amounts of 2a,b, we turned our attention to 
the above mentioned temperature effect. To our delight, the yield of the cyclization product 2a,b dramatically increased upon 
increase of the temperature (Table 1). Finally, when the reaction was carried out at 80 °C and at slightly higher dilution 
(0.8x10-3 M), the desired product 2a,b was isolated in 75% yield.37 
The observed temperature effect could be rationalized by assuming that due to strain, activation enthalpy of 
intramolecular cyclization is higher than the activation enthalpy of intermolecular dimerization. Therefore, as follows on 
                                                          
37 For the procedure and analytical data see Experimental Section for Chapter 4.4 (Publication). 
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from Eyring equation,38 with increase in temperature, a reaction with a higher activation enthalpy will be accelerated more 
than a reaction with a lower activation enthalpy. 
Table 1 
Reaction of 4a,b* with NaClO in H2O/DCM to give 2a,b 
Conc., M Temp. Solvent Yield**; dr 2b : 2a 
1.5x10-2 0 °C DCM 37%; 32 : 5 (31%; 28 : 3) 
1.5x10-3 0 °C DCM 53%; 46 : 7 
1.5x10-3 22 °C DCM or DCE 63%; 53 : 10 
1.5x10-3 40 °C DCM or DCE 70%; 59 : 11 
1.5x10-3 60 °C DCE 74%; 59 : 15 
1.5x10-3 80 °C DCE 76%; 60 : 16 
0.8x10-3 80 °C DCE 79%; 61 : 18 (75%; 60 : 15) 
* 4b : 4a 75:25 
** Yields were estimated39 from NMR using 4,4′-di-tert-
butyl-biphenyl as an internal standard. Isolated yields and 
diastereoselectivity are given in parentheses. Yields are given 
for the mixture 2a+2b. 
 
Favoring of cyclization over dimerization or over some other intermolecular processes due to an increase in 
temperature was reported for quite a number of different reactions,40 but never observed for intramolecular 1,3-dipolar 
cyclization. Regarding the present work, this temperature effect was crucial for improving the intramolecular [3+2] 
cycloaddition leading to the key intermediate in our synthesis of branimycin. 
 
Acknowledgment We thank Dr. Uwe Rinner (Universitiy of Vienna) and Dr. Neil Sheddan (LOBA Feinchemie 
GmbH) for help in the preparation of the manuscript. 
 
 
 
 
                                                          
38 Eyring equation: 
 ݇ ൌ ௞್௛ ܶ݁ሺ
ష∆ಹಯ
ೃ೅ ሻ݁ሺ∆ೄಯೃ ሻሺܿ୭ሻଵି୬              ሺ݁ݍ. 1ሻ 
    Where k = reaction rate constant, kB = Boltzmann′s constant [1.381·10-23 J K-1]; T = absolute temperatures in degrees Kelvin (K); R = 
gas constant [8.314 J · K−1 · mol−1]; h = Plank constant [6.626·10-34 J · s]; ∆H≠ = activation enthalpy [J mol-1]; ∆S≠ = activation entropy 
[J · K−1 · mol−1]; co = standard-state concentration [mol · L-1], n = molecularity of the reaction. 
39 Although absolute values of yields determined from NMR are obviously affected by a certain measurement error, the tendency of yields 
changes is apparent. 
40 Yamaguchi Macrolactonization: (a) Evans, D. A.; Black, W. C. J. Am. Chem. Soc. 1993, 115, 4497-4513. (b) Evans, D. A.;Trotter, B. 
W.; Coleman, P. J.; Côté, B.; Dias, L. C.; Rajapakse, H. A.; Tyler, A. N. Tetrahedron 1999, 55, 8671-8726. (c) Burke, S. D.; Heap, C. 
R.; Porter, W. J.; Song, Y. Tetrahedron Lett. 1996, 37, 343-346, 1996. 
    SN2-Macrolactonization: (d) Karim, M. R.; Sampson, P.; J. Org. Chem. 1990, 55, 598-605. Compare dependence of rate constants at 
different temperatures demonstrate for cyclization and dimerization: (e) Galli, C.; Illuminati, G.; Mandolini, L.; Tamborra, P. J. Am. 
Chem. Soc., 1977, 99, 2591-2597. 
Macrolactamization: (f) Hammond, P. J.; Beer, B. D.; Hall, C. D. J. Chem. Soc., Chem. Commun. 1983, 1161–1163. 
RCM: (g) Yamamoto, K.; Biswas, K.; Gaul, C.; Danishefsky, S. J. Tetrahedron Lett. 2003, 44, 3297–3299. 
Intramolecular oxidative coupling of acetylenes: (h) Höger, S.; Bonrad, K.; Karcher, L.; Meckenstock, A.-D. J. Org. Chem. 2000, 65, 
1588-1589. 
Radical cyclization: (i) Curran, D. P.; Tamine, J. J. Org. Chem., 1991, 56, 2746-2750. 
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5. Oxa-Bridge Opening – RCM Approach Towards the cis-Decalin Core of 
Branimycin 
One of earlier developed in Mulzer group approaches towards the cis-decalin core of branimycin was based on SN′-
opening of the oxa-bridge in compound 102 (Scheme 21). Partly based on these results, a new synthetic plan to cis-decalin 
core 132 (corresponds to D2) was elaborated (Scheme 35). Oxygen functionality at C5 in 132 should allow introduction of 
the requisite C2-appendage at the C3 position either via an SN′-substitution or a Claisen rearrangement (depending on 
configuration). 
 
Scheme 35: Oxa-bridge opening – RCM approach towards D2 
We envisioned that the target cis-decalin compound could be created by ring closing metathesis of corresponding diene 
135. The latter could be derived from aldehyde 134, derived via regioselective opening of PMB-acetal 133. The vinyl 
substituent in 133 could be introduced by addition of vinyl-anion to aldehyde 105′, which was synthesized previously in the 
Mulzer group (Chapter 2.12). 
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Table 1: Addition of vinyl organometallics to aldehyde 105’ 
 
 
 Conditions dr (yield) 
 THF, -78 to -20 °C decomp. 
 THF, -78 °C decomp. 
 THF, -78 °C to rt decomp. 
 THF, -100 to -78 °C 1 : 1 
 Et2O, -78 °C 1 : 1 
 THF, -78 °C 2.5 : 1 
 + LiClO4a THF, -78 °C 8 : 1 (89%) 
a Ratio vinylLi : LiClO4 : RCHO = 6 : 5 (0.4 M in THF) : 1. 
 
Our approach started from the addition of various vinyl-nucleophiles to aldehyde 105′ (Table 1). Amongst the tested 
conditions, remarkable results were obtained with vinyl lithium and LiClO4 as an additive, giving alcohol 136 in high yield 
and good stereoselectivity (dr 8 : 1). LiClO4 was chosen as a potential Lewis acid41 which does not form an ate-complex with 
vinyl lithium; but at the same time ccoul discriminate carbonyl sites via possible complexation: with substrate 105’ and vinyl 
lithium. Selection of LiClO4 over LiCl was made due to its higher solubility in THF (which could become substantial at low 
temperatures) and presumably higher Lewis acidity.  
Although the relative configuration of the OH-group in 136 was not known at this stage, both configurations were 
suitable (Scheme 35), and if necessary one could be interconverted to the other. We therefore continued our investigations 
and turned our attention to the regioselective opening of the PMB-acetal. 
Towards this end, alcohol 136 was protected as a MOM-ether (133a) or as a TBS-ether (133b). Surprisingly, treatment 
of 133a or 133b with DIBAL resulted in formation of equal amounts of regioisomeric alcohols: desired 137 and undesired 
138 (Scheme 36). Unprotected substrate 136 gave slightly better results (ratio 2 : 1). 
 
Scheme 36: Reductive opening of the PMB acetal moiety in 136 
                                                          
41 For a similar effect of LiClO4 on MeLi addition to carbonyl group see: Ashby, E. C.; Nodling, S. A. J. Org. Chem. 1979, 44, 4371-4377. 
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Although there was room for optimization, further investigations were not carried out on this synthetic route, as at this 
time another approach became our main focus.  
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6. Desymmetrization of Diepoxynaphthalene. General Concept for Approaching 
the cis-Decalin Core of Branimycin 
It was imagined that desired cis-decalin core D1 could be derived from its corresponding dienic precursor L (Scheme 
37) via a regioselective epoxidation, relying on coordination of an epoxidizing reagent (e.g. peroxy acids, V or Ti 
hydroperoxides) with the 9-CH2OMe-group or 9-CH2OH-group (i.e. L with R = OMe or OH resp.). 
As can be seen from, the structure of L is pseudo-symmetrical.  
 
Scheme 37: Pseudo-symmetry of diene L 
As taking advantage of this symmetry element was both practical and potentially efficient, a new synthetic plan was designed 
to incorporate it (Scheme 38).  
 
Scheme 38: Desymmetrization of diepoxynaphthalene 141 with carbon nucleophiles 
The new plan was based on desymmetrization of diepoxynaphthalene 141 via sequential SN′ openings of two oxa-bridges. 
For creation of the pattern of ring A, an oxa-bridge would have to be opened in a syn fashion. On the other hand, for 
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functionalization of ring B, the other oxa-bridge would have to be opened anti. The symmetry of this new approach gave us a 
very important flexibility: we could desymmetrize 141 in two ways, starting either from ring A followed by ring B or vice 
versa. To our delight, literature study revealed that both types of oxa-bridge openings (syn and anti) were known, albeit for 
substrates containing only one oxa-bridge. Enantioselective syn opening has been described with diorganozinc nucleophiles 
under palladium catalysis42; or alternatively with organoboron nucleophiles under rhodium43 catalysis. Anti SN′ opening is 
reported in a racemic mode with RMgX under copper catalysis44 for not activated substrates; and enatioselectively (with 
R2Zn45 or RMgX46 under copper catalysis) for more reactive substrates with benzylic47 oxa-bridges. 
It should be noted that nucleophiles in reactions of oxa-bridge opening cannot contain any type of functionalities. Taking 
these restrictions into consideration, we concluded that suitable for our purposes nucleophiles would either be of vinyl type 
or of silyl-bearing alkyl type (Scheme 38). For conversion of introduced side chains to the desired CH2-CH2-OR fragment, a 
vinyl substituent should be hydroborated, followed by oxidative cleavage. On the other hand, oxidative cleavage of an 
aliphatic silicon group (Tamao-Fleming oxidation) would give us access to an alcohol moiety (with one or two C-atoms) 
which could be further converted to a desired fragment (Scheme 38). 
 
Scheme 39: Desymmetrization of diepoxynaphthalene 141 with carbon and hydride nucleophiles 
Alternatively to the discussed scheme, employing a hydride anion for enantioselective opening of the oxa-bridge48 in ring A 
in 141 (Scheme 39) would also provide a route to cis-decalin core of type D2, which was envisioned as an alternative  option 
in our synthesis (Scheme 15). 
 
 
 
                                                          
42 (a) Lautens, M.; Hiebert, S. J. Am. Chem. Soc. 2004, 126, 1437-1447. (b) Lautens, M.; Hiebert, S.; Renaud, J.-L. 
J. Am. Chem. Soc. 2001, 123, 6834-6839. (c) Cabrera, S.; Arrayás, R. G.; Alonso, I.; Carretero, J. C. J. Am. Chem. Soc. 2005, 127, 17938-
17947. 
43 Lautens, M.; Dockendorff, C.; Fagnou, K.; Malicki, A. Org. Lett. 2002, 4, 1311-3114.  
44 Arrayás, R., G.; Cabrera, S.; Carretero, J. C. Org. Lett. 2003, 5, 1333-1336. 
45 Bertozzi, F.; Pineschi, M.; Macchia, F.; Arnold, L. A.; Minnaard, A. J.; Feringa, B. L. Org. Lett. 2002, 4, 2703-2705. 
46 Zhang, W.; Wang, L.-X.; Shi, W.-J.; Zhou, Q.-L. J.Org.Chem. 2005, 70, 3734-3736. 
47 To date, enantioselective anti-opening with C-nucleophiles was reported only for substrates with benzylic oxa-bridges:  
48 Lautens, M.; Rovis, T. Tetrahedron 1998, 54, 1107-1116. 
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7. Synthesis of Diepoxynaphthalene (141) 
The new synthetic scheme discussed in Chapter 6 apparently required a reliable approach to the starting diepoxynapthalene 
141. Although this compound was literature known, the overall yield of 141 was < 2%, therefore a new synthesis had to be 
developed. Results of this work were submitted for publication in Synthetic Communications (for a copy of the manuscript 
see Chapter 7.1). Some further improvements in the synthesis of 141 were achieved additionally (see Chapter10.2). 
7.1. Improved synthesis of parent fused 7-oxanorbornenes (Publication in Synthetic 
Communications)49 
IMPROVED SYNTHESIS OF PARENT FUSED 7-OXANORBORNENES 
 
Alexey Gromov*, Valentin Enev* and Johann Mulzer* 
 
Address correspondence to A. Gromov or V. Enev or J. Mulzer, Institute of Organic Chemistry, University of Vienna, 
Währingerstrasse 38, A-1090 Vienna, Austria. Tel.: +43-1-4277-52190. Fax: +43-1-4277-52189.  
E-mails: alexey.gromov@univie.ac.at, valentin.enev@univie.ac.at, johann.mulzer@univie.ac.at 
 
Abstract: The synthesis of parent fused 7-oxanorbornenes 1 and 2 based on double Diels-Alder reaction of methyl 
propiolate with furan, followed by saponification and reductive Barton decarboxylation is described. 
 
Keywords: fused 7-oxanorbornenes, diepoxynaphthalenes, acyl tosylate, Barton decarboxylation, saponification. 
 
Compounds bearing 7-oxanorbornene units have high potential in organic synthesis. Probably one of the most 
potential synthetic applications of this class of compounds is the opening of the oxa-bridge with different nucleophiles giving 
access to highly functionalized synthetic intermediates.1 Moreover, such kind of oxa-bridged compounds are perspective 
copolymers2 and building blocks for interesting molecules with extended π-systems. 3 
Herein we wish to report an improved synthesis4 of fused 7-oxanorbornenes 1 and 2 (Figure 1), the parent systems 
of the corresponding classes of compounds.1g-h The approach is based on Diels-Alder formation of 2 and 3 (Scheme 1), 
followed by saponification and reductive Barton decarboxylation. 
H
O O
H
H
O O
H
1 2  
Figure 1 
Our first goal was to improve a literature known5 double Diels-Alder reaction of methyl propiolate with furan 
(Scheme 2). A number of different Lewis acids have been tested (Et2AlCl, EtAlCl2, TiCl4, Ti(OiPr)4, Yb(OTf)3, ZnCl2, 
LiClO4) from which EtAlCl2 proved to be far superior also in respect to AlCl3 which has been employed in earlier studies.5 
                                                          
49 Accepted for publication. Numbering of schemes, compounds and references is used as in the original publication. 
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Under optimized conditions cycloaddition results in 79% yield of a 2.3:1 mixture of bis-adducts 3 and 4, which were 
separated by column chromatography and used for subsequent transformations.  
All further steps were optimized for the synthesis of 1 from 3, whereas 2 was synthesized from 4 in full analogy. Initial 
attempts to isolate the corresponding acid after saponification of 3 were not successful because of low solubility of the acid 
in organic solvents suitable for extraction (CHCl3, Et2O, DCM, EtOAc). This problem was solved by saponification with  
O
+
CO2Me
EtAlCl2
DCM, -20°C
CO2Me
O O
H
+
CO2Me
O O
H
3 4
53% 23%  
Scheme 1 
Ba(OH)2 followed by acidifying with H2SO4, removal of water, addition of Et3N and dissolving the thriethylammonium salt 
5 in DCM/CH3CN. By following this procedure yields up to 99% were obtained. Interestingly, the use of KOH-HCl or 
NaOH-HCl instead of Ba(OH)2-H2SO4 resulted in non reproducible yields of 75-95%. 
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4
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2. Et3N/DCM/CH3CN
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H
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Scheme 2 
Direct preparation of 6 (with 7 and Me2N(CH2)3N=C=NEt*HCl ) as well as conversion of 5 into the corresponding 
acid chloride followed by reaction with 7 or its sodium salt proved problematic and low yielding. The best results were 
obtained by in situ conversion of 5 into the corresponding acyl tosylate followed by reaction with 7 in the presence of Et3N. 
The resulting crude thiohydroxamic ester 6 was further subjected to reductive Barton decarboxylation6 to give 1 in 67% yield 
starting from ester 3. Interestingly, a corresponding product with inversion of configuration was not detected. By employing 
identical conditions, 2 was synthesized from 4 in 60% yield. 
In conclusion, we have developed an efficient synthesis of fused 7-oxanorbornenes 1 and 2 starting from methyl 
propiolate and furan. 
EXPERIMENTAL  
See Experimental Section for Chapter 7.1. 
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8. cis-Decalin Core of Branimycin via Desymmetrization of Diepoxynaphthalene:  
1st Generation Approach 
8.1.  First Oxa-Bridge Opening 
With a reliable synthesis of 141 in hand we could put our synthetic plans for the synthesis of the branimycin cis-decalin 
core into practice. From the three options discussed above (Scheme 38, Scheme 39) we chose first to approach ring A by 
opening of one of oxa-bridges with a carbon nucleophile in a syn fashion, followed by opening of the second oxa-bridge with 
a carbon nucleophile in an anti fashion to create the functional pattern required for ring B (Scheme 40).  
 
Scheme 40: 1st Generation approach  
Boronic acids were chosen as the first type of nucleophiles to be investigated. Although, for the synthetic scheme, 
vinylboronic acid was required as the nucleophile, its instability50 could complicate initial investigations. Therefore, we 
decided to test first a model nucleophile, p-tolylboronic acid. Unfortunately, selective opening of only one of oxa-bridges 
                                   Table 2: Syn opening of diepoxynaphthalene 141 oxa-bridges with nucleophiles 
 
Entry 
#  Convers. 
Ratio 
142#/143# 
Yieldd  brsm of 
142#, % (er) 
a pTolB(OH)2
a
 ca. 60 % 1 : 1 142a, “good yield” 
b (vinyl)4Sn no rxn - 142b, no rxn 
c (vinyl)2Zn
e no rxn - 142c, no rxn 
d Et2Zn
b 86 % 6.8 : 1 142d, 68 % 
e (TMSCH2)2Zn
b, f 100 % 1 : 0 142e, 50% (> 95 : 5)c 
a 5 mol % [Rh(COD)Cl]2, Cs2CO3, 10 mol % (S)-(R)-PPF-PtBu2, H2O, THF, rt. b 7 
mol % [(R)-Tol-BINAP]PdCl2,  Zn(OTf)2, DCM; then EtMgBr.51 c Determined from 
1H NMR of corresponding Mosher esters.d Yields were not optimized. e Prepared 
from ethereal solutions of vinyllithium52 and ZnCl2 following the 
general42a procedure. f Prepared from TMSCH2Li and ZnCl2 following 
the general42a procedure 
was not possible following literature43 conditions. Treatment of 141 with p-tolylboronic acid in the presence of a chiral 
rhodium catalyst and aqueous cesium carbonate delivered equal amounts of mono- and bis-opened products  (142a and 143a 
                                                          
50 Peyroux, E.;Berthiol, F.;Doucet, H.; Santelli, M. Eur. J. Org. Chem. 2004, 1075-1082. 
51 EtMgBr is necessary for this type of reaction and was used for any ZnR2, as Et does not become incorporated into the product. For an 
explanation see ref. 42a. 
52 Solid vinyllithium was prepared according to Eyferat, D.; Weiner, M. J. Am. Chem. Soc. 1961, 83, 3583-3586. 
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resp.) even at ca. 60% conversion (Table 2, entry 1). Attempts to substitute boronic acids with tetravinyl tin under the same 
reaction conditions (with or without Cs2CO3) resulted in no reaction. At this point we decided to switch to another option: 
use of diorganozinc nucleophiles under chiral palladium catalysis.42a  
Although attempts to react 141 with in situ prepared divinylzinc resulted in no reaction, employment of an aliphatic model 
nucleophile ZnEt2 provided the desired mono-opened product53 142d in good yield (Table 2). Moreover, prepared in situ 
(Me3SiCH2)2Zn also gave53 very promising results: 50% yield of corresponding product 142e was formed in enantiomeric 
ratio > 95 : 5. It should be noted, that the later nucleophile introduced an appendage potentially suitable for further 
transformation via oxidative silicon cleavage.  
8.2.  Attempts Towards Second Oxa-Bridge Opening 
Next, we turned our attention to functionalization of ring B in 142d (Scheme 41). To this end, three derivatives of 
alcohol 142d were prepared, two of which (144a: P = ZnEt and 144b: P = MOM) were planned to facilitate the opening of 
the oxa-bridge via possible complexation with a metal and the oxa-bridge. Unfortunately, all attempts to achieve the oxa-
bridge opening either with EtMgBr or Me2PhSiCH2MgCl resulted in no reaction at room temperature, and decomposition at 
higher temperatures. 
 
a 144a, P = ZnEt: ZnEt2, toluene, 0°C (in situ); 144b, P = MOM: MOMCl, iPr2EtN, DCM, rt, 80% (not optimized); 144c, P = Bn: BnBr, 
NaH, DMF, THF, rt, 82% (not optimized). 
Scheme 41: Attempts towards second oxa-bridge opening 
Parallel studies in another approach gave more promising results and therefore further investigations of this 1st 
generation approach were abandoned. 
 
 
 
 
 
 
 
                                                          
53 Absolute configuration of corresponding products 142a-e were assigned in analogy to literature precedents. 
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9. cis-Decalin Core of Branimycin via Desymmetrization of Diepoxynaphthalene:   
2nd Generation Approach 
9.1.  Opening of the First Oxa-Bridge 
As was mentioned above (Chapter 6), another option consisted of reversing the order of oxa-bridge openings: first anti 
opening could lead to the functional pattern of ring B, followed by syn opening of the second oxa-bridge and thus 
functionalization of ring A (Scheme 42): 
 
Scheme 42: 2nd Generation approach 
 The main drawback of this approach was the absence of developed methodology which would allow enantioselective anti 
opening of non-activated oxa-bridges. Despite this disadvantage, investigations were started. 
 
Scheme 43: Anti opening of the oxa-bridge in 141 
Gratifyingly, already the first attempts to make selective opening of only one of two oxa-bridges in 141 proved to be 
successful. Treatment of diepoxynaphthalene with a silyl bearing nucleophile, Me2PhSiCH2MgCl, under CuCl/Ph3P 
catalysis44 resulted in formation of the desired product, 148, in good yield (Scheme 43). Noteworthy, no products of a double 
opening were detected in the reaction mixture. 
Table 3: Attempts towards enantioselective anti opening of the oxa-bridge in 141 
 
 
Conditions era,b 
EtMgBr, 2 eq. 5 mol % Cu(OTf)2, 13 mol % L1, toluene, 0 to +6 °C 55 : 45 
EtMgBr, 2 eq. 10 mol % CuCl, 20 mol % L1, toluene, 0 to +6 °C 52 : 48 
Et2Zn, 1 eq. 5 mol % Cu(OTf)2, 1 eq. Zn (OTf)2, 13 mol % L1, toluene, 0 °C syn-opening 
a Determined from 1H NMR of Mosher esters. b Absolute configuration was not established. 
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A few attempts towards enantioselective anti opening were done employing model54 nucleophiles (Table 3), based on 
methodologies developed for enantioselective opening of activated oxa-bridges with Grignard46 and diorganozinc45 reagents. 
Unfortunately (although not surprisingly)47 almost no enantioselection was observed, and for the sake of strategy it was 
decided to abandon investigations on enantioselective anti opening and to concentrate on further steps. 
9.2.  Second Oxa-Bridge Opening 
Racemic alcohol 148 was further protected as its TIPS-ether to obtain 149 (Scheme 43), which could be tested in the 
opening of the second oxa-bridge. To our surprise, a reaction of 149 with model nucleophile ZnEt2 under chiral palladium 
catalysis lead to a mixture of expected product 151 of the oxa-bridge opening and a product 152 of the simple addition to the 
double bond without opening of the oxa-bridge (Scheme 44).  
 
Conditions: 149 + ZnEt2 1.5 eq. +7 mol % [(R)-Tol-BINAP]PdCl2, Zn(OTf)2, DCM, rt; then EtMgBr.42a,51 
Scheme 44: Reaction of 149 with Et2Zn 
Although absolute configurations of products were not established, we speculated that 151 came from undesired 
enantiomer 149u, whereas 152 derived from desired enantiomer 149d (u = undesired, d = desired). The following points 
supported our assumption: 
1. Chiral ligand of Pd-catalyst should lead (in principle) to the same chiral sense of    
attack of Et on the double bond for 149u and 149d. 
2. Two other possible regioisomeric products (153 and 154, Scheme 44) were not detected. 
To explain formation of products 151 and 152, we proposed the following hypothesis. In the first step ZnEt2 adds under 
chiral palladium catalysis to the double bond of each enantiomer to give two corresponding organometallic intermediates  
                                                          
54 Me2PhSiCH2MgCl was not tested as RMgCl are known to give low enantiomeric ratio, and preparation of Me2PhSiCH2MgBr was not 
developed at that time. ZnEt2 was chosen as no reliable method for synthesis of (Me2PhSiCH2)2Zn was developed at that time. 
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155u-M and 155d-M (M = metal).55 For intermediate 155u-M, a subsequent opening occurs smoothly giving the expected 
product 151. In contrast, in the case of intermediate 155d-M (which comes from desired enantiomer 149d), opening of the 
oxa-bridge would lead to increase of the eclipsing of the developing “C-O-“ substituent and the bulky OTIPS-group. This 
unfavorable interaction presumably suppresses opening of the oxa-bridge (Figure 1).  
We reasoned that if 155d-M does correspond to the “not opened product” just before work up, then M is mostly Zn56 
and we should be able to react this organometallic intermediate with D2O. This hypothesis was supported by literature 
precedent where authors observed sluggish oxa-bridge openings for certain substrates and corresponding organozinc 
intermediates(similar to intermediates 155d-M and 155u-M, M = ZnR, Scheme 44) had been trapped with some 
electrophiles.42a 
 
 
Figure 1: Proposed transition state for opening of the oxa-bridge in 155d-M 
(Geometry of 155d-M is simplified for the sake of clarity) 
 
In contrast, in our case quench of the reaction mixture with D2O resulted in no incorporation of deuterium57 into product 152 
indicating that intermediate 155d-M abstracts hydrogen from another source58 before quench. From this results we 
concluded, that after the full conversion of 149d (i.e. at the end of the reaction of addition of Et to the double bond of 149d), 
there is no organometallic intermediate 155d-M (M = ZnR) in the reaction mixture. Consequently, applying forcing 
conditions (increase in temperature or reaction time, addition of Lewis acids etc.) at this stage would not lead to opening of 
the oxa-bridge.  
Basing on the proposed eclipsing in the course of oxa-bridge opening (Figure 1), we decided to change TIPS with less 
sterically demanding protecting groups. To this end, alcohol 148 was protected with BnBr or PMBBr to obtain 156a or 156b 
respectively (Scheme 45). To our delight, opening of the oxa-bridges of these new substrates 156a,b proceeded equally well 
for both enantiomers.59 
According to our synthetic plan, the position C9 had to bear not CH2SiMe2Ph, but CH2O-appendix, therefore 156b was 
subjected to oxidative cleavage of silicon to obtain 159, in good yield (Scheme 45). The newly formed alcohol was converted 
to two derivatives: protection as its TBS-ether to give 156c, or methylation to give 156d. Similar to 156a,b, reactions of 
these “real” substrates with ZnEt2 gave expected products without substantial complications.60 
 
                                                          
55 Exact structure of intermediates 155u-M and 155d-M are not known. Although proposed mechanisms imply M = Pd (ref 42b,c), in 
certain cases intermediates with M = Zn were detected (ref. 42a,b).  
56 Palldaium was used in catalytic amounts (7 mol %), therefore it cannot present in more than 7% of 155d-M. 
57 No changes in 13C (JMODE) specatra were observed such as appearing of a new signal in CH/CH3-hemiplane or a signal with a large 
(not suppresed) 1JCH. 
58 E.g. via β-hydride elimination from a possible Pd-Et intermediate and subsequent reductive elimination. 
59 A possible role of chelation between oxa-bridge and OBn or OPMB (what is less likely to occur in case of OTIPS) cannot be excluded, 
although it should be noted that for another enantiomer 155u-M opening occurred smoothly even with the TIPS-group. Another reason 
could lie in possibly different geometry of corresponding intermediates 155d-M in case of the bulky TIPS and the less bulky Bn (or 
PMB). This in turn could reflect on extent of overlap of CM-bond and breaking CO-bond of the oxa-bridge. 
60 Reactions with TBS group had to be carried out at 0 °C as partial TBS-deprotection took place. 
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Scheme 45: Preparation of new substrates and their reactions with Et2Zn 
 
Moreover, when pure enantiomer 156d-u61 was submitted to a reaction with Et2Zn under standard conditions, corresponding 
product 157d was formed with good regioselectivity (>10 :1). This experiment shows that a reaction of racemic 156 likely 
leads to formation of a mixture of enantioenriched products 157 and 158. Consequently, this approach could be suitable for 
synthesis of enantiopure cis-decalins starting from racemic precursors. 
 
 
Scheme 46: Reaction of enantiopure 156d-u with Et2Zn 
 
Encouraged by these promising preliminary results, we switched our attention from model nucleophile ZnEt2 to 
nucleophiles bearing substituents suitable for further elaboration. Literature analysis showed that the presence of oxygen 
substituents in ZnR2 inhibits the desired reaction,42a therefore divinylzinc or aliphatic silicon-containing diorganozinc 
reagents were chosen as potential nucleophiles. 
                                                          
61 156d-u and 156d-d were obtained after separation of racemic 156d by chiral HPLC. The experiment with Et2Zn was carried out in order 
to determine the absolute configuration of enantiomers after separation. The corresponding reaction with enantiomer 156d-d was not 
carried out as the results would not give an information on regioselectivity (i.e. enantioselectivity) of reaction with “real” (not model) 
nucleophiles. 
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Table 4: Reaction of 156a-d with different nucleophiles 
 
     Entry 
#  
Substarte Conditions Yielda, b of 161-# 
1 (vinyl)2Znc 156a h, rt n.r. 
2 (Me2PhSiCH2CH2)2Zn
d 156c h, 0 °C n.r. 
3 (Me2PhSiCH2CH2)2Zn
e 156c h, 0 °C n.r. 
4 (Me2PhSiCH2CH2)2Zn
e 156b h, rt n.r. 
5 (Me2PhSiCH2CH2)2Zn
e  h, rt n.r.
62 
6 (TMSCH2)2Zn
f 156d h, rt traces65 
7 (Me2PhSiCH2)2Zn
g 156b h, rt n.r. 
8  156a 
i, rt or 0 °C traces 
9  
156d i, 40 °C traces 
10  156a i or j, rt n.r. 
11 
 
156a i, rt traces 
12 vinylB(OH)2 , (Ref. 63) 156a i, rt traces 
13  (Ref.64) 
156b i, rt very slow 
conversion 
14   (Ref.64) 
156b i, 40 °C 90% 
a In some cases a yield of a reaction was estimated semi-quantitaevely from crude NMR 
and TLC. b n.r. = no reaction. c Prepared from ethereal solutions of vinyllithium52 and 
ZnCl2 following the general procedure (ref. 42a). d Prepared from ethereal 
solutions of RMgBr and ZnCl2 following the general procedure. e 
Prepared from ethereal solutions of RLi (from RCl and Li°) and ZnCl2 
following the general procedure (ref. 42a). f Prepared from ethereal 
solutions of RLi and ZnCl2 following the general procedure (ref 42a). g 
Prepared from ethereal solutions of RMgCl and ZnCl2 following the general procedure 
(ref. 42a). h [(R)-Tol-BINAP]PdCl2, Zn(OTf)2, DCM; then EtMgBr. iRh(COD)Cl]2, 
Cs2CO3, (S)-(R)-PPF-PtBu2, H2O, THF, rt. j The same as i, but without Cs2CO3 and 
H2O. 
                                                          
62 Subsequent addition of ZnEt2 into reaction mixture resulted in conversion into corresponding Et-substituted product, although slower 
than in a reaction with ZnEt2 as the only nucleophile. This experiment demonstrates that although a partial deactivation of a catalyst 
occurred, it was still potentially active. 
63 Braun, J.; Normant, H. Bull. Soc. Chim. Fr. 1966, 2557-2564. 
64 Pereira, S.; Srebnik, M. Organometallics 1995,  14(7),  3127-3128. 
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To our great disappointment, divinylzinc (Table 4, Entry 1), (Me2PhSiCH2CH2)2Zn (entries 2-5) and Zn(Me2PhSiCH2)2 
(entry 7) gave no reaction even after extended reaction times, whereas Zn(TMSCH2)2 (entry 6) resulted only in traces of the 
product together with substantial decomposition.65 Attempts to perform the oxa-bridge opening with boronic acids under Rh 
catalysis also gave rather poor results. Thus, reaction with vinylboronic acid (entry 12) or its derivatives (entries 8-11) gave 
only traces of the desired product together with a mixture of undefined side products.  
Employing silyl-substituted vinyl boronic acids (entries 13-14) provided desired product 161-14 in 90% yield (45% 
from 50% theor.). Unfortunately, we were not able to cleave the silyl substituent under variety of conditions (Scheme 47). 
Employing unbuffered TBAF led to conjugation of the double bond (162), whereas change to milder conditions resulted in 
no reaction. 
 
 
Scheme 47: Attempts to cleave the silicon substituent in 161-14 
 Moreover, it should be noted, that skipped diene 161-14 proved to be unexpectedly air sensitive. Exposure of neat 161-
14 to air for 20 min at room temperature resulted in almost quantitative conversion to dienic hydroperoxide 163 (Scheme 
48). Later on a similar oxidation was observed for relative compounds 164 and 165. For discussion see Supporting 
Information for the Organic Letters publication, Chapter10.2).  
In light of potential instability of products, reactions of oxa-brdige opening with vinylB(OH)2 and Zn(TMSCH2)2 were 
reinvestigated. However, in these cases low yields (estimated from crude NMR) most probably cannot be attributed to 
autooxidation processes, as characteristic signals of diene moiety CH=CCH=CH (d, range 6-6.5 ppm) and OOH (s, range 7-
7.5 ppm) were not detected. 
 
TMS
OH OPMB
OMe
air, dark
20 min, rt
TMS
OH OPMB
OMe
HOO
ca. 80%
OH OPMB
OMe
O OPMB
OMe
161-14 163
164 165  
Scheme 48: Autooxidation of 161-14 
Although this approach had proved to some extent promising, it became obvious, that for obtaining practically valuable 
results we would have to invest  a substantial amount of additional time and effort to optimize the second oxa-bridge 
opening. At the same time, parallel investigations in another direction proved more promising. As a result, this approach was 
abandoned. 
                                                          
65 It should be noted, that Zn(TMSCH2)2 was successfully used in our 1st generation approach; moreover, ZnEt2 prepared in situ from 
EtMgCl and ZnCl2 gave identically good results to commercial ZnEt2. [Therefore our laboratory equipment and skills proved suitable for 
this rather sensitive area of chemistry.] 
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10. cis-Decalin Core of Branimycin via Desymmetrization of 
Diepoxynaphthalene: 3rd Generation Approach 
10.1.  Synthetic Outline and Initial Attempts Towards Functionalization of Rings A and B 
Although openings of the oxa-bridges with carbon nucleophiles gave rather poor results in both opening orders (first 
ring A, then ring B or vice versa) there was still another option: employing formal “H-“ nucleophile for the second oxa-
bridge opening would give us access to cis-decalin core of type D2 (Scheme 49). 
 
Scheme 49: 3rd Generation approach 
As a substrate for the second oxa-bridge opening, we chose PMB-protected compound 156d. Following the procedure 
developed by Lautens et al.,48 compound 156d was treated with DIBAL under chiral nickel-complex catalysis to give the 
products of SN′ oxa-bridge opening 167 and 168 in a 91 % combined yield (Scheme 50). From two obtained products, 167 
and 168, only the former was suitable for further elaboration. 
Ni(COD)2 (20 mol %)
(R)-BINAP (30 mol %)
DIBAL, toluene, rt, 6 h
H
H
OPMB
OMe
HO
H
H
OPMB
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HO
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+
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Scheme 50: Opening of the second oxa-bridge with formal hydride anion 
As the cis-decalin 167 was expected to have a shape of an “open book”, we planned to epoxidize both double bonds from the 
convex side. This would provide bis-epoxide 169. The alcohol should be then oxidized to ketone 170. Selective enolization 
at C3 would lead to opening of one of epoxides to give compound 171 as a representative of targeted D2. Similar to the plan 
discussed earlier in Scheme 35, the oxygen functionality at C5 would have to allow introduction of the C2-appendage at the 
C3 position, either via SN′-substitution or via Claisen rearrangement. However, in the latter case configuration at C5 would 
have to be inverted. 
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Scheme 51: Double epoxidation strategy towards D2 
Following the outlined plan, diene 167 was epoxidized by treatment with mCPBA. To our surprise two regioisomeric mono-
epoxides 172 and 173 were isolated, and configuration of epoxides in both cases was opposite to the expected one. Selective 
epoxidation from the concave side of the cis-decalin was attributed to delivery of mCPBA by the OH-group. Employing 
dimethyldioxirane (DMDO) resulted in full decomposition. In order to prevent coordination of the OH-group with mCPBA, 
alcohol 167 was oxidized to ketone 174 by the Dess-Martin reagent. Unfortunately, subjection of 174 to epoxidation with 
DMDO or mCPBA gave a complex mixture of products.  
 
Scheme 52: Attempts towards epoxidation of 167 and 174 
Although room for studies on epoxidation remained, we turned to another option, which at that time proved more promising. 
The new approach resulted in a publication submitted to Organic Letters (for a copy of the manuscript see Chapter10.2.)      
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10.2. A Desymmetrization Approach Towards Highly Oxygenated cis-Decalins (Publication in 
Organic Letters)  
A Desymmetrization Approach Towards 
Highly Oxygenated cis-Decalins 
Alexey Gromov*, Valentin Enev and Johann Mulzer* 
University of Vienna, Institute of Organic Chemistry, Währingerstrasse 38 
A-1090 Vienna, Austria. 
alexey.gromov@univie.ac.at; johann.mulzer@univie.ac.at 
Received Date (will be automatically inserted after manuscript is accepted) 
ABSTRACT 
The cis-decalin core 2 of the antibiotic branimycin has been prepared by desymmetrization of diepoxy-naphthalene 4. 
The key steps involve two successive SN′ opening of the oxa-bridges. An improved procedure for the synthesis of 4 
is also described.  
In recent years our group became interested in the 
development of various novel approaches towards the 
synthesis of highly functionalized cis-decalins in the 
context of an ongoing study towards the total synthesis of 
the highly active antibiotic branimycin66,67 (1). 
In our new approach, we envisioned that the 
construction of the cis-decalin core 2 of branimycin (1) 
could be accomplished by desymmetrization68 of 
diepoxynaphthalene 4 (Scheme 1) via two successive SN´ 
reactions. First a copper mediated SN´ opening of one of 
the oxa-bridges was performed with a Grignard reagent 
containing a silyl group as a latent hydroxy group, 
                                                          
66 (a) Enev, V. S.; Drescher, M.; Mulzer, J. Org. Lett. 2008, 10, 413-416. 
(b) Enev, V. S.; Drescher, M.; Mulzer, J. Tetrahedron 2007, 63, 5930-
5939. (c) Marchart, S.; Mulzer, J.; Enev, V. S. Org. Lett. 2007, 9, 
813−816.(d) Felzmann, W.; Arion, V. B.; Mieusset, J. L.; Mulzer, J. 
Org. Lett. 2006, 8, 3849−3851. (e) Review: Mulzer, J.; Castagnolo, D.; 
Felzmann, W.; Marchart, S.; Pilger, C.; Enev V. S. Chem. Eur. J. 2006, 
12, 5992 – 6001. 
67 Isolation and biological activity of branimycin: (a) Speitling, M. Ph.D. 
Thesis, Universität Göttingen, 1998. (b) Speitling, M.; Grün-Wollny, I.; 
Hannske, F. G.; Laatsch, H. 12. And 13. IRSEER Naturstofftage der 
DECHEMA e.V. Irsee 2000, 2001, poster sessions 
68 For similar desymmetrizations, see: (a) Lautens, M.; Fillion, E. J. 
Org. Chem. 1996, 61, 7994-7995. (b) Lautens, M.; Fillion, E. J. Org. 
Chem. 1998, 63, 647-656 
. 
followed by an enantioselective SN´ opening of the 
second oxa-bridge with a formal hydride anion. 
 
Scheme 1. Retrosynthetic Overview of Compound 2 
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The synthesis of diepoxynaphthalene 469 commenced 
with the twofold Diels-Alder reaction between methyl 
propiolate and furan (Scheme 2). When we performed 
this reaction at 0 °C for 4 h, both diastereomers 5a (52%) 
and 5b (14%) were formed. However, on longer reaction 
times, the undesired diastereomer 5b slowly disappeared, 
leaving 5a as a single diasteromer along with some 
decomposition products.70 This protocol avoids the 
tedious chromatographic separation of 5a and 5b and is 
suitable for the synthesis of 5a on a multigram scale. 
 
Scheme 2. Synthesis of Tetracycle 4 
 
HPT = 1-hydroxypyridine-2(1H)-thione. 
 
The four-step elaboration of ester 5a to 
diepoxynaphthalene 4 proved straightforward.69 
Saponification of 5a provided the corresponding acid, 
which was isolated as the triethylammonium salt 6. 
Activation of the carboxylate via the acyl tosylate and 
conversion to N-thionopyridyl ester 7 was followed by 
reductive Barton decarboxylation to furnish the desired 
tetracyclic compound 4 in 67% overall yield from 5a. 
With a reliable route to diepoxynaphthalene 4 in hand, 
the selective opening of the oxa-bridges could be tested. 
We were delighted to find that exposure of 4 to 
Me2PhSiCH2MgCl/CuCl/Ph3P under the conditions 
described by Carretero et al.71 resulted in an anti SN´ 
opening of only one of the oxa-bridges to give compound 
8 in 75% yield (82% brsm). Alcohol 8 was protected as a 
                                                          
69 For preliminary studies on the synthesis of 4 see: Gromov, A.; Enev, 
V.; Mulzer, J. Syn. Comm. in press. 
70 For a discussion of this phenomenon see comment 1 in the Supporting 
Information. 
71 Arrayás, R., G.; Cabrera, S.; Carretero, J. C. Org. Lett. 2003, 5, 1333-
1336.  
PMB-ether with PMBBr (prepared in situ from PMBCl72 
and NaBr in DMF). Next, the C-Si bond was cleaved 
oxidatively to deliver the corresponding primary alcohol 
which was converted to methyl ether 3 in 73% yield over 
two steps. 
 
Scheme 3. Desymetrization of Compound 4 
 
 
The stage was now set for the conversion of the 
remaining oxa-bridge into the α,β-unsaturated ketone 
moiety of 2 (Scheme 4). Following a procedure by 
Lautens et al.73 racemic compound 3 was treated with 
DIBAL and Ni(COD)2/(R)-BINAP. Indeed, a pseudo-
enantiotopos-selective hydrogen attack was achieved on 
both enantiomers of 3 to give the enantiomerically 
enriched regioisomers 1174 and 12 in 91% yield, easily 
separable by chromatography.75 
                                                          
72 A reliable scalable procedure for preparation of PMBCl: Chaudhari, 
S., S.; Akamanchi, K., G. Synlett 1999, 11, 1763–1765. 
73 Lautens, M.; Rovis, T. Tetrahedron 1998, 54, 1107-1116. 
74 It has to be pointed out that skipped dienes 11 and 13 (not shown, see 
Supporting Information) proved to be air sensitive to give dienyl 
hydroperoxides (for a discussion see comment 2 in the Supporting 
Information). 
75 Toluene as a solvent was essential for a high yield of the desired 
products. Performing the reaction in THF resulted in the formation of ca 
50% of compound 3′. This solvent 
effect might be attributed to the higher Lewis acidity of aluminum 
species in the non-coordinating toluene. An increase in Lewis acidity 
presumably favors coordination of Al with the oxa-bridge and therefore 
facilitates the C-O bond cleavage. For other examples of Lewis acids 
influence on oxa-bridges opening see: Lautens, M.; Chiu, P.; Ma, S.; 
Rovis, T. J. Am. Chem. Soc. 1995, 117, 532-533 and ref. cited therein. 
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Scheme 4. Opening of the Second Oxa-Bridge and Synthesis of Compound 2 
 
a The major diastereomer is shown. 
 
The synthesis of 2 was continued with a Dess-Martin 
oxidation of 11, followed by base catalyzed double bond 
isomerization to provide α,β-unsaturated ketone 14 in 
88% yield. Regioselective epoxidation of diene 14 with 
mCPBA gave a 3:1 mixture of diastereomeric epoxides, 
easily separable by chromatography. To avoid 
competitive Bayer-Villiger oxidation, the reaction was 
stopped at ca. 50% conversion. The relative configuration 
of the major diastereomer 2 was determined by single 
crystal diffraction (see Supporting Information).  
To secure the absolute configuration of our products 
racemic compound 3 was separated into the enantiomers 
by chiral HPLC. Under the same conditions used for the 
racemate, enantiomer (+)-3 gave 11. On the other hand, (-
)-3 was converted into alcohol 15 and then into crystalline 
urethane 16, the X-ray analysis of which allowed the 
determination of the absolute configuration based on the 
anomalous dispersion of chlorine atoms. 
In conclusion, we have demonstrated that 
organometallic catalysis can be used for a successive 
desymmetrization of diepoxynaphthalene 4. This opens a 
direct access to highly functionalized cis-decalin systems 
as exemplified by the core of branimycin.  
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A Desymmetrization Approach Towards 
Highly Oxygenated cis-Decalins 
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Comment 1. The disappearing of 5b could be explained by decomposition, facilitated by a possible formation of cyclic 
complex 5b′ (Scheme S1) which is not possible in the case of 5a. A similar difference in decomposition rates was observed76 
earlier for the corresponding ethyl esters in the presence of AlCl3, but even for the more stable isomer degradation was still 
very substantial. 
 
Scheme S1 
Comment 2. Skipped dienes 11 and 13 proved to be relatively unstable when exposed to air even at -20 °C in the 
absence of light, giving rise to a mixture of hydroperoxides (Scheme S2). These dienyl hydroperoxides have characteristic 
signals in 1H NMR (CDCl3): a doublet at ca. 6.0-6.5 ppm (CH=C-CH=CH) and a singlet at ca. 7.5-8.0 (OOH). 
As was proposed earlier,77 oxidation presumably proceeds via initial abstraction of a hydrogen radical by 3O2 and 
formation of a corresponding stabilized allylic C-radical (Scheme S2). As not all alkenes and skipped dienes are equally 
sensitive to oxygen, facile oxidation of 11 and 13 could be explained by conformationally fixed alignment of the allylic C-H 
bond to the π-system. 
 
Scheme S2 
For other examples of autooxidation of alkenes and dienes see ref. 3.78 
10.3.  Further Studies on the Synthesis of the cis-Decalin Core 
As was reported in Chapter 10.2 (publication in Organic Letters), our investigations resulted in the development of a reliable 
route to epoxy ketone 175, where the final epoxidation resulted in a 3:1 mixture79 of epoxides. Further investigations80 also 
revealed, that a change from OPMB to OTBS-group, results in an increase in diastereomeric ratio to 10:1 (93% yield). The 
                                                          
76 McCukkoch, A. W.; Smith, D. G.; McInnes, A. G. Can. J. Chem. 1974, 52, 1013-1018. 
77 Nickon, A.; Mendelson, W. L. J. Org. Chem. 1965, 30, 2087-2089. 
78 (a) Williams, R. D.; Robinson, L. A.; Nevill, C. R.; Reddy, J. P. Angew. Chem. Int. Ed. 2007, 46, 915 –918. (b) Methot, J. L.; Roush, W. 
R. Org. Lett. 2003, 5, 4223-4226. (c) Smith, A. B.; Ishiyama, N. K. H.; Minakawa, N.; Rainier, J. D.; Hartz, R. A.; Cho, Y. S.; Cui, H.; 
Moser, W. H. J. Am. Chem. Soc. 2003, 125, 8228-8237. (d) Enev, V. S.; Drescher, M.; Mulzer, J. Org. Lett. 2008, 10, 413-416. 
79 Diastereomeric epoxides are easily separable by chromatography. 
80 Together with Mag. S. Marchart (Prof. Mulzer research group). 
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best yields were obtained at ca. 60% conversion, whereas full conversion resulted in decrease in yield down to 77%, mostly 
due to a competitive Bayer-Villiger oxidation.  
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Scheme 53: Further studies on the synthesis of the cis-decalin core  
To synthesize 178, compound 176 was subjected to PMB deprotection to give 177 in ca. 98% yield. It is worth mentioning, 
that in this rather trivial transformation, low temperature was important for obtaining a high yield. Crude81 177 was further 
protected with TBSOTf to give 178. Best results (89%) were obtained with 2,6-di-tert-butylpyridine, whereas with 2,6-
collidine yield decreased to 75%. Finally, epoxidation of 178 was carried out as discussed in the previous paragraph. 
                                                          
81 Alcohol 177 was not purified from PMPCHO due to its instability on silica gel. 
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11. Synthesis of the C13-C18 Side Chain 
Earlier investigations in the Mulzer group resulted in development of the very elegant synthesis82 of side chain 182 (Figure 
2). Nevertheless, we found it necessary to undertake certain optimization studies due to high price of starting (S)-glycidol 
and need in large quantities of the side chain. Additionally, we decide to exchange TIPS protecting group with the easier 
cleavable TBS group. 
 
Figure 2: The side-chain synthesized by Muzer group  
Methylation of (S)-glycidol with MeI/Ag2O under original82 conditions required reflux for 24-48 h and never resulted in 
full conversion, giving isolated yield of 183 ca. 60-65%. To our delight, addition of molecular sieves83 resulted in full 
conversion after 2 h and isolated yield of 75-78%.84,85  
 
 
Scheme 54: Synthesis of aldehyde 185 
Opening of 183 with sulfur ylide,86 followed by TIPS protection of resulting allylic alcohol and ozonolysis were 
performed in accordance with reported procedures providing aldehyde 185 in 60% over 3 steps.  
Unfortunately, the reaction of chiral allenylsilane 186 with aldehyde 185 under reported82 conditions (1 eq. TiCl4, -78 
°C) in our hands gave low yield of the desired product 187 (Table 5). Side product 18890 together with products of 
decomposition comprised material balance. Variations in Lewis acid87 (Et2AlCl, EtAlCl2, TMSOTf, TiF4, LiClO4, Eu(OTf)3, 
(CF3)CHOH88) and quench (aq. NH4Cl or Et3N/aq. NaHCO3) resulted in no improvement in the yield. Therefore we decided 
to come back to TiCl4 and investigate this reaction in details.  
                                                          
82 Felzmann, W.; Castagnolo, D.; Rosenbeiger, D.; Mulzer, J. J. Org. Chem. 2007, 72, 2182-2186. 
83 Reymond, S.; Cossy, J. Tetrahedron 2007, 63,  5918–5929. 
84 As in the course of the methylation reaction, water liberates as a byproduct, it competes with glycidol in reaction of methylation, 
producing MeOH, which, in turn, can also compete with glycidol. Therefore, a beneficial effect of molecular sieves 4Å could be 
attributed to adsorption of water and MeOH, and, therefore, no Ag2O getting consumed in “side methylations”, allowing the desired 
methylation to go to completion. 
85 This reaction is virtually “quantitative”, but volatility of the product 183 resulted in some loss during isolation. 
86 Interestingly, for obtaining of full conversion in this reaction, employing of 2.5 M nBuLi was necessary. Use of 1.6 M BuLi resulted in 
lower solubility of ylide in reaction mixture (due to higher amount of hexane coming from nBuLi hexane solution) and consequently 
much longer reaction times. These results were obtained by Ing. M. Drescher and Univ. Doz. V. Enev (University of Vienna, Prof. 
Mulzer research group). Mechanism of this reaction: 
 
87 Other Lewis acids were tested earlier: BF3*Et2O, SnCl4, AlCl3 and TiBr4.82 
88 Ratnikov, M. O.; Tumanov, V. V.; Smit, W. A. Angew. Chem. Int. Ed. 2008, 47, 9739-9742. 
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Table 5: Propargylation of aldehyde 185 
 
TiCl4 (eq.) T (°C) Yielda,b of 187, % Yield
a,b of 188, % 
1.0 -78 8 40 
1.2 -78 40 32 
1.7 -78 82 18 
1.7 -95 to -78 89 (85, dr 20 :1) 11 
1.7 -50 68 32 
3.0 -78 79 21 
a Yields were estimated from NMR using 4,4′-di-tert-butyl-biphenyl as an internal standard. 
Isolated yields are given in parentheses. b Although absolute values of yields determined  
from NMR are obviously affected by a certain measurement error, the tendency of yields 
changes is apparent. 
Itis known, that titanium species can exist in aggregated forms89. Consequently, an outcome of reactions in principle 
could be sensitive to concentration. With this idea in mind, we decided to vary amount of TiCl4. As can be seen from Table 
5, changes in the number of equivalents of TiCl4 had dramatic effect on products distribution. To our great delight, yield of 
the desired product 187 increased up to 85% employing 1.7 eq. of TiCl4 at low temperatures. Noteworthy, the latter results 
were obtained on 12 mmol scale, what allowed us preparation of 187 in large quantities.  
The subsequent four-step elaboration of side chain 192 proved straight forward (Scheme 55). Alcohol 187 was protected 
with MOMCl/iPr2EtN; the triple bond was hydrozirconated, followed by iodination to give the corresponding vinyl iodide. 
 
Scheme 55: Synthesis of side-chains 192a,b 
Finally, the TIPS protecting group was exchanged with TBS in two steps to obtain 192a in 69% over four steps. In a similar 
manner derivative side chain 192b was prepared employing PMBBr instead of MOMCl. 90 
                                                          
89 M. Santelli and J.-M. Pons. Lewis Acids and Selectivity in Organic Synthesis, CRC Press, Boca Raton, FL (1995). 
90 Formation of 188 was also reported earlier.82 Proposed mechanism for formation of 188: 
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12. Connection of the cis-Decalin Core and the Side Chain and Further 
Transformations 
12.1. The synthetic plan 
Development of the syntheses of epoxy ketone 179 and side chain 192a,b set the stage for connection of these two 
fragments. Our plan was similar to the strategy described earlier by Kallmerten (Scheme 6): metallated side chain 192-Li 
should be added to the carbonyl of 179 and the resultant alkoxide should open the epoxide to give the desired compound 193 
with the oxa-bridge.  
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Scheme 56: Further synthetic plans 
Next, we planned introduction of the alcohol functionality at the C5 position and perform a Claisen rearrangement to 
introduce C2-apendix at the C3 position. Subsequent macrolactonization, introduction of CH2OMe at the α–position to the 
carbonyl (at C2) and global deprotection should finish the synthesis. As a further option, the sequence: macrolactonization - 
introduction of CH2OMe could be reversed. 
 
12.2. Coupling of the cis-Decalin Core with the Side Chain, and Introduction of the C5-Oxygen 
Functionality 
Synthesis of two side chains described in Chapter 11 requires some comments. According to our synthetic plan, one of 
transformations had to include an allylic oxidation to obtain the oxygen functionality required at the C5 position. We 
believed, that one of the most suitable protecting group at 16-OH is PMB, as its deprotection at later stage of the synthesis 
could be achieved under very mild conditions, orthogonal to other present functionalities. On the other hand, concerns about 
behavior of the PMB-group under allylic oxidation conditions prompted us to secure the approach by preparation of 
alternative side chain 192a with MOM protecting group, which should be more stable towards oxidation.  
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Scheme 57: Coupling of the side-chain with the cis-decalin core; allylic oxidation 
Vinyliodide 186a was metallated with tBuLi, followed by reaction with epoxy ketone 179, what resulted in clean conversion 
into desired compound 195 (shown in Scheme 56) possessing the oxa-bridge. Formation of the oxa-bridge was demonstrated  
by observation of a 3JC-H between C12 and H7. The newly formed C8 alcohol was protected as its TBS ether, to give 196a. In 
the same, way compound 196b was synthesized starting from 186b. The stage was now set for an allylic oxidation at the C5 
position. Unfortunately, only decomposition was observed upon subjection of 196b to Mn(OAc)3*2H2O/tBuOOH.91 
Employing an excess of CrO3*3,5-dimethylpirazole92 resulted in oxidation of PMB-ether to its corresponding p-
methoxybenzoic ester 197, but no products of the allylic oxidation were observed in the crude reaction mixture93 even after 
extended reaction times. 
In contrast, substrate 196a bearing a MOM-group instead of a PMB-group gave the desired product of the allylic oxidation 
198 in a 55% together with 12% of regioisomeric C3 ketone. Studyingof the influence of solvents showed that performing 
the reaction in EtOAc, CH3CN or PhCl gave almost no difference with respect to CH2Cl2, whereas no reaction was observed 
in DMF or THF. Conducting oxidation in DCM at -78 °C gave no reaction even if the reaction mixture was subsequently 
warmed to the standard temperature -20 °C.94 At -60 to -40 °C ratio of regioisomers improved to 7:1, but the reaction stopped 
at ca. 50% conversion, and no substantial difference in yield of the desired regioisomer (brsm) was observed. Employing 
PhIO2/(PhSe)2 led to decomposition, and Mn(OAc)3*2H2O/tBuOOH gave the desired product 198 in very low yield (ca. 
30%). Therefore, original conditions (CrO3*3,5-dimethylpirazole , CH2Cl2, -20 °C) so far gave the best results for this 
transformation.  
                                                          
91 Mn oxidation 
92 Salmond, W. G.; Rarta, M.  A.; Havens, J. L. J. Org. Chem. 1978, 43, 2057-2059. 
93 α,β-Unsaturated ketones could be easily distinguished from crude 1H NMR by appearing of characteristic low field C=CH-signals. 
94 Complex CrO3*3,5-dimethylpirazole is prone to polymerization in solution at temperatures above -20°C.92 Too low temperatures could 
result in precipitation of the complex from solution and subseqent polymerization.  
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Scheme 58: Stereoselective Luche reduction of 198 
Mixture95 of ketones 198 and its isomer was reduced under Luche conditions, to give desired allylic alcohol 199 in high 
yield and diastereoselectivity. Exact reason for high stereoselectivity of the reduction is not totally understood. Complexation 
of cerium with the carbonyl group and the oxa-bridge is unlikely, as the lone pairs of these two oxygen atoms are not suitably 
oriented. Transfer of the hydride anion from the less sterically hindered side could be considered as a possible explanation. 
 
12.3. Claisen Rearrangemets 
The stage was now set for the crucial introduction of the C2-appendage at C3, which was planned via one of variations 
of the Claisen rearrangement. To this end, 199 was subjected to a number of conditions for the Johnson- 
 
Scheme 59: Attempts towards Johnson-Claisen and Ireland-Claisen rearrangements 
Claisen rearrangement. Unfortunately, in all cases no desired product 200 was detected. At lower temperatures, reactions led 
to recovery of some starting material and formation of the corresponding acetate; and at higher temperatures, decomposition 
took place. All attempts to perform the Ireland-Claisen rearrangement from the corresponding acetate 201 also proved 
fruitless. Formation of a lithium enolate, with LHMDS, followed by reaction with TMSCl resulted in prevailed formation of 
C-silylation product 202. Changing to KHMDS/TMSCl, with subsequent heating at 60 °C, resulted in recovery of starting 
acetate 201 with and ca. 30 mol % of C-silylation product 202.  
                                                          
95 Isomeric ketones 198 and 198’ in our hands proved inseparable by conventional flash column chromatography. However, after reduction 
to their corresponding alcohols in the next step, regioisomers could easily be separated. 
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Table 6: Eschenmoser-Claisen rearrangement in a closed vessel 
 
Entry Solvent 4Å MS Temp. (Time) Yield 
a,b 
1 Xylenes
c + oil bath, 130 →150 °C 
(12 h) 
traces 
2 Tetralin - oil bath, 130 → 170 °C (open vessel) 
no product 
3 DMF
c + µW, 150 °C (5h) 30% 
4 DMF
c + µW, 190 (20 min) 72% 
5 DMF
c - µW, 220 °C 41% 
6 DMF
c + µW, 220 °C (4 min) 72% (64%) 
7 DMF
c +d µW, 220 °C 72% 
8 DMF
c + µW, 250 °C 68% 
a Yields were estimated from NMR using 4,4′-di-tert-butyl-biphenyl as an internal 
standard. Isolated yields are given in parentheses. b Although absolute values of  
yields determined from NMR are obviously affected by a certain measurement 
error, the tendency of yields changes is apparent. c Reaction was conducted in a 
closed vessel. d 4Å MS were used in 1.5 time higher than in the entry 6 (see 
experimental part).  
 
Although room for optimization of the Ireland-Claisen rearrangement remained, at this time the Eschenmoser-Claisen 
rearrangement gave much more promising results (Table 6). Initial attempts to carry out the rearrangement in an open vessel 
in tetralin gave no product at all. Conducting the reaction in a sealed tube in xylenes in the presence of 4Å MS20 (beads) 
resulted to formation of traces of 203 after 12 h ad 150 °C. However, the product was detected in substantial amount when 
the reaction was performed in DMF in a closed vessel in the presence of powdered 4Å MS (entry 3). Increasing the 
temperature to 190 °C and shortening of the reaction time, to 20 min, resulted in pronounced improvement in the yield; up to 
72% (from NMR). The most practical conditions were found to be irradiation at 220 °C for 4 min to obtain the desired 
product in 64% isolated yield (72% from NMR) on 100 mg scale. Increasing the amount of molecular sieves by a factor of 
1.5,with respect to the “standard” amount (see Experimental Section for Chapter 12), did not result in any significant 
difference. Finally, the beneficial effect of molecular sieves was demonstrated (entry 5 vs. 6). An exact reason as to why 
molecular sieves are beneficial for the reaction remains unclear. We believe that 4Å MS could shift equilibrium towards 
reactive species in the Eschenmoser-Claisen rearrangement by adsorption of MeOH. Nevertheless, additional effects could 
not be a priori excluded, e.g. overheating on the surface of molecular sieves.96  
                                                          
96 It was observed that reaction mixtures containing MS adsorb microwave irradiation much more efficient. From this, we hypothesized, 
that MS strongly adsorb microwave irradiation (due to their ionic character) and therefore their surface could be overheated, whereas the 
temperature in media would be lower. As the beneficial effect of higher temperatures was demonstrated (entrie 4 vs. 3), reaction could 
proceed or become initiated on the surface of overheated MS, whereas the product could be preserved in the “cold” solvent. 
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The beneficial effect of higher temperatures and shorter reaction times could be explained by possibly higher activation 
enthalpy ΔH≠ for the rearrangement compared to ΔH≠ for side reactions. Follows on from the Eyring equation,97 with 
increase in temperature, a reaction with a higher activation enthalpy will be accelerated more than a reaction with a lower 
activation enthalpy. 
Although it is too early to generalize, obtained results demonstrate, however, that developed conditions for the 
Eschenmoser-Claisen rearrangement (4Å MS, DMF, high temperatures and short reaction times) can be highly beneficial 
for unreactive substrates, with respect to the conventional reaction performed in an open vessel.98 
12.4. Synthesis of the Seco Acid and Macrolactonization 
 
Scheme 60: Synthesis of seco acid 207 
Amide 203 was reduced to alcohol 204 by treatment with Super-Hydride®. Selective MOM-deprotection in the presence 
of three OTBS groups was achieved under very mild conditions (MgBr2*Et2O/Me2S).99 The resulting diol 205 was subjected 
to oxidation with TEMPO/PhI(OAc)2. To our delight, only the primary alcohol was oxidized providing aldehyde 206 in high 
yield, and no products of oxidation of the secondary alcohol were detectable in crude 1H NMR. Finally, aldehyde 206 was 
oxidized to its corresponding carboxylic acid 207, and thus the stage was set for the crucial macrolactonization step. 
Molecular modeling of the desirable macrolactone showed that it should be significantly strained, which is to be 
expected taking into consideration its size (9 membered ring); and the presence of the trans-double bond! Following the 
conclusion from our theoretical approach to the effect of the temperature on cyclizations into strained and hindered cycles 
(see Chapter13), we conducted the cyclization at high temperature.  
                                                          
97 Eyring equation: 
݇ ൌ ௞್௛ ܶ݁ሺ
ష∆ಹಯ
ೃ೅ ሻ݁ሺ∆ೄಯೃ ሻ             ሺ݁ݍ. 1ሻ 
Where k = reaction rate constant, kB = Boltzmann′s constant [1.381·10-23 J K-1]; T = absolute temperatures in degrees Kelvin (K); R = gas 
constant [8.314 J K−1 · mol−1]; h = Plank constant [6.626·10-34 J s]; ∆H≠ = activation enthalpy [J mol-1]; ∆S≠ = activation entropy [J K−1 
mol−1]. 
98 The Meerwein–Eschenmoser–Claisen Rearrangement; Gradl, S. N.; Trauner, D. In Claisen Rearrangement; Hiersemann, M., 
Nubbemeyer, U., Eds.; Wiley-VCH, Weinheim, 2007; Chapter 7, pp 367–396. 
99 Onoda, T.; Shirai, R., Iwasaki, S. Tetrahedron Lett. 1997, 38, 1443-1446. 
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Scheme 61: Macrolactonization 
Initial attempts to perform macrolactonization under Boden-Keck conditions (EDCI100, DMAP, DMAP*HCl, CHCl3, reflux) 
resulted in formation of no product at all. However, employing modified Yamaguchi lactonization conditions at 80°C gave 
the desired lactone 208, albeit in rather low ca. 25% yield, together with undefined side products. Although these preliminary 
investigations produced a low yield of the desired product 208, they demonstrate that a 9-membered macrolactone with a 
trans-double bond could be, in principle, formed via a macrolactonization reaction. This is a very rare, if not the first 
example of, lactonization to provide suck kind of macrolactone. 
 
                                                          
100 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride 
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13. Effect of the Temperature on Cyclization Reactions in Competition with Side 
Reactions 
The beneficial effect of higher temperatures for the intramolecular [3+2] cycloaddition (Chapter 4.4) encouraged us to 
carry out a literature investigation and generalize this observation to virtually all types of cyclizations. Obtained results are 
discussed in Chapter 13.1 and are in preparation for publication.  
13.1. Intramolecular Cyclization vs. Oligomerization: Effect of Temperature101 
X
Y
X
Y
X
Ydimercycle
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Analysis of a number of literature examples shows that higher temperatures are often beneficial for intramolecular 
cyclizations. Explanations of this effect which were proposed in literature for selected reactions are discussed. A possible 
kinetic background of this phenomenon is proposed in terms of enthalpy, in contrast to entropy factors suggested by some 
authors. Thus, cyclizations often can be characterized by higher apparent enthalpy of activation (e.g. due to strain and 
rotational barriers), than some common side reactions such as intermolecular dimerizations or radical terminations. As 
follows on from Eyring equation, increase in temperature should more accelerate a reaction with higher enthalpy of 
activation (cyclization) than a reaction with lower enthalpy of activation (dimerization etc.). 
 
Intramolecular cyclization reactions, especially those leading to strained cycles or macrocycles, are often considered as 
key steps in the course of a synthesis, as there are many precedents when such kind of intramolecular cyclizations gave rather 
poor results. Therefore, it is not surprising that so much attention is paid to the development of new methods of 
intramolecular cyclizations. The other direction of intensive investigations is the determination of the best conditions for 
cyclizations, under which impact of side reactions would be minimal. To date studies deal with the influence of 
concentrations of reagents and substrates. Surprisingly, less studies were directed on the effect of the temperature on 
intramolecular cyclizations. In the present work we discuss the influence of the temperature on the competition between 
intramolecular cyclizations and oligomerizations or other “side”102 reactions. Analysis of a number of literature examples 
shows that higher temperatures are often beneficial for intramolecular cyclizations. To the best of our knowledge this 
phenomenon is not generalized in synthetic organic literature. In this work we also discuss explanations of this effect which 
were proposed in literature for selected reactions and propose a possible kinetic background of this phenomenon in terms of 
enthalpy, in contrast to entropy terms proposed by some authors. 
1. Influence of temperature on rate constants. Eyring equation (Eq. 1) describes the temperature dependence of a 
reaction rate constant: 
݇ ൌ ݇௕݄ ܶ݁
ሺష∆ಹ
ಯ
ೃ೅ ሻ݁ሺ∆ೄ
ಯ
ೃ ሻሺܿ୭ሻଵି୬             ሺܧݍ. 1ሻ 
                                                          
101 Compounds numbering is kept independently from the previous numbering. 
102 For clarity we choose cyclizations as desired reactions, whereas any other competitive reactions are regarded as “side” reactions. Of 
course, which reaction is “desired” depends on the purpose of the investigations. 
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 k = reaction rate constant, kB = Boltzmann's constant [1.381·10-23 J · K-1]; T = absolute temperatures in degrees Kelvin (K); R = gas 
constant [8.314 J · K−1 · mol−1]; h = Plank constant [6.626·10-34 J · s]; ∆H≠ = activation enthalpy [J · mol-1]; ∆S≠ = activation entropy [J · 
K−1 · mol−1], co = standard-state concentration103 [mol · L-1], n = molecularity of the reaction.  
Increase in a rate constant upon rising the temperature from T1 to T2 (T2 > T1) can be expressed by the ratio104 of rate 
constants at temperatures T2 and T1: 
݇ሺ మ்ሻ
݇ሺ భ்ሻ
ൌ TଶTଵ ݁
ሺ∆ಹ
ಯሺ೅మష೅భሻೃ೅భ೅మ ሻ             ሺܧݍ. 2ሻ 
݇ሺ భ்ሻ,݇ሺ మ்ሻ ൌ rate constants at ଵܶ and ଶܶ respectively. 
Consequence 1 from Eq. 2. The ratio k(T2)/k(T1) increases with ∆H≠. In other words, with increase in temperature a 
reaction with higher activation enthalpy will be higher accelerated, than a reaction with lower activation enthalpy. 
Consequence 2 from Eq. 2. Although activation entropy ∆S≠ influences the absolute value of a rate constant k (Eq. 1) 
and therefore can be responsible for a chemical outcome of a reaction,105 it does not have influence on temperature 
dependence of a rate constant.106 Consider two reactions: a reaction #1 (∆H1≠,∆S1≠) and a reaction #2 (∆H2≠,∆S2≠), where 
∆H1≠ > ∆H2≠. As follows on from Eq. 2, increase in temperature will result in higher acceleration of the reaction #1, than of 
the reaction #2 independently from relation of activation entropies (i.e. whether ∆S1≠ > ∆S2≠ or ∆S1≠ < ∆S2≠). 
For a reversible reaction (Eq. 3): 
  
products distribution is determined by the ratio of rate constants for a forward (k1) and a backward (k-1) reaction (Eq. 4): 
ܭ ൌ  ݇ଵ݇ିଵ ൌ  
ሾܤଵሿሾܤଶሿ …
ሾܣଵሿሾܣଶሿ …                           ሺܧݍ. 4ሻ 
K = equilibrium constant 
Combining Eq. 2 and Eq. 4 we obtain the ratio of equilibrium constants at temperatures T2 and T1 (Eq. 5):  
ܭሺ మ்ሻ
ܭሺ భ்ሻ
ൌ  ݁
൫∆ுభಯି∆ுషభಯ ൯ሺ మ்ି భ்ሻ
ோ భ் మ்           ሺܧݍ. 5ሻ 
∆H1≠, ∆H-1≠ = activation enthalpy for the forward and the backward reactions; 
Consequence 1 from Eq. 5. At higher temperatures equilibrium shifts towards products with higher enthalpy of formation.  
Consequence 2 from Eq. 5. The direction and the value of an equilibrium shifts with change of the temperature depends only 
on enthalpy parameters and does not depend on entropy106 (cf. consequence 2 from Eq. 2). 
                                                          
103 IUPAC Compendium of Chemical Terminology 2nd Edition (1997): http://www.iupac.org/goldbook/E02142.pdf 
104 In this range of temperatures T1-T2 values of ∆H≠ and ∆S≠ are assumed to be almost constant. This is a common assumption in kinetic 
investigations of reactions in a relatively narrow temperature window. Nevertheless, if a reaction is studied in a broader temperature range, 
a rate constants can become influenced by changes in ∆H≠ and/or ∆S≠ if changes are substantial. To the best of our knowledge an extent of 
these changes is case sensitive and to date is not generalized. From this, all theoretical descriptions discussed in this work should be taken 
as an approximation valid for a certain range of temperature, which is in turn case sensitive. 
105 So called “entropy driven reactions”. 
106 Unless entropy parameter substantially changes within the studying range of temperature, which cannot be generalized (see ref.104). 
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Noteworthy, reactions under thermodynamic control will give different product distribution at different temperatures, and 
with certain relation of ∆S and ∆H parameters107 this may result in a switch in selectivity. 
In principle, any reaction can be considered as a combination of irreversible and reversible (e.g. conformational changes) 
processes.  Consequently, as follows on from the discussion above, temperature dependence of reaction rate constants (or 
equilibrium constants) are determined rather by enthalpy term, whereas entropy in general has no influence on it.106 This 
could be described in other words, if to recall physical meanings of ∆H≠ and ∆S≠.108  Thus, roughly speaking, activation 
enthalpy is connected with energies of breaking and creating bonds in the transition state. At different temperatures a 
probability (i.e. a rate constant) for reacting partners to surpass the required barrier is different. Therefore, the enthalpy term 
should be highly temperature dependent. In contrast, the meaning of ∆S≠ is a probability to meet an appropriate orientation of 
reacting partners (i.e. reactants and solvent) in the transition state. Apparently, this term should be much less temperature 
dependent. 
2. Intramolecular cyclization vs. dimerization and other “side”102 reactions. 
We believe that an increase in a reaction temperature will likely favor cyclizations (with strain and/or slow 
conformational changes) over dimerizations and some other intermolecular reactions with low activation enthalpy.  
Consider a competition between a cyclization and a linear dimerization of a bi-functional substrate (Scheme 1). Each 
reaction (cyclization and dimerization) in reality can involve a few processes e.g. a series of conformational changes, 
coordination with a reagent (catalyst) etc. Nevertheless, each overall reaction (cyclization and dimerization) has apparent rate 
constant with corresponding apparent activation parameters (∆H≠, ∆S≠). To assess relative values of ∆H≠cycl vs. ∆H≠dim we 
have to consider some possible factors influencing them. 
X
Y
X
Y
X
Y
X
Y
X
Y
dimerization
cyclization
Hdim
= Hcycl
=
 
Scheme 1: Competition between a cyclization and a dimerization 
Strain. Illuminati et al.109 demonstrated, that the activation enthalpy ∆H≠cycl of the cyclization of unsubstituted aliphatic 
substrates (Table 1) are in most cases higher, then activation enthalpy of intermolecular alkylations (∆H≠dim), where the latter 
ones were chosen as a model reaction to mimic a corresponding linear dimerization. 
Based on these results it is reasonable to anticipate that the activation enthalpy of a cyclization (∆H≠cycl) is often higher 
than activation enthalpy of a linear dimerization (∆H≠dim), which can be attributed to strain and some other unfavorable 
intramolecular stereoelectronic interactions resulting in the course of cyclization, especially in case of hindered substrates. 
For cyclizations under thermodynamic control (products are in equilibrium) enthalpies of formation of a cyclic product 
vs. a dimeric (oligomeric) product should be considered. In this case the strain in a cyclic product apparently will favor the 
latter at higher temperatures (consequence 1 from Eq. 5). 
 
                                                          
107 ΔH≠1 > ΔH≠-1 and  ΔS≠1 > ΔS≠-1 or  ΔH≠1 < ΔH≠-1 and  ΔS≠1 < ΔS≠-1 . 
108 Schmid, R., Sapunov, V. N. Non-formal Kinetics; Verlag Chemie: Weinheim, 1982. 
109 For a review see: Illuminati, G.; Mandolini, L. Acc. Chem. Res., 1981, 14, 95-102. 
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Table 1: Activation enthalpy for cyclizations 
Entry Reaction size of the ring (n) with ∆H≠cycl > ∆H≠dim 
size of the ring (n) with 
∆H≠cycl < ∆H≠dim 
1 6-11, 14, 16, 24a 
2 8-10 5 6a,7a 
3 7-13, 14
a, 
16, 18, 23a - 
a difference between ∆H≠cycl and ∆H≠dim is in the range of the sum of experimental errors. 
Rotational barriers. Consider a substrate A (Scheme 2) which can exist in two conformations: As-conformation (X and 
Y are remote from each other, i.e. the conformation looks like the letter “S”) and Ac-conformation (X and Y are close to each 
other, i.e. the conformation looks like the letter “C”). Apparently cyclization reaction can occur only from the conformation 
Ac. In contrast, it is intuitively clear, that dimerization reaction should be much less sensitive to in which conformation110 
reacts A (unless a remote part of the molecule substantially hinders the reacting center). If conformational changes are 
necessary for cyclization111 and their rates are comparable to rates of chemical reactions,112 then rotational barier (∆H≠rot) can 
have more impact in increase of an apparent activation enthalpy of cyclization ∆H≠cycl rather than ∆H≠dim. 
                                  
Scheme 2a:  
                                                          
110 Although here we discuss only two conformation, the general point is that among all possible conformations of a substrate, the number 
of conformations suitable for the dimerization is much higher than a number of conformations leading to the intramolecular cyclization. 
111 I. e. if the conformation Ac does not substantially prevail. 
112 At given concentrations. 
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a Relative enthalpies of Ac and AS here are shown arbitrarily. 
Population of conformers. If conformational changes are fast and rate of cyclization from conformer Ac is 
comparable112 to the rate of dimerization, then population of conformers will influence competition between cyclization and 
dimerization.113 As geometry of conformer Ac resembles the product of cyclization Acycl and both ends are brought into 
proximity, it is reasonable to assume that conformer Ac can experience some “transannular” repulsion and other strain forces, 
especially in case of hindered substrates. Therefore it is probably not an unusual situation when enthalpy of formation for Ac 
is higher than for As. Consequently, higher temperatures will favor conformer Ac with respect to conformer As (consequence 
1 from eq. 5, vide supra). 
Summarizing, it seems to be a not uncommon situation when apparent activation enthalpy of cyclization ∆H≠cycl is 
higher than ∆H≠dim due to strain or rotational barriers. Applying consequence 2 from eq. 2 we can conclude that   increase in 
temperature will likely favor cyclization over dimerization.  
For consistency, we should note that besides discussed strain or rotational barriers, other points may play a role in 
products distribution: 
1.  Thermal stability. For example, if the dimer is more stable towards decomposition at higher temperatures as the 
corresponding monomer, then a yield and a proportion of the monomer will decrease.  
2. Template or chelate driven cyclizations. Increase in temperature will likely lead to dissociation, although the 
outcome will depend on relative values of ∆H (see e.g. an example shown in Table 4, vide infra). 
3. Change in reaction mechanism upon change in temperature. For example, in a two step process each reaction is rate 
limiting but at different temperatures. The other possibility is a change of a reaction mechanism (e.g. activated acid 
derivative vs. ketene). 
4. As was mentioned above, for Eq. 2 we assumed that values of ∆H≠ and ∆S≠ are constant within the temperature 
range studied. Nevertheless, for some reactions this assumption can become unvalid; however it is rather 
unpredictable as well as the influence of this effect. 
So far we discussed only a competition of cyclization with dimerization. Nevertheless, similar considerations can be 
applied to competition with any other “side” reaction, although relative ranking of ∆H≠cycl vs. ∆H≠dim should be considered 
separately for each type of competition. Presented discussion of course is not comprehensive and it is called here just to 
illustrate a possible nature of the favoring of cyclizations at higher temperatures, what is exemplified by a number114 of 
literature precedents presented below.  
3. Literature survey. 
Yamaguchi macrolactonization. In the course of synthesis of (+)-A83543A Evans et al.115 showed a beneficial effect of 
higher temperatures for cyclization of 1 to 2 (Table 2). As can be seen, the amount of monomeric macrocycle 2 substantially 
increased upon increase of the temperature. 
                                                          
113 I.e. with this conditions Curtin-Hammett principle is not applicable. 
114 It should be noted, that in this work we discuss all literature examples on influence of temperature on cyclizations found during the 
survey. However, the conducted literature search cannot pretend to be exhaustive due to its non-triviality, and therefore further examples 
will show the generality of the discussed phenomena. 
115 Evans, D. A.; Black, W. C. J. Am. Chem. Soc. 1993, 115, 4497-4513.  
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Table 2: Yamaguchi Macrolactonization (1 ? 2)a 
 
T 
(°C) 
addn time 
(h) 
macrocycle 
prod. 2 (%) 
destannylated 
monomer 2’ (%) 
dimer 
(%) 
25 0.5 13 - 33 
70 0.5 63 7 10 
110 10 10 63 1 
110 1 78 3 3 
a Final cyclization concentration was 0.007 M in toluene 
Noteworthy, as the product 2 proved to be sensitive to prolonged heating due to destannylation, the best results were 
obtained at shorter reaction times. 
A similar trend was observed for macrolactonization of 3 to 4 (Scheme 3).116 Although in this case no detailed 
temperature studies were not provided, the authors mentioned that for optimal results high temperatures (refluxing benzene) 
were required. 
 
 
Scheme 3: Yamaguchi macrolactonization 3 to 4 
Cyclization of 5 in refluxing toluene was shown to yield the monomeric lactone 6 as the major product, whereas at lower 
temperatures formation of cyclic dimers was prevailed.117 
  
                                                          
116 Evans, D. A.;Trotter, B. W.; Coleman, P. J.; Côté, B.; Dias, L. C.; Rajapakse, H. A.; Tyler, A. N. Tetrahedron 1999, 55, 8671-8726. 
117 Burke, S. D.; Heap, C. R.; Porter, W. J.; Song, Y. Tetrahedron Lett. 1996, 37, 343-346. 
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TCB = 2,4,6-trichlorobenzoyl 
Scheme 4 Yamaguchi macrolactonization 5 to 6 
The authors provided the following explanation for the observed temperature effect: “Based upon the assumption that 
dimerization to the larger ring is the entropically less-favored pathway, it was reasoned that the yield of 6’ might increase if 
lactonization was attempted at lower temperature.” Although reported results are undoubtedly valuable, the proposed 
explanation seems to us rather questionable in view of the consequence 2 from Eq. 2 or consequence 2 from Eq. 5118 (vide 
supra). 
In studies of cyclooligomerization of acid 7 Seebach et al.119 observed that at higher temperatures distribution of 
products shifts towards formation of smaller rings (Table 3). 
Table 3: Ratio of oligomers at different temperaturesa 
 
Temp. n = 5 n = 6 n = 7 
rt 1 1 1 
110 °C 6 3 1 
a Yield at rt was 50%. Yield at 
110° C was not reported. 
 
Tin mediated macrolactonization. Picard et al.120 reported the formation of macrodiolide 10 from diacid fluoride 9 and 
tin alcoholates 8. It was demonstrated that although selectivity of the formation of monomer 10 vs. dimer 11 decreased at 
higher temperature, the yield of the desired diolide 10 slightly increased (Table 4). 
                                                          
118 An eveidence for certain degree of reversibility of formation of ester bond under Yamaguchi conditions were reported (ref. 16). 
119 Seebach,D.; Brändli, U.; Schnurrenberger, P.; Przybylski, M. Helv. Chim. Acta 1988, 71, 155–167. 
120 Picard, C.; Cazaux, L.; Tisnes, P. Tetrahedron 1986, 42, 3503–3519. 
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Table 4: Tin mediated macrolactonization 
 
T 
(°C) 
Yield of 10 
(%) 
Yield of 11 
(%) 
Ratio 
10/11 
20 73 3 24 
80 80 4 20 
 
The decrease in selectivity is explained by the authors based on a template directed nature of cyclization. Presumably, at 
higher temperatures constant of coordination with tin is lower. This example shows that although temperature does have 
promoting effect on cyclization (the combined yield of cyclic products 10 and 11 increased at the expense of side reaction 
e.g. oligomerization or decomposition), there are other factors (such as complexation) which sometimes also influence 
product distribution. 
 
Scheme 5: SN2 macrolactonization 12 to 13 
SN2 macrolactonization. Sampson and Karim121 developed a new method for a macrolactonization via intramolecular 
cyclization of chloro keto acids under basic conditions (Scheme). Performing the reaction at 22 °C led to formation of a 
substantial amount of the diolide 13’, whereas at 50 °C the yield of the desired lactone 13 increased, and the proportion of 
the dimer 13’ decreased. 
As mentioned above (Table 1, entry 3), Illuminati et al. studied the kinetics of cyclizations of ω-bromo acids sodium 
salts into corresponding lactones.109,122  Obtained activation parameters were compared with corresponding activation 
parameters for linear dimerization reaction (intermolecular esterification). The latter reaction was not studied for each 
substrate, but a model reaction of sodium n-butyrate with n-BuBr was taken instead (Table 5). 
Reaction rate constants were measured at different temperatures which allows the use of these data for the discussion of 
influence of temperature on relative rate constants of intramolecular cyclizations and the intermolecular esterification (i.e. 
“dimerization”). 
 
                                                          
121 Karim, M. R.; Sampson, P.  J. Org. Chem. 1990, 55, 598-605. 
122 (a) Galli, C.; Illuminati, G.; Mandolini, L.; Tamborra, P. J. Am. Chem. Soc.1977, 99, 2591-2597; (b) Galli, C.; Illuminati, G.; 
Mandolini, L. J. Am. Chem. Soc., 1973, 95, 8374-8379. 
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Table 5: SN2 macrolactonization 
 
na T °C 
Rate constant b,c 
kT, s-1 
Acceleration 
k50/k35 
∆H≠ c 
kcal mol-1 
∆S≠ c 
cal K–1 mol–1 
13 35 50 
1.1x10-3
3.6x10-3 3.3 15.3 -22.5 
7 35 50 
3.0x10-3 
1.1x10-2 3.6 17.4 -13.6 
8 35 
d 
50 
2.2 x10-5 d 
1.1 x10-4 5.0 21.8 -9.2 
intermolecular 
alkylation 
35 
50 
6.7x10-2 b 
2.0x10-1 b 3.0 14.1 -18.4 
a Ring size of the ring to be formed. bFor intermolecular alkylation rate constant has 
dimention mol s-1 L-1. c All values here have certain experimental errors which are not 
presented here, but given in the original publications.122 The values of accelerations were 
calculated from average values of ∆S≠ and ∆H≠. d A rate constant at 35 °C is not reported by 
authors, therefore it was estimated from ∆S≠ and ∆H≠ values via Eyring eq. (Eq. 1). 
 
As can be seen from the Table 5, the activation entropy of the cyclization into 13-membered lactone is more negative 
than the activation entropy of the intermolecular alkylation. On the other hand, the activation entropy of cyclization into the 
7-membered lactone is substantially less negative than the activation entropy of the intermolecular alkylation. Nevertheless, 
in both cases increase in temperature from 35 to 50 °C results in higher acceleration of the intramolecular cyclizations, 
compared to the intermolecular esterification. These examples clearly demonstrate that, as follows on from Eyring equation 
(Eq. 2), activation entropy ∆S≠ in general does not have an impact in the temperature dependence of rate constants.106 In 
contrast, a rate constant is sensitive to temperature rather due to the activation enthalpy term. And the higher the activation 
enthalpy ∆H≠ , the higher the temperature sensitivity of the rate constant. For example, upon rising the temperature from 35 to 
50 °C the acceleration of the cyclization into 8-membered lactone (∆H≠ = 21.8 kcal mol-1) is ca. 5 times, whereas 
intermolecular esterification (∆H≠ = 14.1 kcal mol-1) is accelerated in only ca. 3 times. As cyclizations into 7-13, 16 and 18 
membered lactones have values ∆H≠cyc > ∆H≠dim, for all these reactions observed accelerations123 are higher than the 
acceleration of “dimerizations”. Cyclizations into unsubstituted 14 and 23 membered lactones have values of ∆H≠cycl very 
close to ∆H≠dim. As a result, in these cases almost no difference in accelerations was observed. 
Williamson synthesis of cyclic ethers. The same authors also carried out kinetic studies of cyclizations of ω-
bromophenolates into the corresponding cyclic ethers (Table 1, entries 1, 2).109 Data obtained show the same trend as 
outlined in Table 5. Thus, for most substrates ∆H≠cycl > ∆H≠dim, and therefore accelerations123 upon rising the temperature for 
these cyclizations are higher than for the intermolecular alkylation (“dimerization”). The only distinct exception is the 
cyclization into 5-membered ether (Table 1, entry 2), for which ∆H≠cycl < ∆H≠dim. 
                                                          
123 In the original publication reported rate constants were not measured in all cases at the same temperatures, therefore for comparing rate 
constants should be recalculated.   
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Scheme 6: Williamson synthesis of cyclic ethers 
Macrolactamization. Hall et al.124 revealed a remarkable effect of temperature in the synthesis of cryptands 17 and 18. 
Dropwise addition of the reactants to vigorously stirred toluene over 3h (final concentration of 1.7 x 10-3 M in monomer) at -
70 °C gave only 6% of the desired monomeric amide 17, together with 20% of the dimer 18 (Table 6, entry 5). Increase of 
the reaction time at the same temperature did not improve the overall yield of 17 and 18 and high molecule weight 
oligomeric products comprised the material balance (entry 6). In contrast, rising of the temperature to 20 °C resulted in an 
improvement of the yield of 17 up to 65%, and the yield of the dimeric macrocycle decreased to 5% (Table 6, entry 2). 
Table 6: Yields of 17 and 18 as a function of temperature 
 
Entry T, °C Yield of 17, % Yield of 18, % 
1 100 63 2 
2 20 65 5 
3 -20 62 9 
4 -40 17 15 
5 -70 6 20 
6 -70 (8 h); 
-40 (8 h) 
no improvement in the  
overall yield of 17 + 18 
An explanation of this phenomenon by the authors is based on presumably hindered rotation about the N-CO bond in 
intermediate 16, which at higher temperatures is faster. 
We would like to note, that for validity of this explanation (from our point of view), it should be specified, that the 
rotation about the N-CO bond is hindered namely with respect to dimerization (i.e. ΔHrotation > ΔH≠dim).  
Formation of macrocyclic phosphodiester (oligonucleotide cyclization). Studies125 on the cyclization of oligonucleotide 
5’-d(pGCCCG)rG showed that the reaction at 0 °C in the presence of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide and 
imidazole gave the desired product with substantial amount of a dimerized oligonucleotide (12-mer). When the cyclization 
was performed at 25 °C, the yield of the dimerized product became negligible (Eq. 6). 
                                                          
124 Hammond, P. J.; Beer, B. D.; Hall, C. D. J. Chem. Soc., Chem. Commun. 1983, 1161–1163. 
125 Kawamura, K.; Nakahara, N.; Okamoto, F.; Okuda, N. Viva origino 2003, 31, 221-232. 
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5’-d(pGCCCG)rG 
 
? 
monomeric 
cyclic 
oligonucleotide 
 
+ 
dimerized 
oligonucleotide 
 
 
        (Eq. 6) 
 
Oxidative cyclizations of bis-acetylenes. The outcome of oxidative cyclodimerization of bis-acetylenes 19a,b with 
copper salts was shown to be temperature dependent (Table 7).126 Thus, the yield of macrocycle 20a increased  
Table 7: Oxidative Cyclodimerization of Bis-acetylenes 19a,b ? 20a,b 
 
 
T 
(°C) 
Yield of 
20a (%) 
Yield of 
20b (%) 
20 40-45 30-35 
60 65-70 45-50 
90 25-30 45-40 
from 40-45% to 65-70% upon rising the temperature from 20 to 60 °C, and accordingly the amount of oligomeric  
side products decreased. In this example conditions had to be carefully controlled as extended reaction times or too high 
temperatures lead to a decrease in yield. A similar trend was observed for oxidative cyclodimerization of 19b. 
Cyclization of related bis-acetylene 21 gave constant amount of cyclic trimer 22 in about 35% yield (Scheme 7) together 
with higher oligomers and polymeric material independently from the reaction temperature (rt or 65 °C).  
 
Scheme 7 Oxidative Cyclooligomerization of Bis-acetylene 21 
                                                          
126 Höger, S.; Bonrad, K.; Karcher, L.; Meckenstock, A.-D. J. Org. Chem. 2000, 65, 1588-1589. 
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However, at 65 °C approximately 15-20% of the cyclic dimer 23 was formed, whereas at room temperature its formation 
was negligible. 
The authors attribute the observed temperature effect to “an increased mobility of the intermediate formed after the first 
coupling reaction.”  
Strictly speaking, we believe, that increase in mobility at higher temperatures could be observed for any molecule. 
Therefore it should be specified, that only if the enthalpic barrier of “mobility” is higher than the enthalpic barrier  for 
intermolecular reaction, only in this case higher temperatures should favor the cyclizations. 
Reductive radical cyclization. Cyclization of hexenyl radical under reductive conditions127 was demonstrated to give 
mainly acyclic product 25 at -78 °C. In contrast, at 0 °C products of cyclization 26 and 27 were prevailed (Scheme 8). 
 
Scheme 8: Reductive radical cyclization 
Atom transfer radical cyclizations. The efficiency of atom transfer cyclization of α-iodoacetamide 28 proved to be 
highly temperature dependent (Scheme 9).128 At 25 °C, 28 showed the signs of a poor chain, as it required excess of ditin 
reagent to prevent the reaction from stopping and long reaction times for considerable conversion. At 80 °C, 28 cyclized 
much more cleanly and rapidly to give 87% of the desired product 29. A similar trend was observed for cyclization of ester 
30, where cyclization gave higher yields at higher temperature. 
 
 
Scheme 9: Atom transfer radical cyclizations 
 
The explanation of authors is based on the fact that typical esters and amides exist mainly in the 32-syn rotamer (Scheme 
10), which is topologically prohibited from cyclizing. The barriers to rotation are much higher than the activation energy for 
typical radical cyclizations. Therefore, lifetime of 32-syn is probably too short to surpass the barrier for ester bond rotation to 
32-anti. Thus, in a tin hydride reaction (not discussed here), direct reduction is observed, and  
                                                          
127 V. Tamara Perchyonok and Carl H. Schiesser Tetrahedron Letters 39 (1998) 5437-5438 
128 Dennis P. Curran, and John Tamine J. Org. Chem., 1991, 56 (8), 2746-2750 
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Scheme 10: Interconversion of rotamers 
 
in the atom-transfer reaction, chains will not propagate. At 80 °C rotation of bonds is quick enough and 32-syn can 
isomerize (at least partly) to 32-anti, what is followed by the rapid cyclization to 33. 
As a conclusion authors say: “Changing solvents129 or substituents can effect either the rotamer population or the barrier 
to rotation; however, temperature is an effective, easily altered variable. If an amide or ester radical cyclization reaction fails, 
heat it up.” 
Ring closing metathesis (RCM). Optimization studies of RCM in course of syntheses of different natural products 
revealed130 that higher temperatures and shorter reaction times lead to increase of yields of monomeric cycles. 
 
 
 
Scheme 11: Ring Closing Metathesis 
 
For example, cyclization of diene 34 (Scheme 11) in toluene at 42 °C (19 h) gave desired monomer 35 in 27% yield, 
together with 48% of dimers. Performing this reaction at 110 °C (10 min) improved the yield of 35 up to 55%, and no dimers 
were observed.131 
Authors provide the following explanation of this phenomenon: “The observations described above may be explained 
by the difference of entropy in activation energy leading to each product. If the formation of the monomer is entropically 
favored over that of the dimer the kinetic ratio of the two products should shift toward the monomer at higher temperature. In 
fact, the ratio obtained after 5–10 min appears to be a kinetic ratio, since runs with longer reaction times resulted in the 
formation of more dimer.” 
                                                          
129 Jung, M. E.; Cervay, J. J. Am. Chem. Soc. 1989, 111, 5469-5470. 
130 Yamamoto, K.; Biswas, K.; Gaul, C.; Danishefsky, S. J. Tetrahedron Lett. 2003, 44, 3297–3299. 
131 Apparently this dramatic change cannot be fully attributed to difference in concentrations. 
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This explanation is similar to the explanation proposed by other authors117 for the example shown in Scheme 4. 
Although the synthetic value of this study is really high, the explanation seems to us rather questionable in view of the 
consequence 2 from Eq. 2 and consequence 2 from Eq. 5 (vide supra). 
Intramolecular [3+2] cycloaddition. Earlier we reported132 a remarkable effect of temperature on intramolecular [3+2] 
cycloaddition (Table 8). Thus, cyclization of 36a,b at 0°C resulted in constantly low yield of ca. 30 % independently from 
the cyclization reagent (not shown, see ref. 132) what was attributed to a competitive intermolecular [3+2] cycloaddition 
leading to formation of polymers. Although dilution did result in increase in the yield, the most pronounced effect was 
observed upon conducting the reaction at higher temperatures. The yield of the desired products 37a,b raised from 51% at 0 
°C to 76 % at 80 °C. 
Table 8: Intramolecular [3+2] Cyclization 
 
Conc., M Temp. Solvent Yielda;  d.r. 2b : 2a 
1.5x10-2 0 °C DCM 
37%; 32 : 5 
(31%; 28 : 3) 
1.5x10-3 0 °C DCM 51%; 46 : 5 
1.5x10-3 22 °C DCM or DCE 63%; 53 : 10 
1.5x10-3 40 °C DCM or DCE 70%; 59 : 11 
1.5x10-3 60 °C DCE 74%; 59 : 15 
1.5x10-3 80 °C DCE 76%; 60 : 16 
0.8x10-3 80 °C DCE 
79%; 61 : 18 
(75%; 60 : 15) 
a Yields were estimated from NMR using 4,4′-di-tert-butyl-
biphenyl as an internal standard. Isolated yields and 
diastereoselectivity are given in parentheses. 
 
Conclusions. A number of the literature examples discussed clearly demonstrate that in many114 cases increase in 
temperature favors cyclizations over oligomerizations and some other side reactions. Although in each case various effects 
can play a role, we believe that there is one effect which could be common for all these examples. Cyclizations can often be 
characterized by higher apparent enthalpy of activation (e.g. due to strain and rotational barriers), with respect to some side 
                                                          
132 Gromov, A.; Enev, V.; Pilger, C.; Mulzer, J. Tetrahedron Lett. submitted. 
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reactions such as intermolecular dimerization or radical termination. As follows on from Eyring equation (Eq. 1, 2), increase 
in temperature should more accelerate a reaction with higher enthalpy of activation (i.e. cyclization) than a reaction with 
lower enthalpy of activation (dimerization etc.).  
With this work we would like to encourage synthetic chemist during the course of optimization studies to vary not 
only reagents, but also temperature of a cyclization. According to examples and conclusions discussed in this work 
examples, there is a big chance that cyclization will work better at higher temperatures. 
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14. Conclusions and Outlook 
The aim of this Ph.D. research was the study towards the total synthesis of branimycin. This general goal included 
several sub-goals: 
1. Development of novel approaches towards highly functionalized cis-decalins applicable to the core of branimycin. 
2. Improvement of the synthesis of the C13-C18 side-chain; and its subsequent coupling with the cis-decalin core, 
leading to the completion of  branimycin. 
3. Investigating  the viability of the macrolactonization approach for formation of the highly strained 9-membered 
lactone containing the trans double bond. 
4. Improvement of certain low-yielding reactions and formulation of “take home messages” for the chemical 
community. 
Results achieved for each listed sub-goal together with outlook are briefly discussed in the following chapter. 
14.1.  Development of Novel Approaches Towards Highly Functionalized cis-Decalins Aiming 
the Core of Branimycin 
In the present work six approaches towards the cis-declin core of branimycin were studied, which could be divided into 
two major groups: 
- RCM-based approaches. 
- Approaches via desymmetrization of diepoxynaphthalene 141.  
Although interesting results were obtained in all approaches, the most significant results were achieved in approaches 
based on the desymmetrization of diepoxynaphthalene 141.  
? An efficient synthesis of diepoxynaphtalene 141 (and also of its isomer 141’) was developed. 
 
Scheme 62 
? It was demonstrated that although diepoxynaphthalene 141 possess two oxa-bridges, a selective mono-opening of 
only one of them could be carried out under certain conditions (Scheme 63): 
- enantioselective in a syn-fashion with aliphatic organozinc nucleophiles under chiral palladium catalysis. 
- in an anti fashion (although racemic) employing Me2PhSiCH2MgCl, as nucleophile, under copper 
catalysis, which introduces the silicon bearing substituent suitable for further elaboration. 
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Scheme 63 
? We demonstrated (Scheme 64) that compounds of the type 156 can be used for the synthesis of highly 
functionalized cis-decalins of type 158, 161 and of type 157, 161’. Different types of substituents can be introduced 
at this stage: alkyl, vinyl, aryl or hydrogen. Moreover, it was shown that, at least, in the case of DIBAL (“H-“-
nucleophile) and (presumably) in the case of ZnEt2 (“Et-“-nucleophile); racemic substrate 156 could be converted to 
their corresponding products, with high enantioselectivity. 
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Scheme 64 
It was also revealed, that remote substituents in 156 can have a somewhat surprising crucial effect on the 
efficiency of the oxa-bridge opening. 
? cis-Decalin 167 was synthesized in enantioenriched form (er 93:7) and was further converted to the cis-decalin 
core(s) (175 and 179) of branimycin. 
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Scheme 65 
Outline. The developed approach to functionalize cis-decalins seems to be an attractive way to access the various cores 
of the members of the Nargenicin family. Moreover, this approach could be tested for the construction of cis-decali moieties 
of other natural products. For example, superstolides133 core could be synthesized starting from enantioenriched mono-
opened product 142e (Scheme 66): 
 
Scheme 66 
14.2. Improvement of the C13-C18 Side-Chain Synthesis and its Coupling with the cis-Decalin 
Core Followed by Subsequent Elaboration Towards Branimycin 
 
? Side-chains 192a,b were synthesized and preparation of their precursor 187 was substantially optimized. The crucial 
improvement came with the discovery that TiCl4 concentration had a critical effect on the key propargylation (with 
chiral allene 186) of aldehyde 185. The yield for this reaction was improved from 8% to 85% (Scheme 67): 
                                                          
133 D’Auria, M. V.; Debitus, C.; Paloma, L. G.; Minale, L.; Zampella, A. J. Am. Chem. Soc. 1994, 116, 6658. (b) D’Auria, M. V.; 
Paloma, L. G.; Minale, L.; Zampella, A.; Debitus, C. J. Nat. Prod. 1994, 57, 1595. 
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Scheme 67 
Synthesized cis-decalin core 179 and side-chain 192a were coupled, which after a few steps resulted in highly 
advanced synthetic intermediate 207 (Scheme 68). 
 
Scheme 68 
14.3. Viability of the Macrolactonization Approach for Formation of the 9-Membered Lactone 
with a trans-Double Bond 
A possibility to carry out the macrolactonization of 207 to 208 and close the highly strained 9-membered lactone with 
the trans-double bond was questionable from the beginning of the synthesis. However, we were able to demonstrate the 
viability of this thesis (Scheme 69). 
 
Scheme 69 
14.4.  Miscellaneous “Take Home Messages” for the Chemical Community 
Besides the achievements discussed above, the following “take home messages” could be suggested for the chemical 
community. 
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? Although it too early to generalize, the new134 developed conditions for the Eschenmoser-Claisen rearrangement 
(4Å MS, DMF, closed vessel, high temperatures and short reaction times) could be highly beneficial with respect to 
the conventional procedure for this reaction in an open vessel for rearrangement of unreactive substrates. The yield 
of transformation of 199 to 203 was improved from “traces” to 64%. 
 
Scheme 70 
1. A new procedure for the in situ preparation of PMBBr from PMBCl and NaBr in DMF was proposed (Scheme 71). 
This procedure avoids isolation of the unstable PMBBr; and for sensitive substrates gave better results with respect 
to the conventional employing PMBCl/Bu4NI(cat.). 
 
Scheme 71 
2. A beneficial effect of higher temperatures was revealed in favour of an intramolecular [3+2] cyclization with 
competition side reactions. These results coupled with literature examples lead to a rather general conclusion: 
 
Scheme 72 
Higher temperatures will likely favor virtually any kind of cyclization of strained or hindered substrates over 
competitive oligomerization or some other side processes with relatively low activation enthalpy. 
A plausible explanation of this effect was proposed. 
                                                          
134 These results are partly based on results obtained in the Prof. Mulzer group by Univ.-Doz. Dr. V. Enev (see ref. 20).  
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15. Experimental Section 
 
15.1. General Information 
All commercially available reagents were used as received. Thin layer chromatography (TLC) was performed on silica 
gel 60 F254
 
plates. Plates were visualized by dipping into ceric sulfate mixture [H2SO4 (10 vol %, 100 mL), 
phosphormolybdic acid (4.5 g), Ce(IV)SO4
 
(0.1 g)] followed by heating with a heat gun. Flash column chromatography was 
carried out with silica gel 60 (0.040-0.063 μm, 240-400 mesh). Dichloromethane was dried by storage over MS 4Å. THF, 
diethyl ether, benzene and toluene were distilled from Na/benzophenone. Dry DMF and NMP (over molecular sieves) were 
purchased from Fluka. Molecule sieves 4Å (Aldrich) in powder (5 µ) or in beads (Merck) 4Å or 3Å were activated by 
heating at 350 °C in high vacuum for 8 h. All reactions were performed under atmosphere of Ar with flame-dried glassware 
unless otherwise stated. Microwave experiments were carried out on a Biotage Initiator (Biotage, Sweden) with reaction 
times specified as the ramp time and hold times at the final temperature. Temperatures were measured at the vessel surface 
by IR-sensors. 
NMR spectra were recorded at 250, 400 or 600 MHz in CDCl3 or C6D6 at 300 K. Chemical shift values were quoted in parts 
per million (ppm), and coupling constants were quoted in hertz. Residual signal of CHCl3 (δ = 7.26 ppm) or C6H6 (δ = 7.16 
ppm) were used as an internal reference for 1H chemical shifts; signals of CDCl3 (δ = 77.16 ppm) or C6D6 (δ = 128.06 ppm) 
were used as an internal reference for 13C chemical shifts. 13C NMR spectra were measured J-modulated and proton 
decoupled unless otherwise stated. Abbreviations for multiplicities are as follows: s = singlet, d = doublet, t = triplet, q = 
quartet, m = multiplet, b = broad. IR spectra were recorded with a FTIR spectrometer and are reported in wave numbers (cm-
1). All compounds were measured as a thin film on a silicon single crystal plate (Si-pellet). 
 
15.2. Experimental Section for Chapter 4.4 (Publication) 
 
Isoxazolines 2a and 2b. An aq. solution of NaClO (available chlorine 10-13%; 50 mL) was heated to 80 °C and added at 
once to a preheated to 80 °C solution of oximes 4a,b (4a : 4b = 3 : 1; 51.1 mg, 0.157 mmol) in dichloroethane (100 mL). The 
mixture was vigorously stirred at 80 °C for 8 min and cooled to rt. The organic phase was separated and the water phase was 
extracted with dichloromethane (30 mL). The combined organic phases were washed with brine, passed through a plug of 
cotton and solvents were removed in vacuo. The residue was purified by flash column chromatography (EtOAc/hexane) to 
give 2b (30.6 mg, 60%) and 2a (7.6 mg, 15%). 
2a: 1H NMR (CDCl3, 400MHz): δ = 5.93-5.83 (m, 1H), 5.36-5.22 (m, 3H), 4.49-4.41 (m, 2H), 4.24 (dd, J = 8.0, 11.9 Hz, 
1H), 3.68 (ddd, J=5.2, 11.6, 11.6 Hz, 1H), 3.32 (d, J = 7.0 Hz, 1H), 2.87 (d, J = 4.7 Hz, 1H), 0.90 (s, 9H), 0.10 (s, 6H); 
 13C NMR (CDCl3, 100MHz): δ = 174.2, 154.9, 133.0, 119.0, 77.2, 68.7, 65.0, 52.5, 49.5, 47.1, 25.7, 18.2, -4.6, -5.0. 
HRMS (ESI): calc. for C16H25NNaO4Si [M+Na]+ 346.1451; found: 346.1455. 
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2b: 1H NMR (CDCl3, 400MHz): δ = 5.92-5.82 (m, 1H), 5.35-5.23 (m, 3H), 4.02-3.96 (m, 2H), 3.64 (ddd, J=7.8, 10.9, 11.8 
Hz, 1H), 2.72 (d, J = 3.1 Hz, 1H), 2.66 (d, J = 6.8 Hz, 1H), 0.91 (s, 9H), 0.15 (s, 3H), 0.08 (s, 3H);  
13C NMR (CDCl3, 100MHz): δ = 172.6, 156.2, 132.2, 119.4, 75.4, 74.3, 74.2, 54.3, 52.0, 50.1, 25.6, 18.0, -4.4, -4.7. 
HRMS (ESI): calc. for C16H25NNaO4Si [M+Na]+ 346.1451; found: 346.1456. 
15.3. Experimental Section for Chapter 7 (Publication in Synthetic Communications) 
Diels-Alder adducts 3 and 4 
To a stirred solution of methylpropiolate (2.00 g, 23.8 mmol) in dry dichloromethane (60 mL) at 0 °C, EtAlCl2 (22.6 mL 
of 1 M solution in hexanes, 22.6 mmol) was added within 3 min and the resulting yellowish solution was stirred for 10 min 
followed by cooling  to -21 °C (ice-salt bath) and a solution of furan (9.70 g, 143 mmol) in dichloromethane (20 mL) was 
added within 5 min. The resulting solution was kept in a freezer at -22 °C for 32 h. The reaction was quenched by pouring 
into a vigorously stirred saturated solution of K,Na-tartrate (100 mL) and stirred for 2 h. The organic phase was separated 
and the water phase was extracted with dichloromethane (2 x 50 mL). Combined organic phases were washed with brine, 
passed through a plug of cotton and solvents were removed in vacuo (CAUTION: distilled off solvents may contain furan 
which is toxic). The crude products were purified by column chromatography (1 g of mixture on 10 g of silica gel, gradient 
elution with Et2O / DCM (0-14 vol % of Et2O)) to yield 3 (2.78 g, 53%; ca. 98 wt % purity from 1H NMR) and 4 (1.20 g, 
23%; ca. 99 wt % purity from NMR). 
NMR data of 3 and 4 was in accordance with the literature.5a  
3: m.p. 186-187 °C. 1H NMR (400 MHz, CDCl3): δ = 6.63 (dd, J =1.7, 5.8 Hz, 2H), 6.30 (dd, J =1.6, 5.8 Hz, 2H), 5.06 
(bs, 2H), 4.88 (bd, J =1.7 Hz, 2H), 3.61 (s, 3H), 2.38 (s, 1H); 13C (100 MHz, CDCl3): δ = 171.8, 140.6, 136.9, 81.6, 81.5, 
66.3, 52.9, 52.2. 
4: m.p. 134-137 °C. 1H NMR (400 MHz, CDCl3): δ = 6.56 (dd, J = 1.8, 5.8 Hz, 1H), 6.47 (dd, J = 1.8, 5.8 Hz, 1H), 6.41 
(dd, J = 1.8, 5.8 Hz, 1H), 6.34 (dd, J = 1.5, 5.6 Hz 1H), 4.92 (m, 1H), 4.90 (bd, J = 4.7 Hz, 1H), 4.62 (d, J = 1.4 Hz, 1H), 
4.47 (d, J = 1.6 Hz, 1H), 3.72 (s, 3H), 3.06 (d, J = 4.9 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ = 173.6, 140.5, 137.3, 136.0, 
133.6, 83.1, 79.5, 77.8, 77.3, 66.1, 52.5, 52.4. 
 
Triethylammonium salts 5 or 8  
A suspension of ester 3 (or 4) (3.65 g, 16.6 mmol) and Ba(OH)2*8H2O (7.85 g, 24.9 mmol) in 40 mL of water was 
heated on an oil bath at 120 °C for 3 h (30 min for 4). The cloudy mixture was cooled and washed with dichloromethane 
(2x20 mL). To the stirred water phase (together with insoluble residue) an aqueous solution of H2SO4  (1.00 M, 24.9 mL, 
24.9 mmol) was added and the resulting white suspension was stirred for 1 h at rt. Then ca. 1 mL of Et3N was added and the 
mixture was concentrated in vacuo at 40 °C to almost dryness (if in the course of evaporation the water solution starts 
foaming, addition of ca. 10 vol % of n-BuOH is recommended, finally, if necessary, traces of n-BuOH can be removed by 
co-evaporation with small portions of water). 
The resulted solid residue was stirred at rt with acetonitrile (50 mL) and Et3N (ca. 4 g, 40 mmol) for 5 min, followed by 
addition of dichloromethane (100 mL) and further stirred for 1 h. Then the suspension was dried over Na2SO4 for 5 min, 
filtered through a plug of Celite® and solvents were removed in vacuo to yield ca. 4.5 g of 5 (or 8) as pale brownish solid, 
which was used without further purification. NOTE: The title salt 5 (or 8) are not very stable and can lose some Et3N upon 
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concentration or storage, yielding a non-stoichiometric ratio of acid : Et3N and even give certain amount of the 
corresponding acid, which is poorly soluble in dichloromethane. The acid can be redissolved by addition of some Et3N. 
5: 1H NMR (400 MHz, CDCl3): δ = 9.70 (bs, 1H), 6.61 (dd, J = 1.7, 5.8 Hz, 2H), 6.37 (dd, J = 1.5, 5.8 Hz, 2H), 5.07 
(bs, 2H), 4.84 (bd, J = 1.7, 2H), 2.99 (q, J = 7.4, 14.8 Hz, ca. 4H), 2.29 (s, 1H), 1.21 (t, 7.4 Hz, ca. 6H); 13C (100 MHz, 
CDCl3): δ = 175.0, 138.7, 136.8, 81.2, 80.7, 66.1, 51.4, 43.7, 7.5. 
8: 1H NMR (400MHz, CDCl3): δ = 7.82 (bs, 1H), 6.52 (dd, J = 5.6, 1.7 Hz, 1H), 6.46 (dd, J = 5.6, 1.7 Hz, 1H), 6.43 (bs, 
2H), 4.96 (bs, 1H), 4.88 (d, J = 4.9 Hz, 1H), 4.63 (d, J = 1.1 Hz, 1H), 4.43 (d, J = 1.7 Hz, 1H), 3.07(q, J = 7.2 Hz, ca. 4H), 
2.99 (d, J = 4.8 Hz, 1H), 1.26 (t, J = 7.3 Hz, ca. 6H); 13C NMR (100 MHz, CDCl3): δ = 177.5, 139.5, 138.3, 135.4, 134.3, 
83.8, 79.6, 77.8, 77.6, 66.4, 52.3, 45.1, 8.6. 
 
N-Thionopyridyl esters 6 or 9 
NOTE: Compound 6 is photo- and thermosensitive, therefore all further manipulations were performed with glassware 
covered with aluminum foil and at temperatures below 30 °C. 
To a solution of 5 or 8 (ca. 14 mmol, synthesized from 14.0 mmol of ester 3 or 4) in dry dichloromethane (75 mL) was 
added TsCl (2.79 g, 14.7 mmol) at 0 °C and the resulting solution was stirred for 2 h (4.5 h for 8). Then 1-hydroxypyridine-
2(1H)-thione 7 (1.86 g, 4.7 mmol) was added and stirring was continued for 2 h (3 h for 8) at 0 °C followed by 1 h at rt. The 
reaction mixture was washed with 5% NaHCO3 (100 mL), 2M NaH2PO4 (2x200 mL, until water phase pH <5), 5% NaHCO3 
(50 mL)and brine (50 mL). The organic phase was passed through a plug of cotton and solvents were removed in vacuo (bath 
temperature 25-27°C) to yield crude 6 (or 9) as a brownish solid. 
 
6: 1H NMR (250 MHz, CDCl3): δ = 7.66 (dd, J = 1.6, 8.9 Hz, 1H), 7.33 (bd, J = 6.8 Hz, 1H), 7.18 (ddd, J = 8.9, 6.8, 1.5 
Hz, 1H), 6.73 (dd, J = 1.3, 5.8 Hz, 2H), 6.69 (dd, J = 1.6, 5.8 Hz, 2H), 6.60 (bt, J = 6.8 Hz, 1H), 5.39 (bs, 2H), 4.96 (bs, 
2H), 2.52 (s, 1H). 
 
9: 1H NMR (250 MHz, CDCl3): δ = 7.68 (dd, J = 1.5, 8.8 Hz, 1H) 7.47 (dd, J = 1.2, 6.9 Hz, 1H), 7.20 (ddd, J = 1.5, 6.8, 
8.9 Hz, 1H), 6.73 (dd, J = 1.6, 5.6 Hz, 1H), 6.59-6.66 (m, 2H), 6.53 (dd, J = 1.6, 5.8 Hz, 1H), 6.48 (dd, J = 1.7, 5.8 Hz, 1H), 
5.64 (bs, 1H), 4.96 (d, J = 5.0 Hz, 1H), 4.88 (d, J = 1.4 Hz, 1H), 4.54 (d, J = 1.6 Hz, H), 3.21 (d, J = 5.0 Hz, 1H). 
 
Products of decarboxylation 1 or 2 
A solution of  Bu3SnH (6.1 g, 5.7 mL, 21 mmol) in dry degased dichloromethane (150 mL) was transferred via cannula 
to a flask (covered with aluminum foil) charged with crude 6 or 9(prepared from ca. 14 mmol of 5 or 8). The resulting clear 
solution was cooled to 0 °C (ice cold water), the aluminum foil was removed and the reaction mixture was irradiated with a 
500 Watt halogen lamp for ca. 20 min until TLC (DCM/Et2O 1:1) showed full conversion of the starting material. The 
solvents were removed in vacuo. 
For compound 1: The residue was dissolved in acetonitrile (200 mL), transferred to a separation funnel and extracted 
with hexane (4x30 mL) to remove excess of Bu3SnH and some of tin byproducts. The combined hexane fraction was washed 
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once with acetonitrile (20 mL). The combined acetonitrile fractions were concentrated in vacuo and the residue was passed 
through a short column of silica gel (6 g SiO2/1 g of mixture; gradient elution with Et2O / DCM (0-30 vol % of Et2O)). After 
removal of solvents in vacuo the residue was triturated with Et2O (50 mL) for 1 h. The resulting white crystals (1.10 g) are 
95 wt % pure 1 (from NMR). The ether fraction was evaporated to dryness in vacuo and the residue subjected to column 
chromatography (50 g SiO2/ 1 g of mixture; gradient elution with Et2O / DCM (0-30 vol % of Et2O)) to obtain additional 
0.42 g of 1. The combined yield of 1 is 67% (1.52 g, ca. 95 wt % pure from NMR) starting from ester 3. Further purification 
can be achieved via recrystallization from EtOAc (ca. 99 wt. % pure from 1H NMR). 
(NOTE: the described procedure was developed for relatively big scale reactions to decrease scale for final column 
chromatography. For small scale reactions the procedure can be simplified and after removal of acetonitrile a residue can be 
directly subjected to column chromatography (5 g SiO2/ 100 mg of mixture; gradient elution with Et2O / DCM (0-30 vol % 
of Et2O)). 
For compound 2: T he residue was dissolved in a mixture acetonitrile (200 mL) and water (7 mL), transferred to a 
separation funnel and extracted with hexane (4x30 mL) to remove excess of Bu3SnH and some of tin byproducts. The 
combined hexane fraction was washed once with acetonitrile/water (20 mL/0.6 mL). The acetonitrile-water fractions were 
combined, the solvents were removed in vacuo, ethanol (200 mL) was added and distilled off in vacuo to remove residual 
water. The residue was subjected to column chromatography (100 g SiO2/ 1 g of mixture; gradient elution with Et2O / DCM 
(0-7 vol % of Et2O)) to obtain 2 (194 mg, 60%, ca. 97 wt. % pure from NMR) as white solid.  
1: m.p. 170-172 °C (Lit.4 m.p. 152-155 °C). 1H NMR (400MHz, CDCl3): δ = 6.43 (s, 4H), 4.84 (s, 4H), 1.90 (s, 2H); 13C 
NMR (100 MHz, CDCl3): δ = 138.3, 79.9, 49.0.  
 
2: m.p. 80-82 °C (Lit.4 m.p. 68-70 °C). 1H NMR (400MHz, CDCl3): δ = 6.33 (dd, J = 0.6, 0.6, 2H), 6.28 (dd, J = 0.8, 0.8 Hz, 
2H), 4.69 (m, 2H), 4.40 (bs, 2H), 2.49 (dd, J = 1.5, 1.5 Hz, 2H); 13C NMR (100 MHz, CDCl3): δ = 138.3, 134.0, 78.8, 76.3, 
48.2. 
 
15.4. Experimental Section for Chapters 9 and 10 
 
 
 
General procedure for opening of oxa-bridged compounds with diorganozinc nucleophiles. Based on literature 
described procedures.42 
 
[(R)-Tol-BINAP]PdCl2. To a mixture of PdCl2*2CH3CN (26 mg, 0.1 mmol) and (R)-Tol-BINAP (68 mg, 0.1 mmol) was 
added dichloromethane (2 mL) and the reaction was stirred at rt for 3h. Volatiles (CH3CN and CH2Cl2) were removed in 
vacuo and the residue was dissolved in dichloromethane (10.0 mL) to obtain a 0.010M stock solution of [(R)-Tol-
BINAP]PdCl2. 
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Diorganozinc nucleophile. To a solution of ZnCl2 (1.0 mmol, 1.0 M in ether) in ether at 0 °C was added slowly a solution of 
alkyllithium or alkylmagnesium halide (titrated, in ether or pentane, 2.0 mmol). The mixture was stirred at 0 °C for 30 min, 
and then pentane added and stirring stopped to allow precipitated salts to settle. The cloudy solution was transferred via a 
syringe to another flask, volatiles were removed in vacuo or blown away with Ar-stream at 0 °C and the residue was 
dissolved in hexane or toluene to obtain ca. 1 M solution. 
 
Oxa-bridge opening. To a solution of a corresponding substrate (0.2 mmol) in dichloromethane (4 mL) was added Zn(OTf)2 
(0.032 mmol) and [(R)-Tol-BINAP]PdCl2 (0.01 M solution in dichloromethane, 1.4 mL, 0.014 mmol) and the resulting 
mixture was stirred at rt or 0 °C for 1 h. A solution of a corresponding diorganozinc nucleophile (ca. 1 M in pentane, 0.3 mL, 
0.3 mmol) and the mixture was stirred at the same temperature until TLC analysis shows full consumption of the substrate or 
no further progress in conversion. A solution of EtMgBr (3.0M in ether, 0.2 mL, 0.6 mmol) was added and the mixture was 
stirred for an additional 15 min at rt. The reaction was quenched by addition of several drops of water. This was stirred 
vigorously for 10 min to allow the precipitation of salts. MgSO4 was added to dry the solution, and then it was filtered and 
evaporated to give crude product. The crude product was purified by flash chromatography. Enantiomeric excess was 
determined from NMR of corresponding Mosher esters. 
 
142d: Yield: 68% (at 86% conv.).  1H (400 MHz, CDCl3): δ = 6.48 (dd, J=1.8, 6.0 Hz, 1H), 6.33 (dd, J=1.7, 6.0 Hz, 1H), 
5.90 (ddd, J=2.5, 2.5, 9.8 Hz, 1H), 5.55 (dm, J= 9.7 Hz, 1H), 5.09 (bs, 1H), 4.66 (bs, 1H), 4.18-4.12 (m, 1H), 2.62 (d, J=9.7 
Hz, 1H), 2.10-2.05 (m, 1H), 2.03 (dd, J= 5.2, 8.3 Hz, 1H), 1.87-1.80 (m, 1H), 1.68-1.48 (m, 2H), 0.99 (dd, J= 7.4, 7.4 Hz, 
1H).  
13C NMR (CDCl3, 75 MHz): δ = 137.7, 134.1, 132.3, 129.4, 82.3, 80.7, 68.3, 43.3, 41.1, 37.9, 24.5, 12.0. 
 
143d: Yield: 10% (at 86% conv.).  1H (400 MHz, CDCl3): δ = 5.69 (dm, J= 10.5 Hz, 2H), 5.56 (bd, J= 10.5 Hz, 2H), 3.87-
3.83 (m, 2H), 3.03 (s, 2H),  2.66-2.59 (m, 2H), 2.12-2.04 (m, 2H), 1.66-1.41 (m, 4H), 1.02 (dd, J= 7.3, 7.3 Hz, 6H). 
13C NMR (CDCl3, 75 MHz): δ = 130.3, 128.5, 67.5, 42.7, 39.6, 24.6, 11.8. 
 
142e: Yield: 50%. 1H (400 MHz, CDCl3): δ = 6.48 (dd, J= 1.7, 5.8 Hz, 1H), 6.33 (dd, J= 1.7, 5.8 Hz, 1H), 5.86 (dm, J= 9.6 
Hz, 1H), 5.51-5.46 (dm, J= 9.6 Hz, 1H), 5.08 (bs, 1H), 4.65 (bs, 1H), 3.99-3.94 (dm, J= 9.6 Hz, 1H), 2.60 (d, J= 9.6 Hz, 1H), 
2.15-2.08 (m, 1H), 2.07-2.01 (m, 2H), 0.89 (dd, J= 9.4, 14.9 Hz, 1H), 0.81 (dd, J= 6.0, 14.9 Hz, 1H), 0.03 (s, 9H). 
13C NMR (CDCl3, 75 MHz): δ = 137.6, 134.3, 134.2, 129.1, 82.3, 80.6, 71.6, 41.3, 37.7, 19.9, -0.7. 
 
 
 
 
 
 
 
General procedure for opening of oxa-bridged compounds with diorganozinc nucleophiles.  
Based on literature described procedures.43 
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To a solution of [Rh(COD)Cl]2 (4.9 mg, 0.010 mmol), (R)-(S)- PPF-P(t-Bu)2 ligand (10.8 mg, 0.020 mmol) and a 
corresponding substrate (0.20 mmol) in THF (1.7 mL) was added a corresponding boronic acid derivative (2.6 mmol). A 
solution of Cs2CO3 (5M in water, 0.1 mmol, 20 μL) was added and the reaction was stirred at rt or 40 °C until TLC showed 
full conversion of the substrate. Reaction mixture was diluted with EtOAc (30 mL) and washed with water (5 mL) and brine 
(5 mL). The organic phase was dried over MgSO4, filtered and concentrated in vacuo. The residue was subjected to column 
chromatography. 
 
161-9: Yield: 24% (12% from 50% theor.). 1H (250 MHz, CDCl3): δ = 7.30 (dm, J=8.7 Hz, 2H), 6.89(dm, J=8.7 Hz, 2H), 
5.97 (ddd, J=6.8, 10.5, 17.3 Hz, 1H), 5.83 (ddd, J=2.9, 4.1, 10.0 Hz, 2H), 5.69-5.51 (m, 3H), 5.23-5.12 (m, 2H), 4.60 (d, 
J=11.5 Hz, 1H), 4.45 (d, J=11.5 Hz, 1H), 4.30 (dm, J=7.9 Hz, 1H), 3.86-3.77 (m, 1H), 3.81 (s, 3H), 3.51 (m, 2H), 3.29 (s, 
3H), 3.09-3.84 (m, 3H), 2.30 (dd, J=6.0, 6.0 Hz, 1H), 1.63 (d, 8.3Hz, OH). 
 
161-14: Yield: 94% (47% from 50% theor.).1H (250 MHz, CDCl3): δ = 7.31 (dm, J=8.6 Hz, 2H), 6.89 (dm, J=8.6 Hz, 2H), 
6.17 (dd, J=6.2, 18.9 Hz, 1H), 5.89-5.77 (m, 2H), 5.68-5.53 (m, 3H), 4.61 (d, J=11.4 Hz, 1H), 4.46 (d, J=11.4 Hz, 1H), 4.33 
(bd, J=6.0 Hz, 1H), 3.87-3.77 (m, 1H), 3.81 (s, 3H), 3.59-3.44 (m, 2H), 3.29 (s, 3H), 3.10-2.89 (m, 3H), 2.41 (bdd, J=5.7, 5.7 
Hz, 1H), 1.59 (d, J=7.0, Hz, 1H), 1.26 (dd, J=7.2, 7.2 Hz, 1H), 0.06 (s, 9H). 
 
 
Procedures for preparation of 148, 156b, 156d and 159 see: experimental section for Chapter 10.2, compounds 8, 9, 10 and 3 
respectively. 
15.5. Experimental Section for Chapter 10.2 (Publication in Organic Letters) 
 
Compound 5a. To a stirred solution of methylpropiolate (1.00 g, 11.9 mmol) in dry dichloromethane (30 mL) at 0 °C, 
EtAlCl2 (11.3 mL of 1 M solution in hexanes, 11.3 mmol) was added within 3 min and the resulting yellowish solution was 
stirred for 10 min. Then a solution of furan (4.90 g, 72 mmol) in dichloromethane (10 mL) was added within 5 min. The 
resulting solution was kept in a fridge at 0 °C for 27 h. The reaction was quenched by pouring into a vigorously stirred 
saturated solution of sodium-potassium-tartrate (100 mL) and stirred for 2 h. The organic phase was separated and the water 
phase was extracted with dichloromethane (2 x 50 mL). The combined organic phases were washed with brine, passed 
through a plug of cotton and the solvents were removed in vacuo (CAUTION: distilled off solvents may contain furan which 
is toxic). The residue was stirred with Et2O (50 mL) for 30 min and filtered. The obtained crude 5a (filter cake) was purified 
by passing it through a short plug of silica gel (1 g / 10 g SiO2 ; DCM, then DCM + 1 vol % MeOH) to obtain 5a (1.21 g, 
Experimental Section 81 
45%) as white solid. Additional 3-5% of 5a can be obtained from the Et2O- filtrate by column chromatography (DCM/Et2O).  
NMR data of 5a were in accordance with the literature.135 
5a: 1H NMR (400 MHz, CDCl3): δ = 6.63 (dd, J =1.7, 5.8 Hz, 2H), 6.30 (dd, J =1.6, 5.8 Hz, 2H), 5.06 (bs, 2H), 4.88 (bd, J 
=1.7 Hz, 2H), 3.61 (s, 3H), 2.38 (s, 1H);  
13C (100 MHz, CDCl3): δ = 171.8, 140.6, 136.9, 81.6, 81.5, 66.3, 52.9, 52.2. 
m.p. 186-187 °C (ethyl acetate). 
5b: 1H NMR (400 MHz, CDCl3): δ = 6.56 (dd, J = 1.8, 5.8 Hz, 1H), 6.47 (dd, J = 1.8, 5.8 Hz, 1H), 6.41 (dd, J = 1.8, 5.8 Hz, 
1H), 6.34 (dd, J = 1.5, 5.6 Hz 1H), 4.92 (m, 1H), 4.90 (bd, J = 4.7 Hz, 1H), 4.62 (d, J = 1.4 Hz, 1H), 4.47 (d, J = 1.6 Hz, 1H), 
3.72 (s, 3H), 3.06 (d, J = 4.9 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ = 173.6, 140.5, 137.3, 136.0, 133.6, 83.1, 79.5, 77.8, 
77.3, 66.1, 52.5, 52.4. 
 
 
Compound 6. A suspension of ester 5a (3.65 g, 16.6 mmol) and Ba(OH)2*8H2O (7.85 g, 24.9 mmol) in 40 mL of water was 
heated on an oil bath at 120 °C for 3 h. The cloudy mixture was cooled and washed with dichloromethane (2x20 mL). To the 
stirred water phase (together with the insoluble residue) an aqueous solution of H2SO4  (1.00 M, 24.9 mL, 24.9 mmol) was 
added and the resulting white suspension was stirred for 1 h at rt. Then ca. 1 mL of Et3N was added and the mixture was 
concentrated in vacuo at 40 °C to almost dryness (if in the course of evaporation the water solution starts foaming, addition 
of ca. 10 vol % of n-BuOH is recommended, finally, if necessary, traces of n-BuOH can be removed by co-evaporation with 
small portions of water). 
The resulting solid residue was stirred at rt with acetonitrile (50 mL) and Et3N (ca. 4 g, 40 mmol) for 5 min, followed by 
addition of dichloromethane (100 mL) and stirred for 1 h. Then the suspension was dried over Na2SO4 for 5 min, filtered 
through a plug of Celite® and the solvents were removed in vacuo to yield ca. 4.53 g (100 %, corresponding to 
RCOOH*0.66Et3N from 1H NMR) of 6 as pale brownish solid, which was used without further purification. NOTE: The title 
salt 6 is not very stable and can lose some Et3N upon concentration or storage, yielding a non-stoichiometric ratio of acid : 
Et3N and even give a certain amount of the corresponding acid, which is poorly soluble in dichloromethane. The acid can be 
redissolved by addition of some Et3N. 
NMR data are given for RCOOH*0.66Et3N: 
6: 1H NMR (400 MHz, CDCl3): δ = 9.70 (bs, 1H), 6.61 (dd, J = 1.7, 5.8 Hz, 2H), 6.37 (dd, J = 1.5, 5.8 Hz, 2H), 5.07 (bs, 
2H), 4.84 (bd, J = 1.7, 2H), 2.99 (q, J = 7.4, 14.8 Hz, 4H), 2.29 (s, 1H), 1.21 (t, 7.4 Hz, 6H); 
13C (100 MHz, CDCl3): δ = 175.0, 138.7, 136.8, 81.2, 80.7, 66.1, 51.4, 43.7, 7.5. 
 
                                                          
135 Lasne, M.-C.; Ripoll, J.-L. Bull. Soc. Chim. Fr. 1986, 5, 766-770. 
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Compound 7 
NOTE: Compound 7 is photo- and thermosensitive, therefore all further manipulations were performed with glassware 
covered with aluminum foil below 30 °C. 
To a solution of 6 (ca. 14 mmol, synthesized from 14.0 mmol of ester 5a) in dry dichloromethane (75 mL) was added TsCl 
(2.79 g, 14.7 mmol) at 0 °C and the resulting solution was stirred for 2 h. Then HPT (1-hydroxypyridine-2(1H)-thione; 1.86 
g, 4.7 mmol) was added and stirring was continued for 2 h at 0 °C followed by 1 h at rt. The reaction mixture was washed 
with 5% NaHCO3 (100 mL), 2M NaH2PO4 (2x200 mL, until water phase pH <5), 5% NaHCO3 (50 mL), brine (50 mL). The 
organic phase was passed through a plug of cotton and the solvents were removed in vacuo (bath temperature 25-27°C) to 
yield crude 7 as a brownish solid. 
NOTE: Purification of 7 by column chromatography led to substantial decomposition, therefore crude 7 was used directly in 
the next step.  
7: 1H NMR (250 MHz, CDCl3): δ = 7.66 (dd, J = 1.6, 8.9 Hz, 1H), 7.33 (bd, J = 6.8 Hz, 1H), 7.18 (ddd, J = 8.9, 6.8, 1.5 Hz, 
1H), 6.73 (dd, J = 1.3, 5.8 Hz, 2H), 6.69 (dd, J = 1.6, 5.8 Hz, 2H), 6.60 (bt, J = 6.8 Hz, 1H), 5.39 (bs, 2H), 4.96 (bs, 2H), 
2.52 (s, 1H). 
 
 
Compound 4. A solution of  Bu3SnH (6.1 g, 5.7 mL, 21 mmol) in dry degassed dichloromethane (150 mL) was transferred 
via a cannula to a flask (covered with aluminum foil) charged with crude 7 (prepared from 14 mmol of 5a). The resulting 
clear solution was cooled to 0 °C (ice cold water), the aluminum foil was removed and the reaction mixture was irradiated 
with a 500 Watt halogen lamp for ca. 20 min until TLC (DCM/Et2O 1:1) showed full conversion of the starting material. The 
solvents were removed in vacuo and the residue was dissolved in acetonitrile (200 mL), transferred to a separation funnel 
and extracted with hexane (4x30 mL) to remove an excess of Bu3SnH and some tin byproducts. The combined hexane 
fraction was washed once with acetonitrile (20 mL). The combined acetonitrile phases were concentrated in vacuo and the 
residue was passed through a short column of silica gel (6 g SiO2/1 g of mixture; gradient elution with Et2O / DCM (0-30 vol 
% of Et2O)). After removal of solvents in vacuo the residue was triturated with Et2O (50 mL) for 1 h. The resulting white 
Experimental Section 83 
crystals (1.10 g) are ca. 97% pure 4 (from NMR). The ether fraction was evaporated to dryness in vacuo and the residue 
subjected to column chromatography (50 g SiO2/ 1 g of mixture; gradient elution with Et2O / DCM (0-30 vol % of Et2O)) to 
obtain additional 0.42 g of 4. The combined yield of 4 is 67% (1.52 g, ca. 97% pure from NMR) starting from ester 5a. 
Further purification can be achieved via recrystallization from EtOAc. 
(NOTE: For small scale reactions the procedure can be simplified and after removal of acetonitrile a residue can be directly 
subjected to column chromatography: 5 g SiO2/ 100 mg of mixture; gradient elution with Et2O / DCM (0-30 vol % of Et2O)). 
m.p. 170-172 °C (ethyl acetate). 
NMR data were in agreement with lit.136 
4: 1H NMR (400MHz, CDCl3): δ = 6.43 (s, 4H), 4.84 (s, 4H), 1.90 (s, 2H); 
13C NMR (100 MHz, CDCl3): δ = 138.3, 79.9, 49.0. 
 
 
Compound  8. 
Grignard reagent.137 A dry, 100 mL, two-necked, round-bottomed flask was equipped with a septum and a reflux 
condenser, the top of which was connected to an argon line. The flask was charged with magnesium turnings (0.84 g, 35 
mmol) and dry diethyl ether (40 mL) and immersed into an ultrasound bath at 32-35° C. To the sonicated mixture was added 
0.05 mL dibromoethane and then a solution of PhMe2SiCH2Cl (10 g, 30 mmol) in dry diethyl ether (10 mL) was added in a 
rate keeping the reaction mixture at reflux (ca. 1 h). At the end of the addition the mixture was kept in the ultrasound bath at 
reflux for additional 1 hour. 
 
Oxa-bridge opening. CuCl (153 mg, 1.54 mmol) and Ph3P (444 mg, 1.69 mmol) in dry toluene (160 mL) were sonicated in 
an ultrasonic bath at 20-40 °C for ca. 1 h until a milky white opalescent solution was formed. Diepoxynaphthalene 4 (2.5 g, 
15.4 mmol) was added and the mixture was further sonicated for additional 30 min to obtain a fine suspension. The flask was 
removed from the ultrasonic bath, charged with a stirring bar and the reaction mixture was cooled to rt under stirring. Then a 
solution of the Grignard reagent (30 mmol) was added, and the reaction mixture was stirred for 48 h at rt until no more 
progress could be observed (TLC). The reaction mixture was quenched with saturated NH4Cl (100 mL) and stirred for 2 h. 
The water phase was separated and extracted with DCM (2x30 mL). The combined organic phases were washed with brine, 
passed through a plug of cotton and concentrated in vacuo to dryness.  (NOTE: If required, the residue can be directly 
                                                          
136 a) Gromov, A.; Enev, V.; Mulzer, J. Syn. Comm. in press; b) Maksimović, L.; Novak, N.; Eckert-Maksić, M. Synth. Comm. 1993, 
23(22), 3119-3125. 
 
137 Based on: Enev, V.; Drescher, M.; Mulzer, J. Org. Lett. 2008, 10, 413–416. 
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subjected to flash column chromatograph (SiO2, EtOAc/toluene, then EtOAc/DCM to elute 4)). The crude  product was 
stirred with Et2O (75 mL), and filtered from the insoluble residue (mostly contains 4). The filtrate was concentrated in vacuo 
to dryness and triturated with hexane (50 mL) for 2 h. The resulting white crystals were filtered, washed with hexane (2x10 
mL) and dried in vacuo to obtain a mixture of 8 (3.1-3.5 g) and 4 (5-10 mol %). The hexane fraction was concentrated in 
vacuo and the residue was subjected to column chromatography (EtOAc/toluene, then EtOAc/DCM to elute 4) to get pure 8 
(ca. 0.3-0.7 g). Combined 8 was used in the next step without further purification. The yield of 8 is 3.60 g (75%, 82 % brsm).  
8: 1H NMR (400MHz): δ = 7.54-7.49 (m, 2H), 7.37-7.33 (m, 3H), 6.40 (dd, J=1.5, 5.8 Hz, 1H), 6.35 (dd, J=1.5, 5.8 Hz, 1H), 
5.76 (dd, J=2.5, 10.0 Hz, 1H), 5.72 (ddd, J=1.7, 4.1, 10.0 Hz, 1H), 5.05 (bs, 1H), 4.65 (bs, 1H), 3.83 (ddd, J=5.5, 5.5, 7.6 Hz, 
1H), 2.66 (bd, J=7.6 Hz, 1H, OH), 2.50-2.41 (m, 1H), 2.13 (bd, J=8.2 Hz, 1H), 2.08 (dd, J=5.5, 8.2 Hz, 1H), 0.96 (dd, J=4.2, 
14.4 Hz, 1H), 0.96 (dd, J=10.7, 14.4 Hz, 1H), 0.33 (s, 3H), 0.32 (s, 3H); 
13C NMR (100 MHz): δ = 139.5, 136.6, 135.4, 133.8, 133.6, 129.1, 128.2, 128.0, 83.6, 79.6, 73.5, 39.0, 38.0, 37.7, 19.6, -1.8, 
-2.2; 
HRMS (ESI): calc. for C21H27NNaO2Si [M+Na+CH3CN]+ 376.1709; found: 376.1717. 
M.p. 94-95 °C 
IR (film): 3468, 2930, 820 cm-1. 
 
 
Compound 9. 
Solution of PMBBr in DMF. Dry NaBr (3.44 g, 33.4 mmol) was suspended in dry DMF (8 mL) at 25 °C, PMBCl (2.62 g, 
16.7 mmol) was added and the reaction mixture was stirred for 2 h at 25 °C. NMR-analysis showed ca. 90 % conversion. 
(NOTE: extension of the reaction time did not result in improvement of conversion.) 
PMB-protection. A stirred solution of PMBBr in DMF (prepared from 16.7 mmol of PMBCl, ca. 15.0 mmol) was diluted 
with DMF (10 mL), cooled to 0 °C and NaH (60 % in mineral oil, 0.61 g, 15.2 mmol) was added. A solution of 8 (2.40 g, 7.6 
mmol) in DMF (11 mL) was added within 5 min and stirring was continued for 6 h at 0°C and 2 h at rt. Then 
NH2CH2CH2NH2 (5 mL) was added and the mixture was stirred for 1 h at 0 °C and 1 h at rt until no more PMBBr and 
PMBCl could be detected by TLC. 138 Volatiles were removed in vacuo at rt, the reaction mixture was diluted with EtOAc 
(200 mL) and washed repeatedly with 1N HCl until pH 5-6 was reached. The combined water phases were extracted with 
EtOAc (3x100 mL). The combined organic phases were washed with water (3x100 mL), brine (50 mL) and passed through a 
plug of cotton. Solvents were removed in vacuo and the residue was subjected to flash column chromatography 
                                                          
138  PMBCl and PMBBr converts into PMB-NH-CH2CH2NH2. 
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(EtOAc/hexane) to give 9 (clear oil; 2.75 g, 85%, 96% brsm) and 8 (0.31 g, 13 %). (NOTE: Extension of reaction times did 
not improve conversion. Equal results were obtained when pure PMBBr was used instead of material prepared in situ). 
9: 1H NMR (400MHz): δ = 7.56-7.50 (m, 2H), 7.36-7.31 (m, 3H), 7.28 (bd, J=8.7 Hz, 2H), 6.89 (bd, J=8.7 Hz, 2H) 6.32 (d, 
J=1.6, 5.8 Hz, 2H), 6.25 (d, J=1.6, 5.8 Hz, 2H), 5.64 (ddd, J=2.8, 4.8, 9.9 Hz, 1H), 5.72 (dd, J=1.3, 9.9 Hz, 1H), 5.07 (bs, 
1H), 4.65 (bs, 1H), 4.54 (d, J=11.6 Hz, 1H), 4.44 (d, J=11.6 Hz, 1H), 3.82 (s, 3H), 3.31 (dd, J=6.1, 9.8 Hz, 1H) 2.53 (bdd, 
J=10.4, 10.4 Hz, 1H), 2.23-2.18 (m, 1H), 2.05 (dd, J=6.3, 7.6 Hz, 1H), 1.44 (dd, J=3.02, 14.7 Hz, 1H), 0.59 (dd, J=11.1, 14.7 
Hz, 1H), 0.33 (s, 3H), 0.20 (s, 3H);  
13C NMR (100 MHz): δ = 159.2, 140.4, 137.7, 134.8, 134.4, 133.7, 131.4, 129.3, 128.8, 127.8, 127.4, 113.9, 85.4, 83.9, 78.3, 
71.4,55.4,39.5, 39.2, 34.8, 19.0, -1.71, -1.73;  
HRMS (ESI): calc. for C27H32NaO3Si [M+Na]+ 455.2018; found: 455.2012. 
IR (film): 2952, 1612, 1513, 1248, 836 cm-1. 
 
 
Compound 10. Potassium hydride (30 wt % suspension in mineral oil, 0.83 g, 20.8 mmol) was placed in a dried 200 mL 
flask under Ar. Mineral oil was removed by washing the suspension with dry hexane (3x5 mL), N-Methyl-2-pyrrolidone 
(NMP, 25 mL) was added and the flask was cooled to 0 °C. Under vigorous stirring tBuOOH (5-6 M in decane, 4.2 mL, 
≥20.8 mmol) was added dropwise over 10 min, followed by addition of a solution of 9 (1.50 g, 3.5 mmol) in NMP (10 mL) 
over 5 min. The reaction mixture was warmed to rt, TBAF (1 M in THF, 7.5 mL, 7.5 mmol) was added and the stirring was 
continued for 3 h. The reaction mixture was quenched with aq. Na2S2O3 (5 M, 50 mL), stirred for 30 min, diluted with water 
(1 L) and extracted EtOAc/toluene 2:1 (5x200 mL). The combined organic phase was washed with water (2x200 mL), brine 
(200 mL) and dried over MgSO4. Solvents were removed in vacuo and the residue was subjected to a flash column 
chromatography (toluene/EtOAc) to yield 10 as a colorless oil (0.89 g, 82 %). 
10: 1H NMR (400MHz): δ = 7.30 (bd, J=8.8 Hz, 2H), 6.90 (bd, J=8.8 Hz, 2H), 6.38 (dd, J=1.7, 5.8 Hz, 1H), 6.31 (dd, J=1.6, 
5.8 Hz, 1H), 5.86-5.81 (m, 1H), 5.47 (dd, J=1.5, 9.9 Hz, 1H), 5.14 (bs, 1H), 4.71 (bs, 1H), 4.64 (d, J= 11.3 Hz, 1H), 4.49 (d, 
J=11.3 Hz, 1H), 3.81 (s, 3H), 3.73 (dd, J= 6.5, 10.5 Hz, H), 3.63 (dd, J=7.3, 10.5 Hz, 1H), 2.64-2.56 (m, 1H), 2.32-2.67 (m, 
1H), 2.17 (dd, J=6.2, 7.6 Hz, H); 
13C NMR (100 MHz): δ = 159.4, 137.4, 134.9, 130.1, 129.7, 129.4, 129.0, 114.0, 85.4, 81.2, 77.9, 70.6, 66.2, 55.3, 40.1, 
39.2, 38.8; 
HRMS (ESI): calc. for C19H22NaO4 [M+Na]+ 337.1416 ; found: 337.1412. 
IR (film): ca. 3460, 3822, 3676, 3651, 3629, 3448, 2931, 1701, 1513, 1249, 1033, 821 cm-1. 
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Compound 3. To a suspension of NaH (60 % in mineral oil, 300 mg, 7.6 mmol) in dry THF (12 mL) at 0 °C was added dry 
DMF (12 mL) and MeI (5.4 g, 2.5 mL, 38 mmol), followed by 10 (1.2 g, 3.8 mmol) in dry THF (5 mL). The reaction mixture 
was stirred at 0 °C for 12 h. Then saturated aq. NH4Cl (1 mL) was added carefully and the volatiles were removed in vacuo 
at rt (CAUTION: distillate contains MeI, which is toxic!). The residue was diluted with water (70 mL) and extracted with 
toluene (5x50 mL). The combined organic phase was washed with water (3x20 mL), brine (30 mL) and passed through a 
plug of cotton. The solvents were removed in vacuo and the residue was subjected to column chromatography 
(EtOAc/hexane) to yield 1.11 g of 3 (89 %) as a colorless oil. 
3: 1H NMR (400MHz): δ = 7.30 (bd, J=8.8 Hz, 2H), 6.90 (bd, J=8.8 Hz, 2H), 6.38 (dd, J=1.6, 5.8 Hz, 2H), 6.28 (dd, J=1.5, 
5.8 Hz, 1H), 5.83 (ddd, J=2.9, 4.6, 9.9 Hz, 1H), 5.71 (dd, J=1.5, 9.9 Hz, H), 5.14 (bs, 1H), 4.68 (bs, 1H), 4.57 (d, J=11.4 Hz, 
1H), 4.50 (d, J=11.4 Hz, 1H), 3.81 (s, 3H), 3.74 (d, J=6.3, 10.4 Hz, 1H), 3.58 (d, J=4.5, 9.0 Hz, 1H), 3.50 (d, J=3.0, 9.0 Hz, 
1H), 3.33 (s, 3H), 2.57-2.49 (m, 1H), 2.29-2.23 (m, 1H), 2.08 (bt, 1H);   
13C NMR (100 MHz): δ = 159.3, 137.7, 134.9, 131.2, 130.8, 129.5, 129.1, 113.9, 85.6, 78.2, 76.8, 72.8, 71.4, 59.2, 55.4, 
39.4, 39.4, 39.3. 
HRMS (ESI): calc. for C20H24NaO4 [M+Na]+ 351.1572 ; found: 351.1570. 
IR (film): 2928, 1612, 1513, 1249, 1117, 1079, 822cm-1. 
A sample of racemic 3 was separated by preparative chiral HPLC: Chiracel OD, hexane/iPrOH 9:1, 22 °C. 
 
  
retention time 7.1 min 10.2 min 
[α]D20 (c 7.05, CHCl3) + 31.7 - 31.7 
 
 
Compounds 11 and 12. A solution of Ni(COD)2 (420 mg, 1.52 mmol) in toluene (dry and degassed; 25 mL) was added to 
(R)-BINAP (1.43 g, 2.29 mmol) and the mixture was stirred at rt for 4 h. (NOTE: the solution became dark burgundy red. 
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Green or brown colors indicate presumably a partial oxidation of Ni° species and may result in lower enantioselectivity).139 
To this burgundy red solution a solution of 3 (2.50 g, 7.62 mmol) in toluene (43 mL) was added (the color stayed dark 
burgundy red, but a weak green-brown shade appeared) and the mixture was stirred for 30 min. Then DIBAL (1.0 M in 
hexanes, 8.8 mL, 8.8 mmol) was added over 6 h at 22 °C via a syringe pump. The reaction was allowed to stir for 1 h, then 
saturated aq. sodium-potassium-tartrate (100 mL) was added and the mixture was stirred for 30 min. The organic phase was 
separated and the water phase was extracted with Et2O (4x50 mL). The combined organic phase was washed with brine, 
passed through a plug of cotton and the solvents were removed in vacuo. The solid residue was triturated with MeOH (50 
mL), the solution was filtered to remove undissolved BINAP and its oxides, and the filtrate was concentrated in vacuo. The 
residue was subjected to flash column chromatography (EtOAc/hexane) to obtain 12 (1.16 g, 46%) as yellowish crystals and 
a mixture of 11 with (R)-BINAP monooxide. The latter mixture was resubjected to flash column chromatography 
(EtOAc/toluene) to yield 11 (1.13 g, 45%) as a colorless oil. (NOTE: 11 is air sensitive! Oxidation happens even at -20 °C. 
See the comment 2 in Supporting Information). 
11: 1H NMR (400MHz): δ = 7.29 (bd, J=8.9 Hz, 2H), 6.88 (bd, J=8.9 Hz, 2H), 5.80-5.74 (m, 1H), 5.69-5.58 (m, 3H), 4.58 
(d, J=11.4 Hz, 1H), 4.43 (d, J=11.4 Hz, 1H), 4.45-4.39 (m, 1H), 3.81 (dd, J=5.3, 9.7 Hz, 1H), 3.81 (s, 3H), 3.53-3.46 (m, 
2H), 3.30 (s, 3H), 3.06-2.98 (m, 1H), 2.98-2.91 (m, 1H), 2.39-2.34 (m, 1H), 2.26-2.22 (m, 2H), 1.90 (d, J=10.3 Hz, 1H, OH). 
13C NMR (100 MHz): δ = 159.3, 131.0, 129.5, 128.8, 128.7, 128.5, 123.6, 113.9, 75.5, 73.3, 70.9, 64.2, 59.1, 55.4, 40.5, 
37.5, 35.2, 34.8. 
The enantiomeric ratio was determined by chiral HPLC: Chiracel OD-H, 22 °C, hexane/iPrOH 9:1, 0.95 mL/min, 100 
mL/min, 8.2 min (major enantiomer), 11.0 min (minor enantiomer).  
[α]D20  = +146.2 (c = 1.10, CHCl3). 
HRMS (ESI): calc. for C20H26NaO4 [M+Na]+ 353.1729; found: 353.1733. 
IR (film): ca. 3480, 2890, 1513, 1247, 772 cm-1. 
 
12: 1H NMR (400MHz): δ = 7.25 (bd, J=8.7 Hz, 2H), 6.87 (bd, J=8.7 Hz, H), 5.79-5.74 (m, 1H), 5.72-5.66 (m, 2H), 5.64-
5.59 (m, 1H), 4.56 (d, J=11.3 Hz, 1H), 4.47 (d, J=11.3 Hz, 1H), 4.00-3.94 (m, 1H), 3.79 (s, 3H), 3.69 (dd, J=3.6, 6.5 Hz, 
1H), 3.45-3.33 (m, 2H), 3.31 (s, 3H), 2.91-2.84 (m, 1H), 2.69-2.63 (m, 1H), 2.26-2.10 (m, 2H); 
13C NMR (100 MHz): δ = 159.3, 130.3, 129.6, 128.3, 126.2, 113.9, 75.7, 73.6, 71.2, 67.7, 59.0, 55.4, 40.5, 39.8, 36.0, 32.4; 
[α]D20  = -151.3 (c 1.6, CHCl3).  
m.p. 104-106 °C. 
IR (film): ca. 3400, 2874, 1612, 1514, 1248, 1077, 671 cm-1. 
The enantiomeric ratio was estimated from the 1H-NMR spectra of the corresponding Mosher esters. 
 
                                                          
139 Lautens, M.; Rovis, T. In Comprehensive Asymmetric Catalysis; Jacobsen, E. N., Pfaltz, A., Yamamoto, H., Eds.; Springer:  
Berlin, Heidelberg, 1999; Vol. I, Chapter 8, pp 8-9. 
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Compound 13. A solution of 11 (330 mg, 1.0 mmol) in dry DCM (10 mL) was added to a suspension of NaHCO3 (1.7 g, 20 
mmol) and Dess-Martin periodinane (DMP, 509 mg, 1.2 mmol) in dry DCM (16 mL) and stirred in an open vessel for 10-20 
min until full conversion was observed (TLC; EtOAc/hexane 1 : 1.5). The reaction was quenched with Na2S2O3 (2M aq., 5 
mL) and stirred for 1 h at rt. The organic phase was separated and the water phase was extracted with DCM (3x20 mL). The 
combined organic phase was washed with brine (20 mL), passed through a plug of cotton and the volatiles were removed in 
vacuo. The residue was passed through a short plug of silica gel (25% EtOAc/hexane) to give 13 (305 mg, 93%).  (NOTE: 13 
is air sensitive, see the comment 2 in Supporting Information). 
13: 1H NMR (400MHz): δ = 7.22 (bd, J=8.6 Hz, 2H), 6.84 (bd, J=8.6 Hz, H), 5.86-5.80 (m, 1H), 5.72-5.66 (m, 1H), 5.57 (d, 
J=11.1 Hz, 1H), (d, J=11.1 Hz, 1H), 4.48(d, J=11.9 Hz, 1H), 4.46(d, J=11.9 Hz, 1H), 3.78 (s, 3H), 3.71 (dd, J= 3.7, 7.8 Hz, 
H), 3.47 (dd, J=4.6, 9.3 Hz, 1H), 3.39 (dd, J=4.4, 9.3 Hz, 1H), 3.37-3.32 (m, 1H), 3.26 (s, 3H), 3.02-2.97 (m, 2H), 2.92 (bd, 
J=21.1 Hz, 1H), 2.77 (bd, J= 21.1 Hz, 1H); 
13C NMR (100 MHz): δ = 208.3, 159.2, 130.8, 129.4, 129.1, 127.7, 127.2, 123.6, 113.8 75.1, 72.9, 71.6, 59.0, 55.3, 47.3, 
41.2, 39.7, 39.6; 
HRSM: calc. for [C20H24NaO4] 351.1572 ; found: 351.1582. 
IR (film): 2874, 1720, 1612, 1513, 1248, cm-1.  
[α]D20  = +85.4 (c 2.40, CHCl3) 
 
Compound 14. To a solution of 13 (110 mg, 0.34 mmol) in dry DCM (9.5 mL) at 40 °C was added DBU (139 mg, 0.92 
mmol) and the resulted green-brown mixture was stirred at 40 °C for 45 min (conversion monitored by 1H NMR). The 
reaction mixture was washed with NaH2PO4 (2 M aq.) until pH 6-7 was reached. The combined water phase was extracted 
with EtOAc (4x30 mL). The combined organic phase was washed with brine (30 mL), dried over MgSO4, filtered, and the 
solvents were removed in vacuo. The residue was subjected to column chromatography (EtOAc/toluene) to yield 14 as a 
clear pale yellow oil (99 mg, 88 % yield) 
14: 1H NMR (400MHz): δ = 7.11 (bd, J=8.7 Hz, 2H), 7.01-6.95 (m, 1H), 6.81 (bd, J=8.7 Hz, 2H), 6.15-6.09 (m, 1H), 5.84 
(ddd, J=1.7, 4.5, 10.1 Hz, 1H), 5.65 (bdd, J=4.5, 10.1 Hz, 1H), 4.42 (d, J=11.4 Hz, 1H), 4.29 (d, J=11.4 Hz, 1H), 4.11 (bs, 
1H), 3.78 (s, 3H), 3.36 (d, J=4.8, 9.5 Hz, 1H), 3.33 (s, 3H), 3.24 (d, J=7.7, 9.5 Hz, 1H), 2.83-2.75 (m, 1H), 2.72-2.66 (m, 
1H), 2.60 (dd, J=3.0, 6.6 Hz, 1H), 2.55 (dddd, J=2.6, 2.6, 10.4, 18.4 Hz, 1H), 2.38 (dddd, J=0.8, 5.7, 5.7, 18.4 Hz, 1H); 
13C NMR (100 MHz): δ = 201.4, 159.1, 150.5, 131.0, 130.5, 130.2, 128.9, 126.0, 113.7, 78.3, 74.5, 71.8, 59.1, 55.4, 45.9, 
40.4, 33.5, 31.4. 
Experimental Section 89 
[α]D20  = -70.0 (c 0.30, CHCl3) 
HRMS calc. for C20H24NaO4 [M+Na]+ 351.1572 ; found: 351.1578. 
IR (film): 2899, 1667, 1613, 1513, 1248 cm-1. 
 
 
Compounds 2, 2′ and 2′′. A solution of 14 (40.0 mg, 0.12 mmol) in DCM (2.3 mL) was cooled to 0 °C and mCPBA (70 wt 
%, 147 mg, 0.60 mmol) was added. The reaction was stirred at 0 °C for 2 h (until TLC analysis shows ca. 50% conversion). 
Then aq. sat. Na2S2O3 (10 mL.) and aq. sat. NaHCO3 (10 mL) were added, and the mixture was stirred for 10 min. The water 
phase was extracted with EtOAc (5x20 mL), the combined organic phase was dried over MgSO4, filtered and concentrated in 
vacuo. Purification by column chromatography (EtOAc/hexane) yielded 14 (19.5 mg), 2 (white solid, 13.1 mg, 64% brsm), 
2’ (oil, 4.3 mg, 21% brsm) and 2′′ (0.2 mg, 0.8%; NOTE: 2′′ is presumably unstable towards column chromatography on 
silica gel, as the crude yield estimated from NMR was ca. 2%. The ratio of 2′′ and 2 was determind by NMR before and after 
chromatography. 
2: 1H NMR (400MHz): δ = 7.08 (d, J=8.7 Hz, 2H), 7.02 (ddd, J=1.9, 6.2, 9.9 Hz, 1H), 6.81 (d, J=8.8Hz, 2H), 6.13 (bd, J=9.9 
Hz, 1H), 4.36 (d, J=11.2 Hz, 1H), 4.15 (d, J=11.2 Hz, 1H), 3.78 (s, 3H), 3.70 (m, 1H), 3.56 (dd, J=6.5, 9.4 Hz, 1H), 3.39 (s, 
3H), 3.34-3.28 (m, 2H), 3.22 (dd, J=1.4, 3.8 Hz, 1H), 2.85-2.70 (m, 2H), 2.62-2.56 (m, 1H), 2.40 (dd, J=2.8, 5.9 Hz, 1H), 
2.38-2.30 (m, 1H). 
13C NMR (100 MHz): δ = 200.5, 159.2, 150.1, 130.7, 130.4, 129.0, 113.7, 76.1, 71.58, 71.56, 59.3, 55.4, 55.3, 51.8, 43.2, 
38.1, 32.2, 28.3. 
M.p. 94-95 °C (EtOAc/hexane) 
[α]D20  = +110.8 (c 2.60, CHCl3). 
HRMS (ESI): calc. for C20H24NaO5 [M+Na]+ 367.1521 ; found: 367.1533. 
IR (film): 2919, 2857, 2835, 1673, 1514, 1250 cm-1. 
For X-ray data see the enclosed CIF file 
 
2′: 1H NMR (400MHz): δ = 7.22 (d, J=8.4 Hz, 2H), 6.85 (d, J=8.8 Hz, 2H), 6.82-6.85 (m, 1H), 6.02 (ddd, J=1.9, 1.9, 10.3 
Hz, 1H), 4.47 (bd, J=11.8 Hz, 1H), 4.42 (d, J=11.8 Hz, 1H), 3.80 (s, 3H), 3.57 (dd, J=4.1, 9.3 Hz, 1H), 3.53 (bs, 1H), 3.49 
(dd, J=3.7, 9.3 Hz, 1H), 3.27 (s, 3H), 3.12-3.06 (m, 2H), 2.67 (bs, 2H), 2.64-2.57 (m, 3H). 
13C NMR (100 MHz; CPD mode): δ = 159.2, 130.9, 130.5, 129.4, 113.7, 77.2, 75.7, 71.7, 71.0, 59.0, 55.3. 53.7, 42.9, 37.1, 
34.9, 29.2. NOTE: two signals of 13C were not visible even with a large number of scans. Chemical shifts at 29.2 and 42.9 
were obtained from HSQC spectra. Some of 13C signals are broad and of very low intensity (compared to the corresponding 
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carbons of diastereomeric 2). This phenomenon could be attributed to slow conformational changes or to long relaxation 
times). 
 [α]D20  = + 12.6 (c 0.135, CHCl3). 
HRMS (ESI): calc. for C20H24NaO5 [M+Na]+ 367.1521 ; found: 367.1516. 
IR (film): 2925, 1683, 1514, 1246 cm-1. 
2′′: 1H NMR (400MHz): δ = 7.19 (d, J=8.5 Hz, 2H), 6.86 (d, J=8.9 Hz, 2H), 6.32 (dd, J=2.2, 5.9 Hz, 1H), 5.49-5.43 (m, 1H), 
4.47 (d, J=11.7 Hz, 1H), 4.37 (d, J=11.7 Hz, 1H), 3.47 (s, 3H), 3.72 (dd, J= 3.1, 8.9 Hz, 1H), 3.56 (dd, J= 7.5, 9.1 Hz, 1H), 
3.49 (dd, J= 2.0, 3.8 Hz, 1H), 3.39 (s, 3H), 3.12 (dd, J= 3.8, 8.3 Hz, 1H), 2.84 (d, J= 3.8 Hz, 1H), 2.66-2.58 (m, 1H), 2.37-
2.27 (m, 1H), 2.24-2.16 (m, 1H). 
13C NMR (100 MHz): δ = 169.9, 159.5, 141.6, 130.4, 129.4, 113.9, 112.2, 73.8, 72.6, 71.8, 59.1, 57.2, 55.3, 54.0, 42.7, 42.5, 
37.3, 26.1. 
The configuration of epoxide 2′′ was proven by reaction of 2 with mCPBA. 
HRMS (ESI): calc. for C20H24NaO6 [M+Na]+ 383.3907 ; found: 383.3895. 
IR (film): 1758, 1513, 1248, 1100 cm-1. 
[α]D20  = + 101.5 (c 0.065, CHCl3). 
 
Compound 15. A flask was charged with (-)-3 (30 mg, 0.09 mmol), DCM (2 mL) and aq. pH 7 buffer (2 mL) was placed in 
an ultrasound bath at 10 °C. DDQ (41 mg, 0.18 mmol) was added and the mixture was sonicated for 40 min at 10-20 °C. 
Then aq. Na2S2O3 (2 M , 1 mL) and DCM (30 mL) were added. The organic phase was washed with saturated aq. NaHCO3 
(4x20 mL), brine (5 mL), passed through a plag of cotton and concentrated in vacuo. The residue was subjected to column 
chromatography (EtOAc/hexane) to yield compound 15 (18 mg).  
Compound 16. Compound A (18 mg) was dissolved in dry CHCl3 (1 mL) at rt, and CCl3C(=O)-N=C=O (0.1 mL) was added 
under stirring. After 10 min water (5 mL) was added and the mixture was extracted with EtOAc (3x10 mL). The combined 
organic phase was washed with brine, dried over MgSO4 and concentrated in vacuo. The residue was subjected to column 
chromatography to yield 16 (21 mg) as a white foam. (NOTE: 16 is unstable on silica gel, therefore chromatography should 
be done as quickly as possible). 
Crystals of 16 suitable for X-ray were obtained by slow diffusion of pentane vapors into a solution of 16 in EtOAc at 0 °C. 
For X-ray data see the attached CIF file. 
 
15.6. Experimental Section for Chapter 10.3 
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Compound 177. To a solution of 176 (50.0 mg, 0.151 mmol) in dichloromethane (1.2 mL) was added aq. pH 7.0 buffer (1 
mL). The mixture was immersed in an ultrasonic bath and sonicated at +1 to + 3 °C for 5 min. To this mixture DDQ (69.1 
mg, 0.305 mmol) was added and the reaction mixture was sonicated for 30 min at +1 to + 3 °C (maintaining the temperature 
in the bath by adding ice). The mixture was transferred into a separation funnel, saturated aq. Na2S2O3 (3 mL) was added and 
the flask was vigorously shacked for 20 sec. Saturated aq. NaHCO3 (30 mL) was added and the flask was vigorously shacked 
for 1 min. The mixture was phase was extracted with EtOAc (2x30 mL), the origin phase was washed with saturated aq. 
NaHCO3 (30 mL). The combined water phases were extracted with EtOAc (4x30 mL). The combined organic phases were 
washed with brine (30 mL) and dried over MgSO4. Solvents were removed in vacuo below 30 °C to obtain crude 177 in a 
mixture with PMPCHO. The yield from NMR is ca. 98% (with CH2Br2 and dichloroethane as internal standards).  
 
177 (in a mixture with PMPCHO): 1H NMR (400MHz, CDCl3): 6.85-6.79 (m, 1H), 5.96 (bdd, J=2.9, 10.0 Hz, 1H), 5.70 
(ddd, J=2.7, 2.7, 10.0 Hz, 1H), 5.4 (bd, J=10.0 Hz, 1H), 4.09 (d, J=11.0 Hz, 1H, OH), 3.75-3.67 (m, 1H), 3.60 (dd, J=3.7, 9.0 
Hz, 1H), 3.53 (dd, J=5.6, 9.0 Hz, 1H), 3.34 (s, 3H), 3.00 (bs, 1H), 2.87 (dd, J=4.5, 4.5 Hz, 1H), 2.74-2.65 (m, 1H), 2.5-2.42 
(m, 1H), 2.43 (bdd, J=6.4, 19.4 Hz, 1H); 
13C NMR (100 MHz): 203.2, 147.9, 131.1, 129.8, 129.7, 77.3, 77.0, 76.6, 72.9, 70.6, 59.0, 49.0, 42.6, 35.4, 31.2 29.6; 
 
Compound  178. Crude mixture of 177 (ca. 0.15 mmol) and PMPCHO obtained from the previous step was dissolved in 
THF (1.4 mL) and cooled to -78 °C. To this solution 2,6-di-tert-butylpyridine (115 mg, 129 µL, 0.60 mmol) was added and 
the mixture was stirred until a clear solution was obtained. Then TBSOTf (86 µL, 99 mg, 0.375 mmol) was added dropwise 
and the mixture was stirred at -78 °C for 1h. The reaction was quenched by pouring into a vigorously stirred saturated aq. 
NaHCO3 (30 mL), stirred for 5 min and extracted with EtOAc (3x30 mL). The combined organic phases were washed with 
brine (20 mL) and dried over MgSO4. Volatiles were removed in vacuo and the residue was subjected to column 
chromatography (EtOAc/toluene) to obtain 178 in 89% (43.6 mg) over two steps.  
 
178: 1H NMR (400MHz, CDCl3): δ = 6.99 (ddd, J=2.1, 6.1, 10.2 Hz, 1H), 6.09 (ddd J=1.0, 2.7, 10.2 Hz, 1H), 5.87 (ddd, 
J=1.6, 4.8, 10.2 Hz, 1H), 5.64 (dddd J=1.3, 4.8, 10.2 Hz, 1H), 4.37 (bs, 1H), 3.33 (s, 3H), 3.31 (dd, J=5.1, 9.6 Hz, 1H), 3.21 
(dd, J=7.8, 9.6 Hz, 1H), 2.87-2.72 (m, 1H), 2.61 (dddd J=2.5, 11.3, 18.4 Hz, 1H), 2.47 (dd, J=2.6, 6.9 Hz, 1H), 2.48-2.40 (m, 
1H), 2.38 (dddd, J=0.8, 5.8, 5.8, 18.3 Hz, 1H), 0.79 (s, 9H), 0.01 (s, 3H), -0.01 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 201.9, 150.9, 130.5, 130.2, 125.3, 74.8, 71.7, 59.2, 46.8, 45.0, 33.1, 31.5, 25.8, 17.9, -4.9, -
5.2. 
[α]D20  = -91.88 (c 0.690, CHCl3). 
HRMS (ESI): calc. for C18H30NaO3Si [M+Na]+ 345.1862; found: 345.1862. 
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Compounds 179, 179’ and 180. To a solution of 178 (700 mg, 2.17 mmol) in dichloromethane (40 mL) at 0 °C was added 
mCPBA (77%, 2.43 g, 10.8 mmol). The mixture was stirred for 2 h at 0 °C, washed with saturated aq. Na2S2O3 (20 mL) and 
saturated aq. NaHCO3 (2x20 mL). The combined water phases were extracted with dichloromethane (5x50 mL). The 
combined organic phases were washed with brine, passed through a plug of cotton and concentrated in vacuo. The residue 
was subjected to column chromatography (EtOAc/hexanes) to obtain starting 178 (281 mg), 179 (371 mg, 84% brsm), 179’ 
(36 mg, 8.4% brsm) and 180 (3 mg, 1% brsm).  
 
179: 1H NMR (400MHz): 7.00 (ddd, J=1.6, 6.1, 10.2 Hz, 1H), 6.08 (bd, J=10.2 Hz, 1H), 3.94 (bs, 1H), 3.50 (dd, J=7.1, 9.5, 
1H), 3.16 (s, 3H), 3.34-3.28 (m, 2H), 3.25 (dd, J=1.0, 3.8, 1H), 2.87-2.76 (m, 2H), 2.45-2.33 (m, 2H), 2.28 (dd, J=2.4, 5.6, 
1H), 0.8 (s, 9H), 0.14 (s, 3H), -0.14 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 200.8, 149.9, 131.0, 71.6, 69.5, 59.4, 55.4, 51.5, 43.9, 42.7, 32.0, 28.5, 25.9, -5.0, -5.3. 
[α]D20  = -100.47 (c 0.645, CHCl3). 
HRMS (ESI): calc. for C18H30NaO4Si [M+Na]+ 361,1811; found: 361,1817. 
IR (film): 2928, 1733, 1674, 1557, 1388, 1326, 1253, 1212, 1067, 1035, 1006, 912, 828, 796, 778 cm-1. 
 
179’: 1H NMR (400MHz, CDCl3): δ = 6.90 (bs, 1H), 6.00 (ddd, J=2.0, 2.0, 10.2 Hz, 1H), 3.97 (bs, 1H), 3.58-3.49 (m, 1H), 
3.46 (dd, J=4.8, 9.4 Hz, 1H), 3.34 (s, 3H), 3.22-3,12 (m, 2H), 2.88-2.76 (m, 1H), 2.76-2.67 (m, 1H), 2.60-2.51 (m, 1H), 2.48 
(dd, J=4.7, 9.7 Hz, 1H), 2.35 (dd, J=2.8, 3.4 Hz, 1H), 0.83 (s, 9H), 0.02 (s, 3H), -0.09 (bs, 3H). 
 
13C NMR (100 MHz, CDCl3): δ = 130.6, 112.7, 72.4, 67.6, 59.3, 55.3, 46.6, 25.8, 18.0, -4.8, -4.9. (NOTE: similar to 
compound 2‘,few signals (in this case 5 signals) are not visible in 13C spectra even at large number of scans, and some of 
signals are relatively broad (up to 20 Hz for the signal at 130.6 ppm). This phenomenon could be attributed to slow 
conformational changes or to long relaxation times) 
HRMS (ESI): calc. for C18H30NaO4Si [M+Na]+ 361,1811; found: 361,1815. 
IR (film): 2928, 2363, 1672, 1557, 1473, 1418, 1388, 1328, 1254, 1213, 1108, 976, 876, 862, 837, 791, 775, 638, 611 cm-1. 
 
180: 1H NMR (400MHz): δ = 6.45 (dd, J= 2.2, 5.8 Hz, 1H), 5.56-5.50 (m, 1H), 3.70 (dd, J= 4.3, 10.0 Hz, 1H), 3.67 (dd, J= 
3.4, 9.0 Hz, 1H), 3.58 (dd, J= 7.4, 9.0 Hz, 1H), 3.49 (dd, J= 2.2, 3.6 Hz, 1H), 3.41-3.33 (m, 1H), 3.40 (s, 3H), 3.12 (dd, J= 
4.3, 8.2 Hz, 1H), 2.85 (d, J= 3.8 Hz, 1H), 2.73 (ddd, J= 6.3, 8.2, 14.8 Hz, 1H), 2.42-2.31 (m, 1H), 2.23 (ddd, J= 6.3, 8.2, 14.4 
Hz, 1H), 0.85 (s, 9H), 0.03 (s, 3H), 0.00 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 169.8, 141.7, 112.5, 72.0, 67.0, 59.2, 57.6, 54.0, 46.8, 43.0, 38.4, 26.2, 25.7, 18.0, -4.5, -
4.9. 
HRMS (ESI): calc. for C18H30NaO5Si [M+Na]+ 377.1760; found: 377.1764. 
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IR (film): 2847, 1843, 1760, 1558, 1233, 1207, 1100, 1029, 847, 791, 778, 700, 610, 458, 427, 420, 415, 412 cm-1. 
15.7. Experimental Section for Chapter 11  
 
 
 
Compound 183. A mixture of (S)-glycidol (11.0 g, 0.149 mol), silver oxide140 (34.5 g, 0.149 mol), methyl iodide (211.0 g, 
1.49 mol) and molecular sieves 4 Å (powder, 13.5 g) in dichloromethane (90 mL) was refluxed for 2h (conversion was 
monitored by NMR). After cooling to rt, the mixture was passed through a short plug of Celite, the filter cake was washed 
with dichloromethane (80 mL). Fractional distillation of the combined organic phases gave 183 in 73% yield (9.6 g).  
Analytical data for 183 were in agreement with literature reported.82Error! Bookmark not defined. 
 1H NMR (, 250 MHz, CDCl3): δ = 3.69 (dd, J = 11.4, 2.9 Hz, 1H), 3.41 (s, 3H), 3.34 (dd, J = 
11.4, 5.8 Hz, 1H), 3.16 (m, 1H), 2.81 (dd, J = 9.1, 4.2 Hz, 1H), 2.61 (dd, J = 5.0, 2.7 Hz, 1H). 
13C NMR (CDCl3, 75 MHz): δ = 73.1, 59.1, 50.7, 44.1. 
 
 
Conversion of 183 into 185 was carried out as previously described.25 
 
 
 
Compound 187. Chiral allene 186 was synthesized as previously described.141 
A solution of aldehyde 185 (3.0 g, 11.5 mmol) in dichloromethane (78 mL) was cooled to -90 °C and a solution of TiCl4 
(3.78g, 19.9 mmol) in dichloromethane (8.7 mL) was added slowly. The mixture was warmed to -80 °C over 20 min and 
then cooled to -95 °C. Allene 186 was added dropwise over 20 min, the reaction mixture allowed to warm to -78°C over 1 h, 
and stirred at -78°C for 2 h. The reaction mixture was quenched by pouring into a vigorously stirred saturated aq. NH4Cl (0.5 
L). The organic phase was separated and the water phase was extracted with Et2O (4 x 100 mL). The combined organic 
phases were washed with saturated aq. NaHCO3 (100 mL), brine (100 mL), dried over MgSO4, filtered and concentrated in 
vacuo. The residue was subjected to column chromatography (EtOAc/hexanes) to obtain 3.22 g of 187 (85%, dr 20 : 1). 
 
1H NMR (400 MHz, CDCl3): δ = 4.44 (dd, J=6.7, 5.7 Hz, 1H), 3.48 (dd, J=9.3, 6.7 Hz, 1H), 3.41 (dd, J=9.3, 5.7 Hz,1H), 
3.35 (s, 3H), 2.49 (m, 1H), 2.36 (bd, J= 9.9 Hz, 1H), 1.77 (d, J=2.6 Hz, 3H), 1.26 (d, J=6.8 Hz, 3H), 1.21 (m, 21H). 13C 
NMR (100 MHz, CDCl3): δ = 81.4, 78.5, 75.6, 75.1, 71.4, 59.3, 30.8, 18.5, 18.2, 13.4, 3.9. 
 
                                                          
140 Tanabe, M.; Peters, R. H.Organic Syntheses, Coll. Vol. 7, p.386 (1990); Vol. 60, p.92 (1981). 
141 Bahadoor, A. B.; Flyer, A.; Micalizio, G. C. J . Am. Chem. Soc .2005, 127, 3694-3695. 
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Compound 189a 
To a mixture of alcohol 187 (4.73 g, 14.4 mmol), iPr2NEt (7.0 g, 54.5 mmol) and dichloromethane (2 mL, NOTE: 
dichloromethane was used in this small amount make the final mixture not too viscous) was added MOMCl (5.8 g, 72.0 
mmol). The mixture was stirred at rt over 12 h. Reaction was quenched by stirring with aq. NaHCO3 (100 mL) over 30 min. 
The water phase was extracted with Et2O (3x50 mL). The combined organic phases were washed with brine (50 mL) and 
dried over MgSO4. Volatiles were removed in vacuo (CAUTION: distillate can contain MOMCl, which is toxic!) and the 
residue was subjected to column chromatography (EtOAc/hexanes) to obtain 189a in 95% yield (5.10 g). 
 
1H NMR (400MHz, CDCl3): δ = 4.73 (d, J=6.5 Hz, 1H), 4.70 (d, J=6.5 Hz, 1H), 4.30 (ddd, J=3.0, 6.1, 6.1 Hz, 1H), 3.53 (dd, 
J=6.1, 9.3 Hz, 1H), 3.49 (dd, J=3.0, 7.7 Hz, 1H), 3.41 (dd, J=6.1, 9.3 Hz, 1H), 3.40 (s, 3H), 3.32 (s, 3H), 2.88-2.78 (m, 1H), 
1.74 (d, J=2.4 Hz 3H), 1.20 (d, J=7.0 Hz 3H), 1.12-1.02 (m, 21H). 
13C NMR (100 MHz, CDCl3): δ = 98.1, 82.9, 82.0, 77.2, 74.5, 72.5, 58.8, 56.1, 27.7, 18.4, 18.3, 18.1, 13.0, 3.7. 
HRMS (ESI): calc. for C20H40NaO4Si [M+Na]+ 395.2594; found: 395,2597. 
IR (film): 2943, 2881, 2867, 1464, 1417, 1384, 1344, 1152, 1079, 1037, 983, 974, 938, 921, 902, 883, 836, 774, 714, 679, 
419 cm-1. 
[α]D20  = +8.68 (c 2.50, CHCl3). 
 
 
 
Compound 190a. To a solution of Cp2ZrCl2 (5.0 g, 17.1 mmol) in THF (120 mL) at 0 °C was added DIBAL (1.0 M in 
hexanes, 17.1 mL, 17.1 mmol). The reaction mixture was warmed to rt and the resulting slurry was stirred for 2 h. Then the 
stirring was stopped, and after 10 min the supernatant liquid was removed with a syringe. To the white precipitate a solution 
of 189a (2.20 g, 5.9 mmol) in benzene (160 mL) was added, and the mixture was stirred at rt over 12 h. Then the reaction 
mixture was cooled to 0 °C, and a solution of I2 (5.0 g, 20 mmol) in benzene (100 mL) was added over 5 min. The reaction 
was quenched by pouring into a vigorously stirred aq. 3M Na2S2O3 (100 mL). After both layers became colorless, the organic 
phase was separated, and the water phase was extracted with Et2O (4x50 mL). The combined organic phases were washed 
with brine (50 mL) and dried over MgSO4. Volatiles were removed in vacuo and the residue was subjected to column 
chromatography (EtOAc/hexanes) to obtain 190a in 83% yield (2.45 g). 
1H NMR (400MHz, CDCl3): δ = 6.23-6.18 (m, 1H), 4.74 (d, J=6.8 Hz, 1H), 4.63 (d, J=6.8 Hz, 1H), 4.01-4.02 (m, 1H), 3.53 
(dd, J=3.9, 9.6 Hz, 1H), 3.44 (dd, J =4.8, 5.8 Hz, 1H), 3.40 (s, 3H), 3.35 (dd, J =6.0, 9.6 Hz, 1H), 3.32 (s, 3H), 2.77-2.66 (m, 
1H), 2.38 (d, J=1.5 Hz, 1H), 1.10-1.06 (m, 21H), 1.00 (d, J=6.9 Hz, 3H).  
13C NMR (100 MHz, CDCl3): δ = 144.7, 98.0, 92.7, 82.9, 74.9, 73.5, 58.9, 56.0, 36.4, 27.8, 18.3, 16.4, 12.9. 
HRMS (ESI): calc. for C20H41INaO4Si [M+Na]+ 523.1716; found: 523.1721. 
IR (film):  2943, 2906, 2866, 1465, 1112, 1076, 1039, 937, 919, 882, 766, 679, 415, 406 cm-1. 
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[α]D20  = +15.36 (c 2.80, CHCl3). 
 
 
 
Compound 191a. To a solution of 190a (2.50 g, 5.00 mol) in THF (18 mL) at rt was added TBAF (1.0 M in THF, 7 mL, 7 
mmol) and the mixture was stirred for 1 h. A saturated aq. NH4Cl (5 mL) was added and volatiles were removed in vacuo. 
The residue was dilueted with half-saturated NH4Cl (50 mL)  and extracted with EtOAc (5x30 mL). The combined organic 
phases were washed with brine (30 mL) and dried over MagSO4. Solvents were removed in vacuo and the residue was 
subjected to column chromatography (EtOAc/hexanes) to obtain 191a in 95% yield (1.63 g). 
 
1H NMR (400MHz, CDCl3): δ = 6.08-6.03 (m, 1H), 4.65 (d, J=6.6 Hz, 1H), 4.62 (d, J=6.6 Hz, 1H), 3.75-3.69 (m, 1H), 3.43-
3.40 (m, 2H), 3.41 (s, 3H), 3.36 (dd, J=4.1, 6.1 Hz, 1H), 3.36 (s, 3H), 2.81-2.73 (m, 1H), 2.79 (d, J=5.8 Hz, 1H, OH), 2.40 
(d, J=1.5 Hz, 3H), 1.00 (d, J=6.8 Hz). 
13C NMR (100 MHz, CDCl3): δ = 143.6, 98.6, 94.8, 83.1, 74.1, 70.4, 59.2, 56.3, 37.4, 28.0, 15.7. 
HRMS (ESI): calc. for C11H21INaO4 [M+Na]+ 367.0382; found: 367.0381. 
IR (film): 3460, 3165, 2931, 2363, 1457, 1326, 1126, 1070, 1029, 809, 671, 611, 590, 587, 458, 452, 449, 434, 421, 410, 
406, 403 cm-1. 
[α]D20  = +44.43 (c 3.00, CHCl3). 
 
 
 
Compound 192a.  A mixture of 191a (1.5 g, 4.36 mmol), imidazole (1.20 g, 20 mmol), TBSCl (1.4 g, 9 mmol) and DMF 
(3.0 mL) was stirred over 12 h at rt. The reaction mixture was quenched with saturated aq. NaHCO3 (10 mL), stirred for 20 
min, diluted with water (200 mL) and extracted with EtOAc (3x50 mL). The combined organic phases were washed with 
water (2x30 mL), brine (30 mL) and dried over MgSO4. Volatiles were removed in vacuo, and the residue was subjected to 
column chromatography (EtOAc/hexanes) to obtain 1.90 g of 192a (95%). 
 
1H NMR (400MHz, CDCl3): δ = 6.22-6.17 (m, 1H), 4.73 (d, J=6.8 Hz, 1H), 4.62 (d, J=6.8 Hz, 1H), 3.89-3.84 (m, 1H), 3.47 
(dd, J=4.0, 9.9 Hz, 1H), 3.41 (s, 3H), 3.39 (dd, J =5.3, 5.3 Hz, 1H), 3.33 (dd, J =5.8, 9.7 Hz, 1H), 3.33 (s, 3H), 2.73-2.63 (m, 
1H), 2.38 (d, J=1.5 Hz, 1H), 1.00 (d, J=6.9 Hz, 3H), 0.90 (s, 9H), 0.08 (s, 3H), 0.07 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 144.7, 98.1, 93.0, 82.5, 74.8, 73.2, 59.1, 56.1, 36.6, 27.8, 26.1, 18.3, 16.1, -4.4, -4.5. 
HRMS (ESI): calc. for C17H35INaO4Si [M+Na]+ 481.1247; found: 481.1253. 
IR (film): 2929, 2911, 2888, 2868, 2857, 2356, 1636, 1557, 1473, 1418, 1378, 1318, 1253, 1229, 1196, 1182, 1105, 1069, 
1037, 999, 980, 836, 818, 778, 665, 631 cm-1. 
[α]D20  = -0.41 (c 2.45, CHCl3). 
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15.8. Experimental Section for Chapter 12 
 
 
Compound  193a. A solution of tBuLi (1.74 M in pentane, 1.13 mL, 1.96 mmol) was added within 10 min to THF (1.7 mL) 
cooled to -90 °C. The resulted yellow slurry was warmed to -80 °C, and a solution of 186a (451 mg, 0.98 mmol) in THF (1.2 
mL) was added within 1.5 h. After stirring for additional 1 h, a solution of 179 (185 mg, 0.55 mmol, er 94 : 6) in THF (1.2 
mL) was added within 5 min. The reaction mixture allowed to warm to rt overnight and stirred at rt for additional 3 h. 
Saturated aq. NH4Cl (5 mL) was added and the mixture was concentrated to half its volume in vacuo. The mixture was 
extracted with EtOAc (3x20 mL), the combined organic phases were washed with brine (20 mL), dried over MgSO4 and 
solvents were removed in vacuo. The residue was subjected to column chromatography (EtOAc/hexanes) to obtain 282 mg 
of 193a (82% yield based on the amount of the desired enantiomer). 
 
1H NMR (400MHz, C6D6): δ = 6.12 (d, J=9.8 Hz, 1H), 5.96 (ddd, J=1.7, 1.8, 9.3 Hz, 1H), 5.51 (ddd, J=3.2, 3.2, 9.3 Hz, 1H), 
4.76 (d, J=6.5 Hz, 1H), 4.64 (d, J=6.5 Hz, 1H), 4.33-4.26 (m, 2H), 4.18-4.09 (m, 2H), 3.72-3.66 (m, 2H), 3.62 (dd, J=5.4, 5.4 
Hz, 1H), 3.57 (dd, J=3.5, 9.7 Hz, 1H), 3.43 (dd, J=6.6, 9.7 Hz, 1H), 3.33 (dd, J=3.0, 9.3 Hz, 1H), 3.31 (s, 3H), 3.14 (s, 3H), 
3.06-2.96 (m, 1H), 2.92 (s, 3H), 2.81 (d, J=5.4 Hz, 1H), 2.78-2.71 (m, 1H), 2.41-2.32 (m, 1H), 2.37 (d, J=2.5 Hz, 1H), 2.09 
(d, J=18.3 Hz, 1H), 1.93 (s, 3H), 1.27 (d, J=6.8 Hz, 1H), 1.06 (s, 9H), 0.99 (s, 3H), 0.224 (s, 3H), 0.216 (s, 3H), 0.08 (s, 3H), 
0.04 (s, 3H). 
13C NMR (100 MHz, C6D6): δ = 139.1, 133.6, 128.2, 127.9, 98.4, 85.5, 85.1, 83.4, 75.8, 74.2, 73.8, 72.6, 72.2, 58.7, 58.4, 
55.9, 49.6, 41.1, 38.0, 33.8, 33.6, 26.5, 26.4, 18.6, 18.5, 17.0, 16.4, -3.1, -4.0, -4.3, 5.6. 
IR (film): 3468, 2930, 1473, 1423, 1388, 1349, 1253, 1223, 1103, 1083, 1039, 928, 898, 880, 835, 797, 775, 722, 671, 649, 
611, 419 cm-1. 
[α]D20  = +22.11 (c 0.90, CHCl3). 
HRMS (ESI): calc. for C35H66NaO8Si2 [M+Na]+ 693.4194; found: 693.4200. 
 
 
 
 
Compound 196a. A mixture of 193a (200 mg, 0.30 mmol), TBSCl (230 mg, 1.5 mmol), imidazole (200 mg, 3 mmol) and 
DMF (0.3 mL) was stirred over 12 h at rt. Saturated aq. NaHCO3 (5 mL) was added and stirring was continued for 10 min. 
The mixture was diluted with water (30 mL) and the water phase was extracted with EtOAc (3x30 mL). The combined 
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organic phases were washed with brine (20 mL), dried over MgSO4 and solvents were removed in vacuo. The residue was 
subjected to column chromatography (EtOAc/hexanes) to obtain 196a in 95% yield (222 mg). 
 
1H NMR (400MHz, C6D6): δ = 6.20 (dd, J= 1.1, 9.8 Hz, 1H), 6.02 (ddd, J= 1.8, 1.8, 9.2 Hz, 1H), 5.55 (ddd, J= 3.1, 3.1, 9.2 
Hz, 1H), 4.76 (d, J= 6.5 Hz, 1H), 4.64 (d, J= 6.5 Hz, 1H), 4.26 (dd, J= 4.5, 4.5 Hz, 1H), 4.19-4.14 (m, 2H), 3.79 (dd, J= 2.7, 
11.0 Hz, 1H), 3.64-3.53 (m, 4H), 3.44 (dd, J= 6.8, 9.6 Hz, 1H), 3.31 (s, 3H), 3.23 (s, 3H), 3.14 (s, 3H), 3.16-3.00 (m, 2H), 
2.70 (d, J= 5.4 Hz, 1H), 2.47-2.38 (m, 1H), 2.37 (d, J= 2.4 Hz, 1H), 2.10 (bd, J= 18.8 Hz, 1H), 1.96 (d, J= 1.1 Hz, 3H), 1.32 
(d, J= 6.9 Hz, 3H), 1.06 (s, 9H), 1.00 (s, 9H), 0.96 (s, 9H), 0.23 (s, 3H), 0.22 (s, 3H), 0.12 (s, 3H), 0.06 (s, 3H), 0.01 (s, 3H), 
0.00 (s, 3H). 
13C NMR (100MHz, C6D6): δ = 139.4, 133.2, 128.5, 127.5 98.4, 85.6, 85.3, 83.4, 75.9, 74.3, 73.9, 71.0, 70.6, 58.7, 58.3, 
55.9, 49.8, 41.2, 38.0, 33.9, 33.6, 26.5, 26.4, 26.2, 18.6, 18.5, 18.4, 17.0, 16.3, -3.1, -3.9, -4.3, -4.6, -5.1, -5.3. 
IR (film): 2955, 2944, 2929, 2911, 2889, 2871, 1557, 1388, 1253, 1117, 1030, 874, 836, 776, 705, 676, 619 cm-1. 
[α]D20  = +44.30 (c 1.00, CHCl3). 
HRMS (ESI): calc. for C41H80NaO8Si3 [M+Na]+ 807.5059; found: 807.5067. 
 
 
 
Compound 198. To a suspension of CrO3 (1.02 g, 10.2 mmol, dried overnight over P2O5 ) in dichloromethane (7.5 mL) at -
20 °C was added at once 3,5-dimethylpyrazole (0.98 g, 10.2 mmol) and the mixture was stirred until all solids dissolved to 
give a dark cherry-red solution. To this solution of CrO3*3,5-dimethylpyrazole complex, a solution of  196a (0.200 g, 0.255 
mmol) in dichloromethane (2 mL) was added slowly and the mixture was stirred at -20 °C for 2h until TLC analysis showed 
full conversion of 196a. The reaction mixture wad diluted with hexanes (10 mL) and washed with portions of aq. NaOH 
(3M, 30 mL) until the water phase stayed colorless. The combined water phase was extracted with EtOAc (3x30 mL). The 
combined organic phases were washed with aq. HCl (1M, 3x30 mL), saturated aq. NaHCO3 (30 mL), brine (30 mL) and 
dried over MgSO4. Concentration in vacuo and purification by column chromatography gave 204 mg (67%) of 198 as a 
mixture of regioisomeric ketones (4.6 : 1 from NMR). 
NMR data are given for the major regioisomer. 
 
198: 1H NMR (400MHz, C6D6): 7.03 (d, J=9.4 Hz, 1H), 6.40 (d, J=9.7 Hz, 1H), 6.15 (dd, J=1.2, 9.4 Hz, 1H), 4.88 (d, J=6.6 
Hz, 1H), 4.72 (d, J=6.6 Hz, 1H), 4.55 (dd, J=4.5 Hz, 1H), 4.29-4.20 (m, 2H), 3.82 (bs, 1H), 3.79-3.58 (m, 5H), 3.53 (dd, 
J=6.2, 9.7 Hz, 1H), 3.40 (s, 3H), 3.28 (s, 3H), 3.25 (s, 3H), 3.2-3.02 (m, 2H), 2.63 (d, J=2.6 Hz, 1H), 1.93 (bs, 3H), 1.78 (s, 
3H), 1.40 (d, J=6.8 Hz, 3H), 1.16 (s, 3H), 1.11 (s, 3H), 1.06 (s, 3H), 0.33 (s, 3H), 0.32 (s, 3H), 0.19 (s, 3H), 0.15 (s, 3H), 
0.02 (s, 3H), -0.01 (s, 3H). 
13C NMR (100MHz, C6D6): 197.9, 159.9, 130.5, 130.4, 130.1, 98.4, 86.9, 83.3, 80.7, 78.4, 75.7, 74.4, 72.1, 70.5, 70.0, 58.7, 
58.4, 55.9, 55.5, 53.8, 41.5, 33.8, 26.33, 26.3, 26.2, 18.4, 16.7, 16.0, -3.3, -4.1, -4.3, -4.5, -5.2, -5.5. 
 HRMS (ESI): calc. for C41H78NaO9Si3 [M+Na]+ 821.4851; found: 821.4847. 
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Compound  199. A solution of CeCl3*7H2O (746 mg, 2.00 mmol) in MeOH (20 mL) was added to a mixture of ketones 
198+198’ (4.5 :1, 800 mg, 1.00 mmol). The mixture was cooled to 0 °C, and NaBH4 (230 mg, 6 mmol) was added. The 
reaction was stirred at 0 °C for 12 h. Saturated aq. NH4Cl (20 mL) was added, the mixture was warmed to rt, stirred for 30 
min. Aq. HCl (1M, 5Most of volatiles were remove in vacuo and the reaction was diluted with saturated aq. NH4Cl (50 mL). 
The water phase was extracted with EtOAc (5x50 mL), combined organic phases were washed with brine (50 mL) and dried 
over MgSO4. Volatiles were removed in vacuo, and the residue was repeatedly concentrated from MeOH (7x30 mL) in 
vacuo. The residue was subjected to column chromatography (EtOAc/Hex) to obtain 199 in 97% yield (638 mg) as a mixture 
of diastereomers (dr 10 : 1). 
NMR data are given for the major diastereomer. 
1H NMR (400MHz, CDCl3): δ = 5.90 (dd, J=1.3, 9.3 Hz, 1H), 5.73 (dd, J=1.2, 9.6 Hz, 1H), 5.67-5.62 (m, 1H), 4.73 (d, J=6.4 
Hz, 1H), 4.69-4.64 (m, 1H), 4.62 (d, J=6.4 Hz, 1H), 4.40 (d, J=5.1 Hz, 1H), 4.09 (dd, J=4.6, 4.6 Hz, 1H), 3.89-3.84 (m, 1H), 
3.56 (dd, J=2.6, 11.0 Hz, 1H), 3.47 (dd, J=4.2, 9.7 Hz, 1H), 3.40-3.29 (m, 4H), 3.38 (s, 3H), 3.30 (s, 3H), 3.24 (s, 3H), 2.79 
(d, J=5.7 Hz, 1H), 2.79-2.68 (m, 2H), 2.32 (d, J=2.4 Hz, 1H), 1.67 (s, 3H), 1.58 (d, J=7.2 Hz, 1H), 1.02 (d, J=6.9 Hz, 3H), 
0.90 (s, 9H), 0.897 (s, 3H), 0.88 (s, 3H), 0.07 (s, 3H), 0.06 (s, 6H), 0.055 (s, 3H), 0.05 (s, 3H), 0.01 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 141.6, 132.1, 129.7, 128.0, 98.3, 84.4, 83.2, 76.7, 75.3, 73.3, 72.9, 70.7, 70.5, 69.4, 58.9, 
58.4, 56.1, 51.9, 45.4, 41.2, 33.3, 26.3, 26.2, 26.1, 18.4, 18.3, 18.2, 16.6, 15.8, -3.11, -4.18, -4.24, 4.38, -5.24,-5.27. 
IR (film): 3470, 2932, 1471, 1422, 1387, 1349, 1253, 1223, 1103, 1083, 1039, 928, 898, 880, 835, 797, 775, 722, 671, 649, 
611, 419 cm-1. 
Optical rotation for the mixture of diastereomers (10:1): [α]D20  = +66.63 (c 2.05, CHCl3). 
HRMS (ESI): calc. for C41H80NaO9Si3 [M+Na]+ 823.5008; found: 823.5014. 
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Compound 203. A microwave vial (2-5 mL) was charged with a stirring bar and 4Å molecular sieves (powder, 1.20 g), 
sealed with a cap and a septa, and subjected to 5 cycles of evacuation - filling with Ar.142 A solution of 199 (100 mg, 0.125 
mmol, dr 10 : 1) in DMF (dry, degassed, 1.4 mL) followed by N,N-dimethylacetamide dimethyl acetal (1.2 mL, 8.2 mmol). 
The mixture was irradiated at 220 °C for 2 min. Additional N,N-dimethylacetamide dimethyl acetal (0.3 mL, 2.05 mmol) 
was added and the mixture was irradiated for additional 2 min. All volatiles were removed in vacuo, the solid residue was 
suspended in EtOAc (10 mL) and passed through a plug of Celite. The filter cake was washed repeatedly with EtOAc (5x10 
mL). The combined fractions were concentrated in vacuo and the residue was subjected to column chromatography 
(EtOAc/haxanes) to yield a mixture of regioisomer 203 (58 mg, 64%). 
1H NMR (400MHz, C6D6): δ = 6.28 (dd, J=0.8, 10.1 Hz, 1H), 6.12 (dd, J=2.4, 9.5 Hz, 1H), 6.00-5.95 (m, 1H), 6.12 (ddd, 
J=1.2, 3.0, 9.2 Hz, 1H), 4.76 (d, J=6.7 Hz, 1H), 4.62 (d, J=6.7 Hz, 1H), 4.34 (d, J=4.8 Hz, 1H), 4.30 (dd, J=4.0, 4.6 Hz, 1H), 
4.15-4.10 (m, 1H), 3.81 (dd, J=2.5, 10.9 Hz, 1H), 3.74-3.69 (m, 1H), 3.60-3.55 (m, 3H), 3.52 (dd, J=3.7, 9.7 Hz, 1H), 3.41 
(dd, J=6.6, 9.7 Hz, 1H), 3.31 (s, 3H), 3.24-3.16 (m, 1H), 3.22 (s, 3H), 3.09 (s, 3H), 3.08-3.01 (m, 1H), 2.85 (d, J=6.5 Hz, 
1H), 2.78-2.71 (m, 1H), 2.75 (s, 3H), 2.63 (s, 3H), 2.57-2.51 (m, 2H), 1.91 (d, J= 0.9 Hz, 3H), 1.34 (d, J=6.8 Hz, 3H), 1.05 
(s, 9H), 0.98 (s, 9H), 0.97 (s, 9H), 0.20 (s, 6H), 0.13 (s, 3H), 0.03 (s, 3H), 0.02 (s, 3H), 0.00 (s, 3H). 
13C NMR (100 MHz, C6D6): δ = 170.7, 131.4, 131.1, 130.1, 127.6, 97.3, 89.4, 89.3, 85.2, 83.0, 74.6, 73.4, 72.0, 69.9, 69.3, 
57.6, 57.4, 54.7, 49.6, 42.3, 39.9, 39.0, 35.6, 34.2, 33.1, 31.8, 25.5, 25.3, 25.1, 17.6, 17.5, 17.4, 15.90, 15.4, -4.1, -5.0, -5.4, -
5.5, -6.1, -6.3. 
IR (film): 2931, 1662, 1474, 1422, 1387, 1349, 1253, 1223, 1103, 1083, 1039, 928, 898, 880, 835, 797, 775, 722, 671, 649, 
611, 419 cm-1. 
HRMS (ESI): calc. for C45H87NNaO9Si3 [M+Na]+ 892.5586; found: 892.5581. 
 [α]D20  = +98.9 (c 0.37, CHCl3). 
 
 
 
Compound 204. To a flask charged with amide 203 (179 mg, 0.206 mmol) under stirring was added dropwise Super-
Hydride (1.0 M in THF, 3.2 mL, 3.2 mmol) at 0°C, and the reaction was stirred for 5 h at 0 °C, 30 min at 5°C and 30 min at 
10 °C.  Saturated aq. NH4Cl (5 mL) followed by MeOH (2mL) were added carefully and the mixture was stirred for 10 min 
at rt. Most of organic solvents were removed in vacuo and the water phase was extracted with EtOAc (5x30 mL). Combined 
organic phases were diluted with toluene (40 mL), washed with brine (40 mL) and concentrated in vacuo. The residue was 
concentrated repeatedly from methanol (5x5 mL) and then subjected to column chromatography (EtOAc/hexanes) to give 
159 mg (93%) of 204. 
 
                                                          
142 A needle (0.8x80mm) was injected into the vial’s septa, the vial with the needle was placed in a flask (250 mL, joint 29/42) and the 
system was subjected to evacuation - filling with Ar cycles. 
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 1H NMR (400MHz, CDCl3): δ = 5.92 (ddd, J=2.1, 6.7, 9.2 Hz, 1H), 5.74 (dd, J=1.0, 10.0 Hz, 1H), 5.57 (dd, J=2.4, 9.5 Hz, 
1H), 4.74 (d, J=6.7 Hz, 1H), 4.66 (d, J=6.7 Hz, 1H), 4.05 (d, J=5.0 Hz, 1H), 3.97 (dd, J=4.3, 4.3 Hz, 1H), 3.94-3.89 (m, 1H), 
3.71-3.61 (m, 1H), 3.62 (dd, J=2.5, 11.0 Hz, 1H), 3.53-3.44 (m, 2H), 3.43-3.27 (m, 4H), 3.41 (s, 3H), 3.33 (s, 3H), 3.23 (s, 
3H), 2.84-2.73 (m, 2H), 2.73-2.68 (m, 1H), 2.68-2.63 (m, 2H), 2.30 (d, J=2.3 Hz, 1H), 1.75-1.66 (m, 1H), 1.68 (s, 3H), 1.55-
1.45 (m, 1H), 1.04 (d, J=6.7 Hz, 1H), 0.903 (s, 9H), 0.900 (s, 9H), 0.89 (s, 9H), 0.09 (s, 3H), 0.08 (s, 3H), 0.07 (s, 3H), 0.04 
(s, 3H), 0.03 (s, 3H), 0.01 (s, 3H). 
13C NMR (100MHz, CDCl3): δ = 132.1, 130.1, 130.4, 129.0, 98.0, 90.1, 85.8, 83.0, 75.7, 73.6, 72.5, 70.5, 69.4, 60.8, 58.9, 
58.4, 56.0, 50.4, 43.1, 40.2, 39.3, 34.4, 32.4, 26.4, 26.1, 26.0, 18.5, 18.4, 18.2, 17.1, 16.5, -3.1, -4.2, -4.3, -4.5, -5.20, -5.22. 
IR (film): 3460, 1470, 1422, 1387, 1349, 1252, 1223, 1103, 1083, 1039, 921, 898, 880, 835, 797, 775, 722, 671, 649, 611, 
419 cm-1. 
[α]D20  = +93.8 (c 0.305, CHCl3). 
HRMS (ESI): calc. for C43H84NaO9Si3 [M+Na]+ 851.5321; found: 851.5320. 
 
 
 
Compound 205. A flask was charged with magnesium turning (400 mg, 16.6 mmol) and diethyl ether (10 mL), equipped 
with a reflux condenser and immersed in an ultrasound bath (20 °C). Dibromoethane (0.65 mL, 7.6 mmol) was added and the 
mixture was sonicated at 20 to 40 °C for 1h. The sonication was stopped and the mixture was allowed to stay at rt for 20 min. 
The separated bottom layer was transferred into a Schlenk flask (10 mL) via a syringe. Most of the solvent was blown away 
with Ar-stream and finally dried in vacuo for 2-3min to obtain a white powder. Into this flask Me2S (2 mL) and a solution of 
substrate 204 (152 mg, 0.183 mmol) in 1.5 mL were added. The flask was immersed in an oil bath (40 °C), heated to reflux 
and the stop-cock to Ar-line was closed. The closed flask was heated at 40 °C for 12 h. Saturated aq. NaHCO3 (5 mL) was 
added and the organic solvents were removed in vacuo. The water phase was extracted with EtOAc (4x15 mL). The 
combined organic phases were washed with brine, dried over MgSO4 and concentrated in vacuo. The residue was subjected 
to column chromatography (EtOAc/toluene) to obtain starting 204 (27 mg, 18%) and 205 (70 mg, 60% brsm). 
 
1H NMR (400MHz, CDCl3): δ = 5.94 (ddd, J=2.2, 6.7, 9.3 Hz, 1H), 5.57 (dd, J=2.3, 9.5 Hz, 1H), 5.53 (dd, J= 0.9, 10.0 Hz, 
1H), 4.08 (d, J=5.0 Hz, 1H), 4.00 (dd, J=4.3 Hz, 1H), 3.88 (ddd, J=1.2, 4.4, 7.0 Hz, 1H), 3.72-3.61 (m, 1H), 3.63 (dd, J=2.5, 
10.9 Hz, 1H), 3.54-3.45 (m, 1H), 3.43 (dd, J=4.4, 9.8 Hz, 1H), 3.37 (dd, J=7.1, 9.7 Hz, 1H), 3.35-3.30 (m, 2H), 3.32 (3H), 
3.22 (s, 3H), 3.20 (dd, J=0.9, 9.4 Hz, 1H), 2.82 (dd, J=5.3, 7.6 Hz, 1H), 2.84-2.74 (m, 1H), 2.74-2.68 (m, 1H), 2.69 (d, J=6.6 
Hz, 1H), 2.56 (d, J=9.4 Hz, 1H), 2.58-2.50 (m, 1H), 2.33 (d, J= 2.2 Hz, 1H), 1.79 (d, J= 0.90 Hz, 1H), 1.66-1.47 (m, 2H), 
1.09 (d, J=6.7 Hz, 1H), 0.91 (s, 9H), 0.90 (s, 9H), 0.88 (s, 9H), 0.11 (s, 3H), 0.10 (s, 3H), 0.07 (s, 3H), 0.04 (s, 3H), 0.03 (s, 
3H), 0.01 (s, 3H). 
13C NMR (100MHz, CDCl3): δ = 133.4, 130.3, 129.9, 129.2, 90.3, 86.1, 76.5, 75.4, 72.4, 72.2, 70.3, 69.2, 60.3, 58.9, 58.4, 
50.5, 43.1, 40.2, 39.3, 37.1, 32.4, 26.4, 26.1, 26.0, 18.5, 18.4, 18.2, 17.4, 17.0, -3.1, -3.7, -4.5, -4.6, -5.19, -5.22. 
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IR (film): 3470, 1474, 1422, 1387, 1349, 1252, 1223, 1103, 1083, 1039, 921, 898, 880, 835, 797, 775, 722, 671, 649, 611, 
419 cm-1. 
HRMS (ESI): calc. for C41H80NaO8Si3 [M+Na]+ 807.5059; found: 807.5063. 
[α]D20  = +105.4 (c 0.280, CHCl3). 
 
 
Compound 206. To substrate 205 (46 mg, 0.060 mmol) at rt was added a solution of TEMPO (3.0 mg, 0.019 mmol) and 
PhI(OAc)2 (45 mg, 0.140 mmol) in dichloromethane (0.45 mL) and the clear solution was stirred at rt for 2 h. Then a mixture 
EtOAc/hexanes (1:1, 3 mL) was added and the solution was passed through a short plug of silica gel (elution with 
EtOAc/hexanes 1:1) to remove PhI(OAc)2. The resulting solution was concentrated, the residue was dissolved in toluene (3 
mL) and passed through a short silica gel column (1.5 g SiO2, elution with toluene; 2% EtOAc/toluene) to separate from 
most of TEMPO. The fractions containing 206 were concentrated and subjected to column chromatography to 
(EtOAc/toluene) to obtain 206 (40 mg, 87%). 
(NOTE: test experiments showed that a commonly used quench procedure with saturated aq. Na2S2O3 or Na2S2O3/NaHCO3 
does not result in reduction of neither PhI(OAc)2 nor TEMPO after 5 min of stirring or shaking. Concentration of the crude 
mixture (PhI(OAc)2 ,TEMPO and product 206) followed by loading on silica gel column resulted in partial oxidation 206 to 
carboxylic acid 207. TEMPO on TLC appears as a yellowish spot, UV-visible at 254 nm if its concentration is high enough).  
206: 1H NMR (400MHz, CDCl3): δ = 9.75 (d, J=1.9 Hz, 1H), 5.96 (ddd, J=2.2, 6.8, 9.4 Hz, 1H), 5.62 (dd, J=0.8, 9.6 Hz, 
1H), 5.54 (dd, J=2.5, 9.4 Hz, 1H), 4.05 (d, J=5.0 Hz, 1H), 4.00 (dd, J=4.5, 4.5 Hz, 1H), 3.80 (ddd, J=1.4, 4.9, 6.5 Hz, 1H), 
3.63 (dd, J=2.5, 11.0 Hz, 1H), 3.41 (dd, J=4.9, 9.5 Hz, 1H), 3.36 (dd, J=6.6, 9.5 Hz, 1H), 3.33-3.25 (m, 3H), 3.32 (s, 3H), 
3.23 (s, 3H), 3.13-3.09 (m, 1H), 2.79-2.72 (m, 1H), 2.70 (d, J=6.3 Hz, 1H), 2.58-2.50 (m, 1H), 2.48-2.43 (m, 2H), 2.40 (dd, 
J=2.5, 8.4 Hz, 1H),  2.32 (d, J=2.2 Hz, 1H), 1.67 (d, J=0.8 Hz, 1H), 1.09 (d, J=6.9 Hz, 3H), 0.92 (s, 9H), 0.89 (s, 9H), 0.88 
(s, 9H), 0.082 (s, 3H), 0.079 (s, 3H), 0.044 (s, 3H), 0.036 (s, 3H), 0.03 (s, 3H), 0.02(s, 3H). 
13C NMR (100MHz, CDCl3): δ = 202.1, 132.8, 130.3, 129.9, 129.5, 89.5, 86.1, 75.6, 75.3, 72.2, 72.1, 70.2, 69.1, 58.9, 58.4, 
50.2, 43.4, 41.1, 40.1, 39.1, 36.6, 26.3, 26.0, 25.9, 18.3, 18.1, 16.9, 16.8, -3.3, 3.8, -4.6, -4.7, -5.3. 
IR (film): 3464, 1730, 1479, 1421, 1387, 1345, 1252, 1223, 1103, 1082, 1039, 921, 898, 885, 835, 797, 770, 722, 671, 649, 
611, 419 cm-1. 
HRMS (ESI): calc. for C41H78NaO8Si3 [M+Na]+ 805.4902; found: 805.4898. 
[α]D20  = +92.0 (c 0.275, CHCl3). 
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Compound 207. To a solution of aldehyde 206 (25 mg, 0.032 mmol) in tBuOH (0.6 mL) was added 2-methyl-2-betene (1.4 
mL) and the mixture was cooled to 17 °C. A solution of NaClO2 (80%, 40 mg, 0.356 mmol) and NaH2PO4*H2O (80mg, 
0.580 mmol) in water (0.4 mL) was added and the mixture was stirred at 17 °C for 40 min. Chloroform (20 mL) was added 
and the organic phase was washed with water (2x5 mL). Combine organic phases were extracted with chloroform (4x15 
mL). Combined organic phases were washed with brine (20 mL), passed through a plug of cotton and concentrated in vacuo. 
The residue was subjected to column chromatography (EtOAc/hexanes + 1% iPrOH) to obtain acid 207 (21.9 mg, 85%).  
1H NMR (400MHz, CDCl3): δ = 5.97 (ddd, J=2.0, 6.9, 9.4 Hz, 1H), 5.60 (dd, J=0.8, 9.6 Hz, 1H), 5.54 (dd, J=2.5, 9.4 Hz, 
1H), 4.11 (d, J=5.0 Hz, 1H), 4.04 (dd, J=4.5, 4.5 Hz, 1H), 3.82 (dd, J=1.1, 6.1 Hz, 1H), 3.46-3.36 (m, 2H), 3.34-3.27 (m, 
3H), 3.33 (s, 3H), 3.23 (s, 3H), 3.07 (m, 1H), 2.82-2.72 (m, 1H), 2.70 (d, J=6.6 Hz, 1H), 2.60-2.49 (m, 2H),  2.32 (d, J=2.2 
Hz, 1H), 2.21 (dd, J=6.8, 16.0 Hz, 1H), 1.72 (bs, 3H), 1.08 (d, J=6.7 Hz, 3H), 0.92 (s, 9H), 0.82 (s, 9H), 0.78 (s, 3H), 0.08 (s, 
3H), 0.044 (s, 3H), 0.036 (s, 3H), 0.025 (s, 3H), 0.017(s, 3H). 
13C NMR (100MHz, CDCl3): δ = 175.5, 133.0, 130.4, 130.2, 129.7, 89.8, 86.2, 75.3, 74.6, 72.4, 71.9, 70.3, 69.2, 59.0, 58.5, 
50.5, 42.4, 40.3, 39.0, 36.7, 34.2, 26.4, 26.1, 26.0, 18.42, 18.39, 18.2, 17.3, 16.9, -3.1, -3.7, -4.5, -4.7, -5.20, -5.23. 
IR (film): 3460, 1710, 1479, 1421, 1387, 1345, 1252, 1223, 1103, 1082, 1039, 921, 898, 885, 835, 797, 770, 722, 671, 649, 
611, 419 cm-1. 
HRMS (ESI): calc. for C41H78NaO9Si3 [M+Na]+ 821.4851; found: 821.4857. 
[α]D20  = +80.0 (c 0.48, CHCl3). 
 
 
Compound 208. To acid 207 (2.5 mg, 0.003 mmol) was added a solution of iPr2NEt (0.4M in toluene, 200 µL, 0.080 mmol) 
and a solution of 2,4,6-trichlorobenzoyl chloride (0.4M in toluene, 130 µL, 0.052 mmol), and the mixture was stirred at rt for 
4 h. The mixture was diluted with toluene (2.2. mL) and added via syringe pump to a solution of DMAP (17.0 mg,  0.14 
mmol) in toluene (2.9 mL) at 80 °C over 4 h. Saturated aq. NaHCO3 (10 mL) was added and the mixture was stirred for 15 
min until phases became clear. The mixture was extracted with Et2O (3x20 mL). The combined organic phases were washed 
with saturated aq. NaHCO3 (20 mL), aq. NaH2PO4 (2M, 30 mL),   saturated aq. NaHCO3 (20 mL), brine (20 mL) and dried 
over Mg2SO4. The solvents were removed in vacuo and the residue was subjected to column chromatography to obtain 
lactone 208 (0.6 mg, ca. 25%). 
The structure of the lactone was confirmed by 1H, DQF-COSY, NOESY, ROESY, HSQC and HMBC NMR experiments. 
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1H NMR (400MHz, C6D6): δ = 6.18 (dd, J=1.0, 9.3 Hz, 1H), 5.83 (ddd, J=2.2, 6.7, 9.3 Hz, 1H), 5.22 (dd, J=2.2, 9.4 Hz, 1H), 
5.18 (dd, J=6.0, 7.2 Hz, 1H), 4.33-4.29 (m, 1H), 4.24-4.18 (m, 2H), 3.89 (dd, J=2.1, 11.4 Hz, 1H), 3.62-3.49 (m, 2H), 3.41-
3.34 (m, 2H), 3.31 (dd, J=3.2, 9.8 Hz, 1H), 3.18 (s, 3H), 3.07 (s, 3H), 3.95-2.96 (m, 1H), 2.87-2.78 (m, 2H), 2.51 (d, J=1.6 
Hz, 1H), 2.02 (dd, J=2.1, 12.9 Hz, 1H), 1.99 (d, J=1.0 Hz, 3H), 1.12 (s, 9H), 1.03 (d, J=6.9 Hz, 3H), 0.97 (s, 9H), 0.96 (s, 
9H), 0.23 (s, 3H), 0.21 (s, 3H), 0.13  (s, 3H), 0.05 (s, 3H), 0.03 (2s, 6H). 
13C NMR shifts were obtained from HSQC and HMBC spectra (C6D6): δ = 173.9, 135.7, 131.6, 129.6, 89.0, 84.7, 79.6, 75.6, 
72.7, 71.8, 70.3, 69.6, 58.4, 57.9, 49.6, 49.92, 41.4, 40.1, 36.5, 32.7, 26.0, 25.86, 25.9, 17.0, 15.0, -3.90, -3.89, -5.10, -5.12, -
5.4. 
HRMS (ESI): calc. for C41H76NaO8Si3 [M+Na]+ 803.4746; found: 803.4742. 
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16. Appendices 
16.1. List of Abbreviations 
 
Ac acetyl 
AIBN 2,2’-azobisisobutyronitrile 
aq. aqueous 
Ar aryl, aromatic 
Bn benzyl 
Bu butyl 
cat. catalyst, catalytic amount 
DBU 1,8-diazabicyclo[5.4.0]undec-7-en 
DDQ 2,3-dichloro-5,6-dicyano-p-quinone 
DIBAL diisobutylaluminum hydride 
DMAP 4-dimethylaminopyridine 
DMF N,N-dimethylaminopyridine 
EE 1-ethoxyethyl 
eq. equvalent 
Et ethyl 
er enantiomeric ratio 
et al. latin: “et alii”, meaning “and others” 
EtOAc ethyl acetate 
Imid. imidazole 
INOC intramolecular nitrile oxide cyclization 
IR infra red 
J coupling constant 
KHMDS potassium hexamethyldisilazide 
LDA lithium diisopropylamide 
LHMDS lithium hexamethyldisilazide 
mCPBA meta-chloro peroxybenzoic acid 
Me methyl 
min minute 
MOM methoxymethyl 
mp melting point 
MS mass spectroscopy 
4Å MS or 3Å MS molecular sieves with pores 4 or 3 angstrom 
NBS N-bromosuccinamide 
NMR nuclear magnetic resonance spectroscopy 
P or PG unspecified protecting group 
ppm part per million 
R, R’, R’’, R1, R2, R3 unspecified substituents 
RCM ring closing metathesis 
TBAF tetrabutylammonium fluoride 
THF tetrahydrofurane 
TBS dimethyl-tert-butylslyl 
TBDPS ter-butyldiphenylsilyl 
TIPS triisopropylsilyl 
TLC thin layer chromatography 
TMS trimethylsilyl 
Ts tosyl 
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16.2. Selcted NMR Spectra  
 
Spectra are given for the following key synthetic intermediates: 
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